Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription Articles published in Vaccine Retrieve available abstracts of 1744 articles: HTML format Text format

Single Articles

August 2019
1. PERRETT SE, Cottrell S, Shankar AG
   Hepatitis B vaccine coverage in short and long stay prisons in Wales, UK 2013-2017 and the impact of the global vaccine shortage.
   Vaccine. 2019;37:4872-4876.
   PubMed     Text format     Abstract available
   
   
   
2. BELINGHERI M, De Vito G, Riva MA
   Italian midwives and influenza vaccination: problems in adherence and perception.
   Vaccine. 2019;37:4851.
   PubMed     Text format    
   
   
   
3. INNIS BL, Scorza FB, Blum JS, Jain VK, et al
   Convening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations.
   Vaccine. 2019;37:4830-4834.
   PubMed     Text format     Abstract available
   
   
   
4. INNIS BL, Berlanda Scorza F, Blum JS, Jain VK, et al
   Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
   Vaccine. 2019;37:4823-4829.
   PubMed     Text format     Abstract available
   
   
   
5. PATON DJ, Reeve R, Capozzo AV, Ludi A, et al
   Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory.
   Vaccine. 2019 Aug 9. pii: S0264-410X(19)31023.
   PubMed     Text format     Abstract available
   
   
   
6. PANDA S, Chatterjee P, Deb A, Kanungo S, et al
   Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine.
   Vaccine. 2019 Aug 9. pii: S0264-410X(19)30920.
   PubMed     Text format     Abstract available
   
   
   
7. THYSEN SM, Byberg S, Martins JSD, Kallestrup P, et al
   Household costs of seeking BCG vaccination in rural Guinea-Bissau.
   Vaccine. 2019 Aug 9. pii: S0264-410X(19)31041.
   PubMed     Text format     Abstract available
   
   
   
8. SOUSA M, Fenge C, Rupprecht J, Tappe A, et al
   Process intensification for Peste des Petites Ruminants Virus vaccine production.
   Vaccine. 2019 Aug 8. pii: S0264-410X(19)30887.
   PubMed     Text format     Abstract available
   
   
   
9. MACINTYRE CR, Shaw PJ, Mackie FE, Boros C, et al
   Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.
   Vaccine. 2019 Aug 8. pii: S0264-410X(19)30993.
   PubMed     Text format     Abstract available
   
   
   
10. WHITE JA, Lal M
    Technical product attributes in development of an oral enteric vaccine for infants.
    Vaccine. 2019;37:4800-4804.
    PubMed     Text format     Abstract available
    
    
    
11. GIERSING BK, Porter CK, Kotloff K, Neels P, et al
    How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?
    Vaccine. 2019;37:4778-4783.
    PubMed     Text format     Abstract available
    
    
    
12. WIERZBA TF
    Implications and measurement of herd protection (indirect effects) for enteric vaccine development.
    Vaccine. 2019;37:4775-4777.
    PubMed     Text format     Abstract available
    
    
    
13. BARRY E, Cassels F, Riddle M, Walker R, et al
    Vaccines Against Shigella and Enterotoxigenic Escherichia coli: A summary of the 2018 VASE Conference.
    Vaccine. 2019;37:4768-4774.
    PubMed     Text format     Abstract available
    
    
    
14. GUO A, Lindley MC, Hurley LP, Allen JA, et al
    Ten years of experience with herpes zoster vaccine in primary care- how attitudes and practices have changed and what it may mean for a new zoster vaccine.
    Vaccine. 2019 Aug 7. pii: S0264-410X(19)31027.
    PubMed     Text format     Abstract available
    
    
    
15. OZAWA S, Yemeke TT, Evans DR, Pallas SE, et al
    Defining hard-to-reach populations for vaccination.
    Vaccine. 2019 Aug 7. pii: S0264-410X(19)30858.
    PubMed     Text format     Abstract available
    
    
    
16. ASTHAGIRI ARUNKUMAR G, McMahon M, Pavot V, Aramouni M, et al
    Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31016.
    PubMed     Text format     Abstract available
    
    
    
17. SOUZA IEL, Fernandes FF, Schiavoni MCL, Silva CL, et al
    Therapeutic effect of DNA vaccine encoding the 60-kDa-heat shock protein from Paracoccidoides brasiliensis on experimental paracoccidioidomycosis in mice.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31011.
    PubMed     Text format     Abstract available
    
    
    
18. HUNG MC, Cho CY, Chen CJ, Lai CC, et al
    Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6years and 2-35months of age- an open-label, randomized phase IIb clinical trial.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31017.
    PubMed     Text format     Abstract available
    
    
    
19. GEBAUER M, Hurlimann HC, Behrens M, Wolff T, et al
    Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31015.
    PubMed     Text format     Abstract available
    
    
    
20. ZHAO F, Zhai Y, Zhu J, Xiao P, et al
    Enhancement of autophagy as a strategy for development of new DNA vaccine candidates against Japanese encephalitis.
    Vaccine. 2019 Aug 6. pii: S0264-410X(19)31014.
    PubMed     Text format     Abstract available
    
    
    
21. HASSAN WS, Giaretta PR, Rech R, Ollivault-Shiflett M, et al
    Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.
    Vaccine. 2019 Aug 3. pii: S0264-410X(19)31013.
    PubMed     Text format     Abstract available
    
    
    
22. CHEN TH, Liu WC, Chen IC, Liu CC, et al
    Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30247.
    PubMed     Text format     Abstract available
    
    
    
23. STARK FC, Akache B, Ponce A, Dudani R, et al
    Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30888.
    PubMed     Text format     Abstract available
    
    
    
24. ROMIJNDERS KAGJ, van Seventer SL, Scheltema M, van Osch L, et al
    A deliberate choice? Exploring factors related to informed decision-making about childhood vaccination among acceptors, refusers, and partial acceptors.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30968.
    PubMed     Text format     Abstract available
    
    
    
25. ROSS TM, DiNapoli J, Giel-Moloney M, Bloom CE, et al
    Corrigendum to "A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains" [Vaccine 37 (2019) 2369-2376].
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30966.
    PubMed     Text format    
    
    
    
26. GERRITZEN MJH, Salverda MLM, Martens DE, Wijffels RH, et al
    Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30161.
    PubMed     Text format     Abstract available
    
    
    
27. PASSWELL JH, Ashkenazi S, Banet-Levi Y, Ramon-Saraf R, et al
    Erratum to 'Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children' [Vaccine 28 (2010) 2231-2235].
    Vaccine. 2019 Aug 1. pii: S0264-410X(19)30986.
    PubMed     Text format    
    
    
    July 2019
28. RAY A, Sarkar K, Haldar P, Ghosh R, et al
    Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)31003.
    PubMed     Text format     Abstract available
    
    
    
29. WILDER-SMITH A, Smith PG, Luo R, Kelly-Cirino C, et al
    Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30894.
    PubMed     Text format     Abstract available
    
    
    
30. YAN R, He H, Zhou Y, Xie S, et al
    Study on factors associated with seroprotection after measles vaccination in children of 6-14years in Eastern China.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30996.
    PubMed     Text format     Abstract available
    
    
    
31. CHEN CH, Su LH, Li HC, Hsu MH, et al
    Evaluation of the impact of 13-valent pneumococcal conjugate vaccine immunization in children by surveillance of culture-confirmed pneumococcal disease: A prospective clinical microbiological study.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30994.
    PubMed     Text format     Abstract available
    
    
    
32. NOH JY, Jang YS, Lee SN, Choi MJ, et al
    Randomized, single-blind, active-controlled phase I clinical trial to evaluate the immunogenicity and safety of GC3114 (high-dose, quadrivalent influenza vaccine) in healthy adults.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30997.
    PubMed     Text format     Abstract available
    
    
    
33. CARTER ED, Tam Y, Walker N
    Impact of vaccination delay on deaths averted by pneumococcal conjugate vaccine: Modeled effects in 8 country scenarios.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)30971.
    PubMed     Text format     Abstract available
    
    
    
34. MUNOZ FM, Anderson EJ, Bernstein DI, Harrison CJ, et al
    Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)31006.
    PubMed     Text format     Abstract available
    
    
    
35. GUIDRY JPD, Carlyle KE, Perrin PB, LaRose JG, et al
    A path model of psychosocial constructs predicting future Zika vaccine uptake intent.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)30972.
    PubMed     Text format     Abstract available
    
    
    
36. O'NEILL LM, Keane OM, Ross PJ, Nally JE, et al
    Evaluation of protective and immune responses following vaccination with recombinant MIP and CPAF from Chlamydia abortus as novel vaccines for enzootic abortion of ewes.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)30879.
    PubMed     Text format     Abstract available
    
    
    
37. ANDREWS N, Stowe J, Thomas SL, Walker JL, et al
    The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self-controlled case-series study in England.
    Vaccine. 2019 Jul 30. pii: S0264-410X(19)30967.
    PubMed     Text format     Abstract available
    
    
    
38. DALAL J, Rana R, Harale K, Hanif S, et al
    Development and pre-clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Neisseria meningitidis serogroup C.
    Vaccine. 2019 Jul 29. pii: S0264-410X(19)30951.
    PubMed     Text format     Abstract available
    
    
    
39. KWAK HW, Park HJ, Ko HL, Park H, et al
    Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response.
    Vaccine. 2019 Jul 29. pii: S0264-410X(19)30991.
    PubMed     Text format     Abstract available
    
    
    
40. GILCA V, Sauvageau C, De Serres G
    A mixed vaccination schedule of HPV vaccine induces a 100% seropositivity to all 9 HPV types included in 9vHPV vaccine.
    Vaccine. 2019;37:4422-4423.
    PubMed     Text format    
    
    
    
41. ROSBERGER Z, Steben M, Norris T, McFadyen A, et al
    A mixed two-dose vaccination schedule: Not enough evidence to support a policy change in Quebec.
    Vaccine. 2019;37:4421.
    PubMed     Text format    
    
    
    
42. HADJ MB, Bouguerra H, Saffar F, Chelly S, et al
    Corrigendum to 'Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia' [Vaccine 36 (2018) 5858-5864].
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30321.
    PubMed     Text format    
    
    
    
43. SPITTELER MA, Romo A, Magi N, Seo MG, et al
    Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30949.
    PubMed     Text format     Abstract available
    
    
    
44. CHEN XX, Wagner AL, Zheng XB, Xie JY, et al
    Hepatitis E vaccine in China: Public health professional perspectives on vaccine promotion and strategies for control.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30988.
    PubMed     Text format     Abstract available
    
    
    
45. ESTEBAN-VASALLO MD, Dominguez-Berjon MF, Garcia-Riolobos C, Zoni AC, et al
    Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases.
    Vaccine. 2019 Jul 25. pii: S0264-410X(19)30970.
    PubMed     Text format     Abstract available
    
    
    
46. YAO PP, Miao ZP, Xu F, Lu HJ, et al
    An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates.
    Vaccine. 2019 Jul 24. pii: S0264-410X(19)30937.
    PubMed     Text format     Abstract available
    
    
    
47. CHANTLER T, Letley L, Paterson P, Yarwood J, et al
    Optimising informed consent in school-based adolescent vaccination programmes in England: A multiple methods analysis.
    Vaccine. 2019 Jul 24. pii: S0264-410X(19)30969.
    PubMed     Text format     Abstract available
    
    
    
48. BRANDILEONE MC, Zanella RC, Almeida SCG, Cassiolato AP, et al
    Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil.
    Vaccine. 2019 Jul 24. pii: S0264-410X(19)30934.
    PubMed     Text format     Abstract available
    
    
    
49. LUCERO MS, Richetta M, Chimeno Zoth S, Jaton J, et al
    Plant-based vaccine candidate against Infectious bursal disease: An alternative to inactivated vaccines for breeder hens.
    Vaccine. 2019 Jul 24. pii: S0264-410X(19)30990.
    PubMed     Text format     Abstract available
    
    
    
50. REED L, Tarini BA, Andreae MC
    Vaccine administration error rates at a large academic medical center and its affiliated clinics - Familiarity matters.
    Vaccine. 2019 Jul 23. pii: S0264-410X(19)30918.
    PubMed     Text format     Abstract available
    
    
    
51. HAN B, Wang S, Wan Y, Liu J, et al
    Has the public lost confidence in vaccines because of a vaccine scandal in China.
    Vaccine. 2019 Jul 22. pii: S0264-410X(19)30950.
    PubMed     Text format     Abstract available
    
    
    
52. CARRYN S, Feyssaguet M, Povey M, Di Paolo E, et al
    Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Vaccine. 2019 Jul 22. pii: S0264-410X(19)30940.
    PubMed     Text format     Abstract available
    
    
    
53. NEVES FPG, Cardoso NT, Cardoso CAA, Teixeira LM, et al
    Direct effect of the 13-valent pneumococcal conjugate vaccine use on pneumococcal colonization among children in Brazil.
    Vaccine. 2019 Jul 20. pii: S0264-410X(19)30954.
    PubMed     Text format     Abstract available
    
    
    
54. GIDUDU JF, Shaum A, Habersaat K, Wilhelm E, et al
    An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
    Vaccine. 2019 Jul 20. pii: S0264-410X(19)30932.
    PubMed     Text format     Abstract available
    
    
    
55. FABIANI M, Volpe E, Faraone M, Bella A, et al
    Influenza vaccine uptake in the elderly population: Individual and general practitioner's determinants in Central Italy, Lazio region, 2016-2017 season.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30952.
    PubMed     Text format     Abstract available
    
    
    
56. SIMOES EAF, Nunes MC, Carosone-Link P, Madimabe R, et al
    Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30915.
    PubMed     Text format     Abstract available
    
    
    
57. EICKHOFF CS, Blazevic A, Killoran EA, Morris MS, et al
    Induction of mycobacterial protective immunity by sublingual BCG vaccination.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30925.
    PubMed     Text format     Abstract available
    
    
    
58. SUSARLA SK, Gupta M, Mantan M, Dhongade R, et al
    Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30844.
    PubMed     Text format     Abstract available
    
    
    
59. VAN SCHALKWYK C, Moodley J, Welte A, Johnson LF, et al
    Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30774.
    PubMed     Text format     Abstract available
    
    
    
60. KENNEDY EM, Dowall SD, Salguero FJ, Yeates P, et al
    A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30914.
    PubMed     Text format     Abstract available
    
    
    
61. GUPTA S, Chaudhary S, Bubber P, Ray P, et al
    Epidemiology and genetic diversity of group A rotavirus in acute diarrhea patients in pre-vaccination era in Himachal Pradesh, India.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30928.
    PubMed     Text format     Abstract available
    
    
    
62. GESSNER BD, Theilacker C, Jodar L
    Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial.
    Vaccine. 2019 Jul 18. pii: S0264-410X(19)30931.
    PubMed     Text format     Abstract available
    
    
    
63. SAFADI MAP, Martinon-Torres F, Weckx LY, Moreira ED Junior, et al
    Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, cont
    Vaccine. 2019 Jul 18. pii: S0264-410X(19)30912.
    PubMed     Text format     Abstract available
    
    
    
64. MADEDDU G, Vroling H, Oordt-Speets A, Babudieri S, et al
    Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries.
    Vaccine. 2019 Jul 18. pii: S0264-410X(19)30892.
    PubMed     Text format     Abstract available
    
    
    
65. DAUGHERTY MA, Hinman AR, Cochi SL, Garon JR, et al
    The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30933.
    PubMed     Text format     Abstract available
    
    
    
66. LEE H, Park SY, Clark A, Debellut F, et al
    Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30921.
    PubMed     Text format     Abstract available
    
    
    
67. WAMBURA G, Mwatondo A, Muturi M, Nasimiyu C, et al
    Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya.
    Vaccine. 2019 Jul 17. pii: S0264-410X(19)30659.
    PubMed     Text format     Abstract available
    
    
    
68. LEHRER AT, Wong TS, Lieberman MM, Johns L, et al
    Recombinant subunit vaccines protect guinea pigs from lethal Ebola virus challenge.
    Vaccine. 2019 Jul 16. pii: S0264-410X(19)30797.
    PubMed     Text format     Abstract available
    
    
    
69. ZHAO B, Marciniuk K, Gibbs E, Yousefi M, et al
    Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1.
    Vaccine. 2019 Jul 16. pii: S0264-410X(19)30935.
    PubMed     Text format     Abstract available
    
    
    
70. VOLCKMAR J, Knop L, Stegemann-Koniszewski S, Schulze K, et al
    The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30910.
    PubMed     Text format     Abstract available
    
    
    
71. DE GROOT C, Musken M, Bleckmann M, Ebensen T, et al
    Novel colloidal associations of soyasaponins and lipid components (DPPC, cholesterol) as potential adjuvants for vaccines.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30911.
    PubMed     Text format     Abstract available
    
    
    
72. SARKISSIAN CA, Alteri CJ, Mobley HLT
    UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30922.
    PubMed     Text format     Abstract available
    
    
    
73. GOODING E, Spiliotopoulou E, Yadav P
    Impact of vaccine stockouts on immunization coverage in Nigeria.
    Vaccine. 2019 Jul 15. pii: S0264-410X(19)30765.
    PubMed     Text format     Abstract available
    
    
    
74. GOCKO X, Poulteau S, Beyens MN, Bertholon P, et al
    Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016.
    Vaccine. 2019 Jul 13. pii: S0264-410X(19)30916.
    PubMed     Text format     Abstract available
    
    
    
75. MAC KEON S, Bentivegna S, Levy EM, Marks MS, et al
    Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model.
    Vaccine. 2019 Jul 13. pii: S0264-410X(19)30909.
    PubMed     Text format     Abstract available
    
    
    
76. REID MC, Peebles K, Stansfield SE, Goodreau SM, et al
    Models to predict the public health impact of vaccine resistance: A systematic review.
    Vaccine. 2019 Jul 12. pii: S0264-410X(19)30891.
    PubMed     Text format     Abstract available
    
    
    
77. DE SERRES G, Billard MN, Gariepy MC, Roy MC, et al
    Nephrotic syndrome following four-component meningococcal B vaccination: Epidemiologic investigation of a surveillance signal.
    Vaccine. 2019 Jul 12. pii: S0264-410X(19)30901.
    PubMed     Text format     Abstract available
    
    
    
78. SEALE AC, Baker CJ, Berkley JA, Madhi SA, et al
    Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.
    Vaccine. 2019 Jul 11. pii: S0264-410X(19)30890.
    PubMed     Text format     Abstract available
    
    
    
79. BRIDGES CB, Watson TL, Nelson NP, Chavez-Torres M, et al
    Challenges with hepatitis B vaccination of high risk adults - A pilot program.
    Vaccine. 2019 Jul 11. pii: S0264-410X(19)30746.
    PubMed     Text format     Abstract available
    
    
    
80. KLEIN NP, Bartlett J, Fireman B, Marks MA, et al
    Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30882.
    PubMed     Text format     Abstract available
    
    
    
81. DECKER MD, Greenberg DP, Johnson DR, Pool V, et al
    Randomized study of immune responses to two Tdap vaccines among adolescents primed with DTaP and comparison with results among adolescents primed with DTwP.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30893.
    PubMed     Text format     Abstract available
    
    
    
82. SHELDENKAR A, Lim F, Yung CF, Lwin MO, et al
    Acceptance and uptake of influenza vaccines in Asia: A systematic review.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30889.
    PubMed     Text format     Abstract available
    
    
    
83. ISLAM MT, Chowdhury F, Qadri F, Sur D, et al
    Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30870.
    PubMed     Text format     Abstract available
    
    
    
84. SI S, Zomer E, Fletcher S, Lee J, et al
    Cost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents.
    Vaccine. 2019 Jul 10. pii: S0264-410X(19)30886.
    PubMed     Text format     Abstract available
    
    
    
85. GUNARATNE K, Coomes EA, Haghbayan H
    Temporal trends in anti-vaccine discourse on Twitter.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30876.
    PubMed     Text format     Abstract available
    
    
    
86. GROVES PJ, Williamson SL, Sharpe SM, Gerber PF, et al
    Uptake and spread of infectious laryngotracheitis vaccine virus within meat chicken flocks following drinking water vaccination.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30877.
    PubMed     Text format     Abstract available
    
    
    
87. BOGLER L, Jantos N, Barnighausen T, Vollmer S, et al
    Estimating the effect of measles vaccination on child growth using 191 DHS from 65 low- and middle-income countries.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30816.
    PubMed     Text format     Abstract available
    
    
    
88. MACINTYRE CR, Ridda I, Trent MJ, McIntyre P, et al
    Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30883.
    PubMed     Text format     Abstract available
    
    
    
89. SIRDAR MM, Fosgate GT, Blignaut B, Gummow B, et al
    A novel method for performing antigenic vaccine matching for foot-and-mouth disease in absence of the homologous virus.
    Vaccine. 2019 Jul 8. pii: S0264-410X(19)30880.
    PubMed     Text format     Abstract available
    
    
    
90. ABBOTT S, Christensen H, Lalor MK, Zenner D, et al
    Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system.
    Vaccine. 2019 Jul 8. pii: S0264-410X(19)30818.
    PubMed     Text format     Abstract available
    
    
    
91. BRESEE JS, Lafond KE, McCarron M, Azziz-Baumgartner E, et al
    The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.
    Vaccine. 2019 Jul 6. pii: S0264-410X(19)30811.
    PubMed     Text format     Abstract available
    
    
    
92. SHEN CF, Guilbault C, Li X, Elahi SM, et al
    Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
    Vaccine. 2019 Jul 6. pii: S0264-410X(19)30881.
    PubMed     Text format     Abstract available
    
    
    
93. ORK V, Woodring J, Shafiqul Hossain M, Wasley A, et al
    Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
    Vaccine. 2019 Jul 5. pii: S0264-410X(19)30850.
    PubMed     Text format     Abstract available
    
    
    
94. MALTEZOU HC, Ledda C, Rapisarda V
    Mandatory vaccinations for children in Italy: The need for a stable frame.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30768.
    PubMed     Text format    
    
    
    
95. MOSER MJ, Hatta Y, Gabaglia C, Sanchez A, et al
    Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30805.
    PubMed     Text format     Abstract available
    
    
    
96. DILOKTHORNSAKUL P, Kengkla K, Saokaew S, Permsuwan U, et al
    An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30776.
    PubMed     Text format     Abstract available
    
    
    
97. HOES J, Knol MJ, Mollema L, Buisman A, et al
    Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands.
    Vaccine. 2019 Jul 4. pii: S0264-410X(19)30817.
    PubMed     Text format     Abstract available
    
    
    
98. PARKER L, Ritter L, Wu W, Maeso R, et al
    Haemagglutinin stability was not the primary cause of the reduced effectiveness of live attenuated influenza vaccine against A/H1N1pdm09 viruses in the 2013-2014 and 2015-2016 seasons.
    Vaccine. 2019 Jul 3. pii: S0264-410X(19)30777.
    PubMed     Text format     Abstract available
    
    
    
99. WILLIAMS M, Ewing D, Blevins M, Sun P, et al
    Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery.
    Vaccine. 2019 Jul 3. pii: S0264-410X(19)30871.
    PubMed     Text format     Abstract available
    
    
    
100. KLEIN NP, Block SL, Essink B, Barbi S, et al
     Antibody persistence and booster response following MenACWY-CRM vaccination in children as assessed by two different assay methods.
     Vaccine. 2019 Jul 3. pii: S0264-410X(19)30853.
     PubMed     Text format     Abstract available
     
     
     
101. BRIGGS L, Fronek P, Quinn V, Wilde T, et al
     Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia.
     Vaccine. 2019 Jul 2. pii: S0264-410X(19)30856.
     PubMed     Text format     Abstract available
     
     
     
102. TANIGUCHI M, Ueda Y, Yagi A, Ikeda S, et al
     Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
     Vaccine. 2019 Jul 1. pii: S0264-410X(19)30839.
     PubMed     Text format     Abstract available
     
     
     
103. ANDREWS N, Kent A, Amin-Chowdhury Z, Sheppard C, et al
     Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
     Vaccine. 2019 Jul 1. pii: S0264-410X(19)30848.
     PubMed     Text format     Abstract available
     
     
     June 2019
104. OZGEN MH, Blume S
     The continuing search for an addiction vaccine.
     Vaccine. 2019 Jun 29. pii: S0264-410X(19)30851.
     PubMed     Text format     Abstract available
     
     
     
105. ADRIEN N, Hyde TB, Gacic-Dobo M, Hombach J, et al
     Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.
     Vaccine. 2019 Jun 29. pii: S0264-410X(19)30838.
     PubMed     Text format     Abstract available
     
     
     
106. DABANCH J, Gonzalez C, Cerda J, Acevedo J, et al
     Chile's National Advisory Committee on Immunization (CAVEI): Evidence-based recommendations for public policy decision-making on vaccines and immunization.
     Vaccine. 2019 Jun 29. pii: S0264-410X(19)30846.
     PubMed     Text format     Abstract available
     
     
     
107. D'OFFAY JM, Fulton RW, Fishbein M, Eberle R, et al
     Isolation of a naturally occurring vaccine/wild-type recombinant bovine herpesvirus type 1 (BoHV-1) from an aborted bovine fetus.
     Vaccine. 2019 Jun 29. pii: S0264-410X(19)30821.
     PubMed     Text format     Abstract available
     
     
     
108. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
     Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
     Vaccine. 2019 Jun 28. pii: S0264-410X(19)30843.
     PubMed     Text format     Abstract available
     
     
     
109. PEYRAUD N, Zehrung D, Jarrahian C, Frivold C, et al
     Potential use of microarray patches for vaccine delivery in low- and middle- income countries.
     Vaccine. 2019 Jun 28. pii: S0264-410X(19)30357.
     PubMed     Text format     Abstract available
     
     
     
110. DURO TORRIJOS JL, Tuells J
     The beginnings of smallpox vaccination in Spain seen through the correspondence of Ignacio Maria Ruiz de Luzuriaga (1801-1802).
     Vaccine. 2019 Jun 28. pii: S0264-410X(19)30735.
     PubMed     Text format     Abstract available
     
     
     
111. YU XY, Chen ZP, Wang SY, Pan HR, et al
     Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65years.
     Vaccine. 2019 Jun 28. pii: S0264-410X(19)30444.
     PubMed     Text format     Abstract available
     
     
     
112. BRYDEN GM, Browne M, Rockloff M, Unsworth C, et al
     The privilege paradox: Geographic areas with highest socio-economic advantage have the lowest rates of vaccination.
     Vaccine. 2019 Jun 28. pii: S0264-410X(19)30822.
     PubMed     Text format     Abstract available
     
     
     
113. VOM STEEG LG, Flores-Garcia Y, Zavala F, Klein SL, et al
     Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.
     Vaccine. 2019 Jun 28. pii: S0264-410X(19)30852.
     PubMed     Text format     Abstract available
     
     
     
114. ALMUDEVAR A, Kaur R, Pichichero M
     Statistical projection of post-vaccination antibody kinetics between dosing schedules.
     Vaccine. 2019 Jun 28. pii: S0264-410X(19)30778.
     PubMed     Text format     Abstract available
     
     
     
115. SAULSBERRY L, Fowler EF, Nagler RH, Gollust SE, et al
     Perceptions of politicization and HPV vaccine policy support.
     Vaccine. 2019 Jun 28. pii: S0264-410X(19)30699.
     PubMed     Text format     Abstract available
     
     
     
116. STUDHOLME L, Sutherland J, Desai T, Hockley J, et al
     Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study.
     Vaccine. 2019;37:3761-3769.
     PubMed     Text format     Abstract available
     
     
     
117. VIPOND C, Sutherland J, Nordgren K, Kemp G, et al
     Development and validation of a monocyte activation test for the control/safety testing of an OMV-based meningococcal B vaccine.
     Vaccine. 2019;37:3747-3753.
     PubMed     Text format     Abstract available
     
     
     
118. BRUUN T, Watle SSV, Tveteraas IH, Flem E, et al
     Intussusception among Norwegian children: What to expect after introduction of rotavirus vaccination?
     Vaccine. 2019 Jun 26. pii: S0264-410X(19)30820.
     PubMed     Text format     Abstract available
     
     
     
119. HAUSER MI, Muscatello DJ, Soh ACY, Dwyer DE, et al
     An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.
     Vaccine. 2019 Jun 25. pii: S0264-410X(19)30801.
     PubMed     Text format     Abstract available
     
     
     
120. CONSTABLE C, Chapman CR
     Bolstering trust in the human papillomavirus vaccine through improved communication in the vaccine information statement.
     Vaccine. 2019 Jun 25. pii: S0264-410X(19)30766.
     PubMed     Text format    
     
     
     
121. TSHILWANE SI, Thema N, Steyn HC, van Kleef M, et al
     A multi-epitope DNA vaccine co-administered with monophosphoryl lipid A adjuvant provides protection against tick transmitted Ehrlichia ruminantium in sheep.
     Vaccine. 2019 Jun 25. pii: S0264-410X(19)30788.
     PubMed     Text format     Abstract available
     
     
     
122. BELLAN SE, Eggo RM, Gsell PS, Kucharski AJ, et al
     An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool.
     Vaccine. 2019 Jun 24. pii: S0264-410X(19)30780.
     PubMed     Text format     Abstract available
     
     
     
123. RUSS SM, Brackney M, Meek J, Niccolai LM, et al
     Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions.
     Vaccine. 2019 Jun 24. pii: S0264-410X(19)30836.
     PubMed     Text format     Abstract available
     
     
     
124. HEWITT JS, Karuppannan AK, Tan S, Gauger P, et al
     A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
     Vaccine. 2019 Jun 24. pii: S0264-410X(19)30806.
     PubMed     Text format     Abstract available
     
     
     
125. SOBEY KG, Jamieson SE, Walpole AA, Rosatte RC, et al
     ONRAB(R) oral rabies vaccine is shed from, but does not persist in, captive mammals.
     Vaccine. 2019 Jun 24. pii: S0264-410X(19)30808.
     PubMed     Text format     Abstract available
     
     
     
126. KNEZEVIC I
     1st WHO International Standard antiserum to RSV: Availability and benefits for RSV vaccine development (Commentary on the collaborative study report published in the vaccine journal (Vaccine 2018 36: 7641-7649)).
     Vaccine. 2019 Jun 24. pii: S0264-410X(19)30783.
     PubMed     Text format    
     
     
     
127. RENSON P, Fablet C, Andraud M, Normand V, et al
     Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
     Vaccine. 2019 Jun 24. pii: S0264-410X(19)30807.
     PubMed     Text format     Abstract available
     
     
     
128. DECEUNINCK G, Lefebvre B, Tsang R, Betala-Belinga JF, et al
     Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch.
     Vaccine. 2019 Jun 22. pii: S0264-410X(19)30782.
     PubMed     Text format     Abstract available
     
     
     
129. LI AJ, Peiris TSR, Sanderson C, Lochlainn LN, et al
     Opportunities to improve vaccination coverage in a country with a fledgling health system: Findings from an assessment of missed opportunities for vaccination among health center attendees-Timor Leste, 2016.
     Vaccine. 2019 Jun 22. pii: S0264-410X(19)30803.
     PubMed     Text format     Abstract available
     
     
     
130. SINGH G, Zholobko O, Pillatzki A, Webb B, et al
     An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs.
     Vaccine. 2019 Jun 21. pii: S0264-410X(19)30792.
     PubMed     Text format     Abstract available
     
     
     
131. RAMANATHAN R, Stibitz S, Pratt D, Roberts J, et al
     Use of controlled human infection models (CHIMs) to support vaccine development: US regulatory considerations.
     Vaccine. 2019 Jun 21. pii: S0264-410X(19)30770.
     PubMed     Text format     Abstract available
     
     
     
132. ZAMAN K, Kingma R, Yunus M, van Straaten I, et al
     Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study.
     Vaccine. 2019 Jun 21. pii: S0264-410X(19)30810.
     PubMed     Text format     Abstract available
     
     
     
133. DOWELL AC, Menning L, MacDonald N, Turner N, et al
     An evolution in thinking to support the post 2020 global vaccine strategy: The application of complexity and implementation science.
     Vaccine. 2019 Jun 21. pii: S0264-410X(19)30790.
     PubMed     Text format    
     
     
     
134. BLOM K, Yin L, Arnheim-Dahlstrom L
     Effectiveness of the herpes zoster vaccine Zostavax(R) in Stockholm County, Sweden.
     Vaccine. 2019 Jun 20. pii: S0264-410X(19)30769.
     PubMed     Text format     Abstract available
     
     
     
135. MANI S, Toapanta FR, McArthur MA, Qadri F, et al
     Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development.
     Vaccine. 2019 Jun 20. pii: S0264-410X(19)30372.
     PubMed     Text format     Abstract available
     
     
     
136. TAMBYAH PA, Oon J, Asli R, Kristanto W, et al
     An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.
     Vaccine. 2019 Jun 20. pii: S0264-410X(19)30784.
     PubMed     Text format     Abstract available
     
     
     
137. SONG S, Li P, Zhang R, Chen J, et al
     Oral vaccine of recombinant Lactococcus lactis expressing the VP1 protein of duck hepatitis A virus type 3 induces mucosal and systemic immune responses.
     Vaccine. 2019 Jun 18. pii: S0264-410X(19)30787.
     PubMed     Text format     Abstract available
     
     
     
138. NANDI A, Shet A, Behrman JR, Black MM, et al
     Anthropometric, cognitive, and schooling benefits of measles vaccination: Longitudinal cohort analysis in Ethiopia, India, and Vietnam.
     Vaccine. 2019 Jun 18. pii: S0264-410X(19)30786.
     PubMed     Text format     Abstract available
     
     
     
139. MANARA C, Brazzoli M, Piccioli D, Taccone M, et al
     Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines.
     Vaccine. 2019 Jun 18. pii: S0264-410X(19)30479.
     PubMed     Text format     Abstract available
     
     
     
140. KWONG JC, Buchan SA, Chung H, Campitelli MA, et al
     Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort.
     Vaccine. 2019 Jun 17. pii: S0264-410X(19)30772.
     PubMed     Text format     Abstract available
     
     
     
141. MANSOUR Z, Brandt L, Said R, Fahmy K, et al
     Home-based records' quality and validity of caregivers' recall of children's vaccination in Lebanon.
     Vaccine. 2019 Jun 17. pii: S0264-410X(19)30656.
     PubMed     Text format     Abstract available
     
     
     
142. MUNGWIRA RG, Maure CG, Zuber PLF
     Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries.
     Vaccine. 2019 Jun 15. pii: S0264-410X(19)30779.
     PubMed     Text format     Abstract available
     
     
     
143. MURTI M, Otterstatter M, Orth A, Balshaw R, et al
     Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada.
     Vaccine. 2019 Jun 13. pii: S0264-410X(19)30767.
     PubMed     Text format     Abstract available
     
     
     
144. GUO Z, Bai L, Gong S
     Some comments on the scandal of rabies vaccine in China.
     Vaccine. 2019 Jun 13. pii: S0264-410X(19)30732.
     PubMed     Text format    
     
     
     
145. MURTI M, Otterstatter M, Orth A, Balshaw R, et al
     Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy.
     Vaccine. 2019 Jun 13. pii: S0264-410X(19)30775.
     PubMed     Text format     Abstract available
     
     
     
146. GENG F, Guo J, Guo QQ, Xie Y, et al
     A DNA vaccine expressing an optimized secreted FAPalpha induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer.
     Vaccine. 2019 Jun 12. pii: S0264-410X(19)30773.
     PubMed     Text format     Abstract available
     
     
     
147. HUIJBERS EJM, van Beijnum JR, Le CT, Langman S, et al
     Corrigendum to "An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature" [Vaccine 36(21) 3054-3060].
     Vaccine. 2019 Jun 12. pii: S0264-410X(19)30771.
     PubMed     Text format    
     
     
     
148. WILKINSON TA, Dixon BE, Xiao S, Tu W, et al
     Physician clinical decision support system prompts and administration of subsequent doses of HPV vaccine: A randomized clinical trial.
     Vaccine. 2019 Jun 11. pii: S0264-410X(19)30595.
     PubMed     Text format     Abstract available
     
     
     
149. DEMARCUS L, Shoubaki L, Federinko S
     Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season.
     Vaccine. 2019 Jun 11. pii: S0264-410X(19)30763.
     PubMed     Text format     Abstract available
     
     
     
150. MULAMA DH, Mutsvunguma LZ, Totonchy J, Ye P, et al
     A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits.
     Vaccine. 2019 Jun 11. pii: S0264-410X(19)30559.
     PubMed     Text format     Abstract available
     
     
     
151. XIA M, Huang P, Jiang X, Tan M, et al
     Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice.
     Vaccine. 2019 Jun 11. pii: S0264-410X(19)30712.
     PubMed     Text format     Abstract available
     
     
     
152. NORDIN JD, Vazquez-Benitez G, Olsen A, Kuckler LC, et al
     Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma.
     Vaccine. 2019 Jun 10. pii: S0264-410X(19)30718.
     PubMed     Text format     Abstract available
     
     
     
153. NARAYANAN N, Elsaid MI, NeMoyer RE, Trivedi N, et al
     Disparities in hepatitis A virus (HAV) vaccination coverage among adult travelers to intermediate or high-risk countries: The role of birthplace and race/ethnicity.
     Vaccine. 2019 Jun 10. pii: S0264-410X(19)30708.
     PubMed     Text format     Abstract available
     
     
     
154. TEIXEISRA AF, Fernandes LGV, Cavenague MF, Takahashi MB, et al
     Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines.
     Vaccine. 2019 Jun 8. pii: S0264-410X(19)30734.
     PubMed     Text format     Abstract available
     
     
     
155. SHINJOH M, Sugaya N, Furuichi M, Araki E, et al
     Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18.
     Vaccine. 2019 Jun 8. pii: S0264-410X(19)30747.
     PubMed     Text format     Abstract available
     
     
     
156. MURALIDHARAN A, Russell MS, Larocque L, Gravel C, et al
     Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice.
     Vaccine. 2019 Jun 8. pii: S0264-410X(19)30753.
     PubMed     Text format     Abstract available
     
     
     
157. LIAO Q, Lam WWT, Wong CKH, Lam C, et al
     The relative effects of determinants on Chinese adults' decision for influenza vaccination choice: What is the effect of priming?
     Vaccine. 2019 Jun 8. pii: S0264-410X(19)30709.
     PubMed     Text format     Abstract available
     
     
     
158. LOH FK, Nathan S, Chow SC, Fang CM, et al
     Vaccination challenges and strategies against long-lived Toxoplasma gondii.
     Vaccine. 2019 Jun 8. pii: S0264-410X(19)30730.
     PubMed     Text format     Abstract available
     
     
     
159. MULLER C, Ulrich R, Schinkothe J, Muller M, et al
     Characterization of protective humoral and cellular immune responses against RHDV2 induced by a new vaccine based on recombinant baculovirus.
     Vaccine. 2019 Jun 7. pii: S0264-410X(19)30537.
     PubMed     Text format     Abstract available
     
     
     
160. YANG H, Luo G, Zeng Y, Li Y, et al
     The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines.
     Vaccine. 2019 Jun 7. pii: S0264-410X(19)30733.
     PubMed     Text format     Abstract available
     
     
     
161. BORG K, Sutton K, Beasley M, Tull F, et al
     Reply to letter to the editor in response to the article "Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial".
     Vaccine. 2019;37:3382.
     PubMed     Text format    
     
     
     
162. ELLA R, Babji S, Ciarlet M, Blackwelder WC, et al
     A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC(R) in comparison with a licensed rotavirus vaccine in healthy infants.
     Vaccine. 2019 Jun 6. pii: S0264-410X(19)30706.
     PubMed     Text format     Abstract available
     
     
     
163. HOU H, Liu X, Peng Q
     The advances in brucellosis vaccines.
     Vaccine. 2019 Jun 5. pii: S0264-410X(19)30731.
     PubMed     Text format     Abstract available
     
     
     
164. GERMAN EL, Solorzano C, Sunny S, Dunne F, et al
     Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density.
     Vaccine. 2019 Jun 5. pii: S0264-410X(19)30717.
     PubMed     Text format     Abstract available
     
     
     
165. HWANG CS, Smith LC, Wenthur CJ, Ellis B, et al
     Heroin vaccine: Using titer, affinity, and antinociception as metrics when examining sex and strain differences.
     Vaccine. 2019 Jun 5. pii: S0264-410X(19)30698.
     PubMed     Text format     Abstract available
     
     
     
166. ANDRASIK M, Grove D, Broder G, Scott H, et al
     A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.
     Vaccine. 2019 Jun 5. pii: S0264-410X(19)30630.
     PubMed     Text format     Abstract available
     
     
     
167. VON MOLLENDORF C, Dunne EM, La Vincente S, Ulziibayar M, et al
     Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine.
     Vaccine. 2019 Jun 4. pii: S0264-410X(19)30715.
     PubMed     Text format     Abstract available
     
     
     
168. JIANG J, Ramos SJ, Bangalore P, Fisher P, et al
     Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses.
     Vaccine. 2019 Jun 4. pii: S0264-410X(19)30691.
     PubMed     Text format     Abstract available
     
     
     
169. SUNAY MME, Martins KAO, Steffens JT, Gregory M, et al
     Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice.
     Vaccine. 2019 Jun 4. pii: S0264-410X(19)30640.
     PubMed     Text format     Abstract available
     
     
     
170. HONG DT, Hien ND, Thao PTP, Anh DD, et al
     Immunogenicity of the AIK-C measles vaccine in infants aged <9months in Vietnam.
     Vaccine. 2019 Jun 4. pii: S0264-410X(19)30476.
     PubMed     Text format     Abstract available
     
     
     
171. CHANG J, Hou Z, Fang H, Meng Q, et al
     Are providers' recommendation and knowledge associated with uptake of optional vaccinations among children? A multilevel analysis in three provinces of China.
     Vaccine. 2019 Jun 4. pii: S0264-410X(19)30707.
     PubMed     Text format     Abstract available
     
     
     
172. LIU X, Adams LJ, Zeng X, Lin J, et al
     Evaluation of in ovo vaccination of DNA vaccines for Campylobacter control in broiler chickens.
     Vaccine. 2019 Jun 3. pii: S0264-410X(19)30729.
     PubMed     Text format     Abstract available
     
     
     
173. CAMACHO LAB
     Duration of immunity in recipients of two doses of 17DD yellow fever vaccine.
     Vaccine. 2019 Jun 3. pii: S0264-410X(19)30672.
     PubMed     Text format     Abstract available
     
     
     
174. FAWOLE OA, Srivastava T, Feemster KA
     Student health administrator perspectives on college vaccine policy development and implementation.
     Vaccine. 2019 Jun 1. pii: S0264-410X(19)30710.
     PubMed     Text format     Abstract available
     
     
     
175. BEISSBARTH J, Smith-Vaughan HC, Harris TM, Binks MJ, et al
     Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene.
     Vaccine. 2019 Jun 1. pii: S0264-410X(19)30716.
     PubMed     Text format     Abstract available
     
     
     
176. ALVIM RGF, Itabaiana I Jr, Castilho LR
     Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
     Vaccine. 2019 Jun 1. pii: S0264-410X(19)30701.
     PubMed     Text format     Abstract available
     
     
     
177. BELL CA, Russell ML, Drews SJ, Simmonds KA, et al
     Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010-2015, a Canadian Immunization Research Network (CIRN) study.
     Vaccine. 2019 Jun 1. pii: S0264-410X(19)30704.
     PubMed     Text format     Abstract available
     
     
     
178. ZHANG J, Liu N, Lu Y, Huang Z, et al
     Phosphorothioated antisense oligodeoxynucleotide suppressing interleukin-10 is a safe and potent vaccine adjuvant.
     Vaccine. 2019 Jun 1. pii: S0264-410X(19)30713.
     PubMed     Text format     Abstract available
     
     
     May 2019
179. NG Y, Nandar K, Chua LAV, Mak TM, et al
     Evaluating the effectiveness of the influenza vaccine during respiratory outbreaks in Singapore's long term care facilities, 2017.
     Vaccine. 2019 May 31. pii: S0264-410X(19)30388.
     PubMed     Text format     Abstract available
     
     
     
180. KEITEL WA, Voronca DC, Atmar RL, Paust S, et al
     Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.
     Vaccine. 2019 May 31. pii: S0264-410X(19)30554.
     PubMed     Text format     Abstract available
     
     
     
181. MARKOWITZ LE, Naleway AL, Lewis RM, Crane B, et al
     Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.
     Vaccine. 2019 May 31. pii: S0264-410X(19)30626.
     PubMed     Text format     Abstract available
     
     
     
182. NOSAN G, Paro-Panjan D, Ihan A, Kopitar AN, et al
     Vaccine immune response, autoimmunity and morbidity after neonatal blood exchange transfusion.
     Vaccine. 2019 May 31. pii: S0264-410X(19)30714.
     PubMed     Text format     Abstract available
     
     
     
183. CABRERA G, Marcipar I
     Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model.
     Vaccine. 2019 May 30. pii: S0264-410X(19)30629.
     PubMed     Text format     Abstract available
     
     
     
184. GRANADILLO M, Batte A, Alfonso AB, Blanco A, et al
     Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate.
     Vaccine. 2019 May 30. pii: S0264-410X(19)30697.
     PubMed     Text format     Abstract available
     
     
     
185. YAKUBOGULLARI N, Genc R, Coven F, Nalbantsoy A, et al
     Development of adjuvant nanocarrier systems for seasonal influenza A (H3N2) vaccine based on Astragaloside VII and gum tragacanth (APS).
     Vaccine. 2019 May 30. pii: S0264-410X(19)30662.
     PubMed     Text format     Abstract available
     
     
     
186. SHAH SFA, Ginossar T, Weiss D
     "This is a Pakhtun disease": Pakhtun health journalists' perceptions of the barriers and facilitators to polio vaccine acceptance among the high-risk Pakhtun community in Pakistan.
     Vaccine. 2019 May 30. pii: S0264-410X(19)30653.
     PubMed     Text format     Abstract available
     
     
     
187. NICOLODI C, Groiss F, Kiselev O, Wolschek M, et al
     Safety and immunogenicity of a replication-deficient H5N1 influenza virus vaccine lacking NS1.
     Vaccine. 2019 May 30. pii: S0264-410X(19)30627.
     PubMed     Text format     Abstract available
     
     
     
188. MORO PL, Arana J, Marquez PL, Ng C, et al
     Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
     Vaccine. 2019 May 30. pii: S0264-410X(19)30576.
     PubMed     Text format     Abstract available
     
     
     
189. GESSNER BD, Jiang Q, Van Werkhoven CH, Sings HL, et al
     A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
     Vaccine. 2019 May 30. pii: S0264-410X(19)30702.
     PubMed     Text format     Abstract available
     
     
     
190. ESPANA PP, Uranga A, Ruiz LA, Quintana JM, et al
     Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001-2014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain).
     Vaccine. 2019 May 29. pii: S0264-410X(19)30689.
     PubMed     Text format     Abstract available
     
     
     
191. HOSHI SL, Seposo X, Shono A, Okubo I, et al
     Cost-effectiveness of Recombinant Zoster Vaccine (RZV) and Varicella Vaccine Live (VVL) against herpes zoster and post-herpetic neuralgia among adults aged 65 and over in Japan.
     Vaccine. 2019 May 29. pii: S0264-410X(19)30599.
     PubMed     Text format     Abstract available
     
     
     
192. VAZ-DE-LIMA LRA, Sato HK, Fernandes EG, Sato APS, et al
     Association between the timing of maternal vaccination and newborns' anti-pertussis toxin antibody levels.
     Vaccine. 2019 May 29. pii: S0264-410X(19)30567.
     PubMed     Text format     Abstract available
     
     
     
193. ZIMMERMANN P, Donath S, Perrett KP, Messina NL, et al
     The influence of neonatal Bacille Calmette-Guerin (BCG) immunisation on heterologous vaccine responses in infants.
     Vaccine. 2019 May 29. pii: S0264-410X(19)30327.
     PubMed     Text format     Abstract available
     
     
     
194. AWASTHI S, Hook LM, Swaminathan G, Cairns TM, et al
     Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.
     Vaccine. 2019 May 29. pii: S0264-410X(19)30705.
     PubMed     Text format     Abstract available
     
     
     
195. RAPPUOLI R
     Towards animal free and science based measures of critical quality attributes for vaccine quality control and release.
     Vaccine. 2019 May 28. pii: S0264-410X(19)30663.
     PubMed     Text format    
     
     
     
196. LIM SI, Choe S, Kim KS, Jeoung HY, et al
     Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BE(rns)) in pregnant sows.
     Vaccine. 2019 May 28. pii: S0264-410X(19)30564.
     PubMed     Text format     Abstract available
     
     
     
197. CAWLFIELD A, Genito CJ, Beck Z, Bergmann-Leitner ES, et al
     Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ).
     Vaccine. 2019 May 28. pii: S0264-410X(19)30696.
     PubMed     Text format     Abstract available
     
     
     
198. KANG CK, Kim NH, Kim CJ, Rhie GE, et al
     Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study.
     Vaccine. 2019 May 28. pii: S0264-410X(19)30694.
     PubMed     Text format     Abstract available
     
     
     
199. VAN BUYNDER P, Cripps AW
     Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
     Vaccine. 2019;37:3141.
     PubMed     Text format    
     
     
     
200. KIM H, Kim AY, Kim JS, Lee JM, et al
     A simple and rapid assay to evaluate purity of foot-and-mouth disease vaccine before animal experimentation.
     Vaccine. 2019 May 25. pii: S0264-410X(19)30690.
     PubMed     Text format     Abstract available
     
     
     
201. GOLDSTEIN ND, LeVasseur MT, Tran NK, Purtle J, et al
     Modeling HPV vaccination scale-up among urban young men who have sex with men in the context of HIV.
     Vaccine. 2019 May 25. pii: S0264-410X(19)30671.
     PubMed     Text format     Abstract available
     
     
     
202. GRANDESSO F, Kasambara W, Page AL, Debes AK, et al
     Effectiveness of oral cholera vaccine in preventing cholera among fishermen in Lake Chilwa, Malawi: A case-control study.
     Vaccine. 2019 May 24. pii: S0264-410X(19)30668.
     PubMed     Text format     Abstract available
     
     
     
203. BEZERRA IPS, Costa-Souza BLS, Carneiro G, Ferreira LAM, et al
     Nanoencapsulated retinoic acid as a safe tolerogenic adjuvant for intranasal vaccination against cutaneous leishmaniasis.
     Vaccine. 2019 May 24. pii: S0264-410X(19)30667.
     PubMed     Text format     Abstract available
     
     
     
204. KADDAR M, Saxenian H, Senouci K, Mohsni E, et al
     Vaccine procurement in the Middle East and North Africa region: Challenges and ways of improving program efficiency and fiscal space.
     Vaccine. 2019 May 23. pii: S0264-410X(19)30480.
     PubMed     Text format     Abstract available
     
     
     
205. BA-NGUZ A, Shah A, Bresee JS, Lafond KE, et al
     Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction.
     Vaccine. 2019 May 23. pii: S0264-410X(19)30670.
     PubMed     Text format     Abstract available
     
     
     
206. TASHANI M, Badahdah AM, Alfelali M, Barasheed O, et al
     Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial.
     Vaccine. 2019 May 22. pii: S0264-410X(19)30639.
     PubMed     Text format     Abstract available
     
     
     
207. GILLARD P, Benninghoff B
     Response to: A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
     Vaccine. 2019;37:2990.
     PubMed     Text format    
     
     
     
208. LAESTADIUS A, Ingelman-Sundberg HM, Myrberg IH, Verme A, et al
     Altered proportions of circulating CXCR5+ helper T cells do not dampen influenza vaccine responses in children with rheumatic disease.
     Vaccine. 2019 May 21. pii: S0264-410X(19)30661.
     PubMed     Text format     Abstract available
     
     
     
209. STANTON SE, Gad E, Corulli LR, Lu H, et al
     Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets.
     Vaccine. 2019 May 21. pii: S0264-410X(19)30638.
     PubMed     Text format     Abstract available
     
     
     
210. JINA A, Wang TL, Seyferth ER, Cohen A, et al
     Increasing antepartum Tdap vaccine administration: A quality improvement initiative.
     Vaccine. 2019 May 20. pii: S0264-410X(19)30669.
     PubMed     Text format     Abstract available
     
     
     
211. FESTJENS N, Vandewalle K, Houthuys E, Plets E, et al
     SapM mutation to improve the BCG vaccine: Genomic, transcriptomic and preclinical safety characterization.
     Vaccine. 2019 May 20. pii: S0264-410X(19)30636.
     PubMed     Text format     Abstract available
     
     
     
212. CHOI WS, Choi JH, Jung DS, Choi HJ, et al
     Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax(R) in healthy adults aged 50 years and older.
     Vaccine. 2019 May 20. pii: S0264-410X(19)30510.
     PubMed     Text format     Abstract available
     
     
     
213. TRAUCHESSEC M, Lambert O, Bonnafous P, Berard Y, et al
     Complementary use of mass spectrometry and cryo-electron microscopy to assess the maturity of live attenuated dengue vaccine viruses.
     Vaccine. 2019 May 20. pii: S0264-410X(19)30624.
     PubMed     Text format     Abstract available
     
     
     
214. LI J, Zhang Y, Yang Y, Liang Z, et al
     Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5years of age.
     Vaccine. 2019 May 20. pii: S0264-410X(19)30418.
     PubMed     Text format     Abstract available
     
     
     
215. NIEMINEN H, Rinta-Kokko H, Jokinen J, Puumalainen T, et al
     Effectiveness of the 10-valent pneumococcal conjugate vaccine among girls, boys, preterm and low-birth-weight infants - Results from a randomized, double-blind vaccine trial.
     Vaccine. 2019 May 20. pii: S0264-410X(19)30657.
     PubMed     Text format     Abstract available
     
     
     
216. PEREZ-VILAR S, Wernecke M, Arya D, Lo AC, et al
     Surveillance for Guillain-Barre syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
     Vaccine. 2019 May 20. pii: S0264-410X(19)30665.
     PubMed     Text format     Abstract available
     
     
     
217. FORRO B, Marton S, Kecskemeti S, Hornyak A, et al
     Vaccine-associated rabies in red fox, Hungary.
     Vaccine. 2019 May 17. pii: S0264-410X(19)30628.
     PubMed     Text format     Abstract available
     
     
     
218. ORTIZ-BRIZUELA E, Leal-Vega F, Cuellar-Rodriguez J, Bobadilla-Del-Valle M, et al
     Vaccine-derived varicella zoster infection in a kidney transplant recipient after zoster vaccine live administration.
     Vaccine. 2019 May 17. pii: S0264-410X(19)30631.
     PubMed     Text format     Abstract available
     
     
     
219. BARTSCH SM, Bottazzi ME, Asti L, Strych U, et al
     Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients.
     Vaccine. 2019 May 16. pii: S0264-410X(19)30652.
     PubMed     Text format     Abstract available
     
     
     
220. KOUL PA, Bali NK, Koul HP
     Influenza vaccination for Hajj for the next decade: A case for quadrivalent SH vaccine.
     Vaccine. 2019 May 16. pii: S0264-410X(19)30602.
     PubMed     Text format    
     
     
     
221. O'LEARY ST, Pyrzanowski J, Brewer SE, Sevick C, et al
     Effectiveness of a multimodal intervention to increase vaccination in obstetrics/gynecology settings.
     Vaccine. 2019 May 15. pii: S0264-410X(19)30658.
     PubMed     Text format     Abstract available
     
     
     
222. MANNING J, Dunne EM, Wang N, Pedersen JS, et al
     Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice.
     Vaccine. 2019 May 15. pii: S0264-410X(19)30324.
     PubMed     Text format     Abstract available
     
     
     
223. BERNSTEIN DI, Flechtner JB, McNeil LK, Heineman T, et al
     Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.
     Vaccine. 2019 May 15. pii: S0264-410X(19)30621.
     PubMed     Text format     Abstract available
     
     
     
224. RATNAPRIYA S, Keerti, Sahasrabuddhe AA, Dube A, et al
     Visceral leishmaniasis: An overview of vaccine adjuvants and their applications.
     Vaccine. 2019 May 15. pii: S0264-410X(19)30600.
     PubMed     Text format     Abstract available
     
     
     
225. OSOWICKI J, Azzopardi KI, Baker C, Waddington CS, et al
     Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study.
     Vaccine. 2019 May 14. pii: S0264-410X(19)30405.
     PubMed     Text format     Abstract available
     
     
     
226. KO EJ, Lee Y, Lee YT, Jung YJ, et al
     Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice.
     Vaccine. 2019 May 14. pii: S0264-410X(19)30632.
     PubMed     Text format     Abstract available
     
     
     
227. KESHERWANI V, Tarang S
     An immunoinformatic approach to universal therapeutic vaccine design against BK virus.
     Vaccine. 2019 May 13. pii: S0264-410X(19)30616.
     PubMed     Text format     Abstract available
     
     
     
228. ZHOU M, Qu S, Zhao L, Kong N, et al
     Trust collapse caused by the Changsheng vaccine crisis in China.
     Vaccine. 2019 May 13. pii: S0264-410X(19)30634.
     PubMed     Text format     Abstract available
     
     
     
229. LIANG B, Li H, Li L, Omange RW, et al
     Current advances in HIV vaccine preclinical studies using Macaque models.
     Vaccine. 2019 May 11. pii: S0264-410X(19)30603.
     PubMed     Text format     Abstract available
     
     
     
230. DAVIES J, Lokuge K, Glass K
     Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study.
     Vaccine. 2019 May 11. pii: S0264-410X(19)30622.
     PubMed     Text format     Abstract available
     
     
     
231. BRUXVOORT KJ, Liang AS, Harpaz R, Qian L, et al
     Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live.
     Vaccine. 2019 May 11. pii: S0264-410X(19)30615.
     PubMed     Text format     Abstract available
     
     
     
232. FELDMAN RA, Fuhr R, Smolenov I, Mick Ribeiro A, et al
     mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials.
     Vaccine. 2019 May 9. pii: S0264-410X(19)30562.
     PubMed     Text format     Abstract available
     
     
     
233. MASTERS NB, Wagner AL, Ding Y, Zhang Y, et al
     Assessing measles vaccine failure in Tianjin, China.
     Vaccine. 2019 May 8. pii: S0264-410X(19)30598.
     PubMed     Text format     Abstract available
     
     
     
234. XIE L, Zai J, Yi K, Li Y, et al
     Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice.
     Vaccine. 2019 May 7. pii: S0264-410X(19)30558.
     PubMed     Text format     Abstract available
     
     
     
235. SAMBALA EZ, Wiyeh AB, Ngcobo N, Machingaidze S, et al
     New vaccine introductions in Africa before and during the decade of vaccines - Are we making progress?
     Vaccine. 2019 May 7. pii: S0264-410X(19)30593.
     PubMed     Text format     Abstract available
     
     
     
236. KLEYNHANS J, Cohen C, McMorrow M, Tempia S, et al
     Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005-2016.
     Vaccine. 2019 May 7. pii: S0264-410X(19)30590.
     PubMed     Text format     Abstract available
     
     
     
237. WANG L, Zhang X, Zhang Q, Zhang S, et al
     Understanding medical students' practices and perceptions towards vaccination in China: A qualitative study in a medical university.
     Vaccine. 2019 May 7. pii: S0264-410X(19)30387.
     PubMed     Text format     Abstract available
     
     
     
238. TRETYAKOVA I, Tibbens A, Jokinen JD, Johnson DM, et al
     Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
     Vaccine. 2019 May 6. pii: S0264-410X(19)30560.
     PubMed     Text format     Abstract available
     
     
     
239. TORCEL-PAGNON L, Bauchau V, Mahy P, Tin Tin Htar M, et al
     Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.
     Vaccine. 2019 May 6. pii: S0264-410X(19)30561.
     PubMed     Text format     Abstract available
     
     
     
240. AWAD S, Abdo N, Yusef D, Jawarneh A, et al
     Knowledge, attitudes and practices related to influenza illness and vaccination in children: Role of awareness campaigns in changing parents' attitudes toward influenza vaccination in Jordan.
     Vaccine. 2019 May 6. pii: S0264-410X(19)30571.
     PubMed     Text format     Abstract available
     
     
     
241. KOCHHAR S, Edwards KM, Ropero Alvarez AM, Moro PL, et al
     Introduction of new vaccines for immunization in pregnancy - Programmatic, regulatory, safety and ethical considerations.
     Vaccine. 2019 May 6. pii: S0264-410X(19)30563.
     PubMed     Text format     Abstract available
     
     
     
242. VEDHARA K, Ayling K, Sunger K, Caldwell DM, et al
     Psychological interventions as vaccine adjuvants: A systematic review.
     Vaccine. 2019 May 6. pii: S0264-410X(19)30591.
     PubMed     Text format     Abstract available
     
     
     
243. MASCARO V, Pileggi C, Curra A, Bianco A, et al
     HPV vaccination coverage and willingness to be vaccinated among 18-30year-old students in Italy.
     Vaccine. 2019 May 4. pii: S0264-410X(19)30569.
     PubMed     Text format     Abstract available
     
     
     
244. HECHTER RC, Qian L, Tartof SY, Sy LS, et al
     Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project.
     Vaccine. 2019 May 4. pii: S0264-410X(19)30568.
     PubMed     Text format     Abstract available
     
     
     
245. KUMAR A, Gupta VK, Mandil R, Rahal A, et al
     Interplay of oxidative stress and antioxidant bio markers in oil adjuvant Brucella melitensis vaccinated and challenged mice.
     Vaccine. 2019 May 4. pii: S0264-410X(19)30536.
     PubMed     Text format     Abstract available
     
     
     
246. SALAS A, Pardo-Seco J, Cebey-Lopez M, Martinon-Martinez JM, et al
     Impact of rotavirus vaccination on childhood hospitalizations for seizures: Heterologous or unforeseen direct vaccine effects?
     Vaccine. 2019 May 4. pii: S0264-410X(19)30574.
     PubMed     Text format     Abstract available
     
     
     
247. BONOMO ME, Kim RY, Deem MW
     Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season.
     Vaccine. 2019 May 3. pii: S0264-410X(19)30417.
     PubMed     Text format     Abstract available
     
     
     
248. KRUBINER CB, Faden RR, Karron RA, Little MO, et al
     Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response.
     Vaccine. 2019 May 3. pii: S0264-410X(19)30045.
     PubMed     Text format     Abstract available
     
     
     
249. ANTONUCCI R, Frassetto R, Vacca N, Mura D, et al
     Poor vaccine-related immunity against HBV in children with autoimmune diseases: Early or late sign of immunological disorder?
     Vaccine. 2019;37:2527-2528.
     PubMed     Text format    
     
     
     April 2019
250. TUNG WC, Lu M, Qiu X, Ervin S, et al
     Human papillomavirus knowledge, attitudes, and vaccination among Chinese college students in the United States.
     Vaccine. 2019 Apr 29. pii: S0264-410X(19)30572.
     PubMed     Text format     Abstract available
     
     
     
251. DOYON-PLOURDE P, Fakih I, Tadount F, Fortin E, et al
     Impact of influenza vaccination on healthcare utilization - A systematic review.
     Vaccine. 2019 Apr 29. pii: S0264-410X(19)30525.
     PubMed     Text format     Abstract available
     
     
     
252. DORA EG, Rossi SL, Weaver SC, Tucker SN, et al
     An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling.
     Vaccine. 2019 Apr 29. pii: S0264-410X(19)30557.
     PubMed     Text format     Abstract available
     
     
     
253. PATO TP, Souza MCO, Mattos DA, Caride E, et al
     Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture.
     Vaccine. 2019 Apr 29. pii: S0264-410X(19)30565.
     PubMed     Text format     Abstract available
     
     
     
254. ELIKAEE S, Mohebali M, Rezaei S, Eslami H, et al
     Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
     Vaccine. 2019 Apr 29. pii: S0264-410X(19)30556.
     PubMed     Text format     Abstract available
     
     
     
255. SHI S, Zhu H, Xia X, Liang Z, et al
     Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity.
     Vaccine. 2019 Apr 29. pii: S0264-410X(19)30529.
     PubMed     Text format     Abstract available
     
     
     
256. JOOSTEN SA, Ottenhoff THM, Lewinsohn DM, Hoft DF, et al
     Harnessing donor unrestricted T-cells for new vaccines against tuberculosis.
     Vaccine. 2019 Apr 27. pii: S0264-410X(19)30524.
     PubMed     Text format     Abstract available
     
     
     
257. FRANCIS MR, Nuorti JP, Kompithra RZ, Larson H, et al
     Vaccination coverage and factors associated with routine childhood vaccination uptake in rural Vellore, southern India, 2017.
     Vaccine. 2019 Apr 27. pii: S0264-410X(19)30534.
     PubMed     Text format     Abstract available
     
     
     
258. ZENG Y, Luo M, Chen J, He H, et al
     An economic evaluation of the current measles vaccination program: A case study in Zhejiang Province, east China.
     Vaccine. 2019 Apr 27. pii: S0264-410X(19)30533.
     PubMed     Text format     Abstract available
     
     
     
259. HABER M, Lopman BA, Tate JE, Shi M, et al
     Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design.
     Vaccine. 2019 Apr 26. pii: S0264-410X(19)30541.
     PubMed     Text format     Abstract available
     
     
     
260. RODRIGUEZ SA, Savas LS, Loomba P, Vernon SW, et al
     Low-income Hispanic parent recall of daughters' HPV vaccination status: Correlates of accurate reporting of daughters' HPV-vaccine naive status compared with electronic health records.
     Vaccine. 2019 Apr 26. pii: S0264-410X(19)30540.
     PubMed     Text format     Abstract available
     
     
     
261. ATKINSON KM, Wilson K, Murphy MSQ, El-Halabi S, et al
     Effectiveness of digital technologies at improving vaccine uptake and series completion - A systematic review and meta-analysis of randomized controlled trials.
     Vaccine. 2019 Apr 26. pii: S0264-410X(19)30412.
     PubMed     Text format     Abstract available
     
     
     
262. MOLLER J, Kraner M, Sonnewald U, Sangal V, et al
     Proteomics of diphtheria toxoid vaccines reveals multiple proteins that are immunogenic and may contribute to protection of humans against Corynebacterium diphtheriae.
     Vaccine. 2019 Apr 26. pii: S0264-410X(19)30535.
     PubMed     Text format     Abstract available
     
     
     
263. JIANG HY, Shi YD, Zhang X, Pan LY, et al
     Human papillomavirus vaccination and the risk of autoimmune disorders: A systematic review and meta-analysis.
     Vaccine. 2019 Apr 26. pii: S0264-410X(19)30523.
     PubMed     Text format     Abstract available
     
     
     
264. VEKEMANS J, Crofts J, Baker CJ, Goldblatt D, et al
     The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations.
     Vaccine. 2019 Apr 25. pii: S0264-410X(19)30501.
     PubMed     Text format     Abstract available
     
     
     
265. COHET C, van der Most R, Bauchau V, Bekkat-Berkani R, et al
     Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
     Vaccine. 2019 Apr 25. pii: S0264-410X(19)30522.
     PubMed     Text format     Abstract available
     
     
     
266. FEATHERSTONE JD, Bell RA, Ruiz JB
     Relationship of people's sources of health information and political ideology with acceptance of conspiratorial beliefs about vaccines.
     Vaccine. 2019 Apr 25. pii: S0264-410X(19)30539.
     PubMed     Text format     Abstract available
     
     
     
267. JONKER EFF, Uijlings MAC, Visser LG, Soonawala D, et al
     Comparison of the immunogenicity of Dukoral(R) oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate - A controlled trial.
     Vaccine. 2019 Apr 24. pii: S0264-410X(19)30448.
     PubMed     Text format     Abstract available
     
     
     
268. VAN DAMME P, Leroux-Roels G, Vandermeulen C, De Ryck I, et al
     Safety and immunogenicity of non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine.
     Vaccine. 2019 Apr 24. pii: S0264-410X(19)30505.
     PubMed     Text format     Abstract available
     
     
     
269. MWENDA JM, Mandomando I, Jere KC, Cunliffe NA, et al
     Evidence of reduction of rotavirus diarrheal disease after rotavirus vaccine introduction in national immunization programs in the African countries: Report of the 11(th) African rotavirus symposium held in Lilongwe, Malawi.
     Vaccine. 2019 Apr 24. pii: S0264-410X(19)30381.
     PubMed     Text format     Abstract available
     
     
     
270. KARPPINEN S, Toivonen L, Schuez-Havupalo L, Teros-Jaakkola T, et al
     Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against all respiratory tract infections in children under two years of age.
     Vaccine. 2019 Apr 23. pii: S0264-410X(19)30477.
     PubMed     Text format     Abstract available
     
     
     
271. DELLEPIANE N, Pagliusi S
     Opportunities for improving access to vaccines in emerging countries through efficient and aligned registration procedures: An industry perspective.
     Vaccine. 2019 Apr 23. pii: S0264-410X(19)30347.
     PubMed     Text format     Abstract available
     
     
     
272. JIANG B, Patel M, Glass RI
     Polio endgame: Lessons for the global rotavirus vaccination program.
     Vaccine. 2019 Apr 23. pii: S0264-410X(19)30474.
     PubMed     Text format     Abstract available
     
     
     
273. XEUATVONGSA A, Mott JA, Khanthamaly V, Patthammavong C, et al
     Progress toward sustainable influenza vaccination in the Lao Peoples' Democratic Republic, 2012-2018.
     Vaccine. 2019 Apr 23. pii: S0264-410X(19)30511.
     PubMed     Text format     Abstract available
     
     
     
274. MING M, Bernardo L, Williams K, Kolattukudy P, et al
     An in vitro functional assay to measure the biological activity of TB vaccine candidate H4-IC31.
     Vaccine. 2019 Apr 19. pii: S0264-410X(19)30486.
     PubMed     Text format     Abstract available
     
     
     
275. BETTAMPADI D, Boulton ML, Power LE, Hutton DW, et al
     Are community health workers cost-effective for childhood vaccination in India?
     Vaccine. 2019 Apr 19. pii: S0264-410X(19)30500.
     PubMed     Text format     Abstract available
     
     
     
276. NGUYEN A, Schwalbe N
     Apples and oranges? Can second generation vaccines become as low cost as generic medicines?
     Vaccine. 2019 Apr 19. pii: S0264-410X(19)30457.
     PubMed     Text format     Abstract available
     
     
     
277. BOILESEN DR, Ragonnaud E, Laursen H, Andersson AC, et al
     CD8+ T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine gamma-herpesvirus 68 infection.
     Vaccine. 2019 Apr 18. pii: S0264-410X(19)30485.
     PubMed     Text format     Abstract available
     
     
     
278. KIM JH, Chun BC, Song JY, Kim HY, et al
     Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study.
     Vaccine. 2019 Apr 17. pii: S0264-410X(19)30458.
     PubMed     Text format     Abstract available
     
     
     
279. PARKER KH, Kemp TJ, Isaacs-Soriano K, Abrahamsen M, et al
     HPV-specific antibodies at the oral cavity up to 30months after the start of vaccination with the quadrivalent HPV vaccine among mid-adult aged men.
     Vaccine. 2019 Apr 17. pii: S0264-410X(19)30413.
     PubMed     Text format     Abstract available
     
     
     
280. BERCOVICH S, Anis E, Kassem E, Rubinstein U, et al
     Validation of parental reports of rotavirus vaccination of their children compared to the national immunization registry.
     Vaccine. 2019 Apr 16. pii: S0264-410X(19)30499.
     PubMed     Text format     Abstract available
     
     
     
281. ABDELLRAZEQ GS, Elnaggar MM, Bannantine JP, Schneider DA, et al
     A peptide-based vaccine for Mycobacterium avium subspecies paratuberculosis.
     Vaccine. 2019 Apr 16. pii: S0264-410X(19)30504.
     PubMed     Text format     Abstract available
     
     
     
282. LACONI A, Catelli E, Cecchinato M, Naylor CJ, et al
     Two similar commercial live attenuated AMPV vaccines prepared by random passage of the identical field isolate, have unrelated sequences.
     Vaccine. 2019 Apr 16. pii: S0264-410X(19)30498.
     PubMed     Text format     Abstract available
     
     
     
283. ATTWELL K, Drislane S, Leask J
     Mandatory vaccination and no fault vaccine injury compensation schemes: An identification of country-level policies.
     Vaccine. 2019 Apr 15. pii: S0264-410X(19)30414.
     PubMed     Text format     Abstract available
     
     
     
284. O'MAHONY JF, Paulden M
     Appraising the cost-effectiveness of vaccines in the UK: Insights from the Department of Health Consultation on the revision of methods guidelines.
     Vaccine. 2019 Apr 15. pii: S0264-410X(19)30421.
     PubMed     Text format     Abstract available
     
     
     
285. ALBERTS CJ, Boyd A, Bruisten SM, Heijman T, et al
     Hepatitis A incidence, seroprevalence, and vaccination decision among MSM in Amsterdam, the Netherlands.
     Vaccine. 2019 Apr 13. pii: S0264-410X(19)30382.
     PubMed     Text format     Abstract available
     
     
     
286. VAN BUYNDER PG, Van Buynder JL, Menton L, Thompson G, et al
     Antigen specific vaccine hesitancy in pregnancy.
     Vaccine. 2019 Apr 13. pii: S0264-410X(19)30472.
     PubMed     Text format     Abstract available
     
     
     
287. PACHECO FC, Franca GVA, Elidio GA, Domingues CMAS, et al
     Trends and spatial distribution of MMR vaccine coverage in Brazil during 2007-2017.
     Vaccine. 2019 Apr 12. pii: S0264-410X(19)30470.
     PubMed     Text format     Abstract available
     
     
     
288. LEROUX-ROELS G, De Boever F, Maes C, Nguyen TL, et al
     Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study.
     Vaccine. 2019 Apr 12. pii: S0264-410X(19)30449.
     PubMed     Text format     Abstract available
     
     
     
289. MCGIRR A, Widenmaier R, Curran D, Espie E, et al
     The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis.
     Vaccine. 2019 Apr 11. pii: S0264-410X(19)30455.
     PubMed     Text format     Abstract available
     
     
     
290. HOFFMAN BL, Felter EM, Chu KH, Shensa A, et al
     It's not all about autism: The emerging landscape of anti-vaccination sentiment on Facebook.
     Vaccine. 2019;37:2216-2223.
     PubMed     Text format     Abstract available
     
     
     
291. HARRIS AM, Millman AJ, Lora M, Osinubi A, et al
     Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
     Vaccine. 2019;37:2188-2193.
     PubMed     Text format     Abstract available
     
     
     
292. POLAND GA, Hall LL, Powell JA
     Effective and equitable influenza vaccine coverage in older and vulnerable adults: The need for evidence-based innovation and transformation.
     Vaccine. 2019;37:2167-2170.
     PubMed     Text format    
     
     
     
293. FABIANI M, Fano V, Spadea T, Piovesan C, et al
     Comparison of early childhood vaccination coverage and timeliness between children born to Italian women and those born to foreign women residing in Italy: A multi-centre retrospective cohort study.
     Vaccine. 2019;37:2179-2187.
     PubMed     Text format     Abstract available
     
     
     
294. PICAZO JJ, Ruiz-Contreras J, Casado-Flores J, Negreira S, et al
     Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study.
     Vaccine. 2019;37:2200-2207.
     PubMed     Text format     Abstract available
     
     
     
295. AZZARI C, Serranti D, Nieddu F, Moriondo M, et al
     Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018.
     Vaccine. 2019 Apr 10. pii: S0264-410X(19)30450.
     PubMed     Text format     Abstract available
     
     
     
296. NEUKAM K, Gutierrez-Valencia A, Llaves-Flores S, Espinosa N, et al
     Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions.
     Vaccine. 2019 Apr 10. pii: S0264-410X(19)30351.
     PubMed     Text format     Abstract available
     
     
     
297. SHAPIRO SZ
     Lessons for general vaccinology research from attempts to develop an HIV vaccine.
     Vaccine. 2019 Apr 9. pii: S0264-410X(19)30442.
     PubMed     Text format     Abstract available
     
     
     
298. GORMAN DR, Bielecki K, Willocks LJ, Pollock KG, et al
     A qualitative study of vaccination behaviour amongst female Polish migrants in Edinburgh, Scotland.
     Vaccine. 2019 Apr 9. pii: S0264-410X(19)30422.
     PubMed     Text format     Abstract available
     
     
     
299. RIES C, Beer M, Hoffmann B
     BTV antibody longevity in cattle five to eight years post BTV-8 vaccination.
     Vaccine. 2019 Apr 9. pii: S0264-410X(19)30440.
     PubMed     Text format     Abstract available
     
     
     
300. MIHIGO R, Okeibunor J, Cernuschi T, Petu A, et al
     Improving access to affordable vaccines for middle-income countries in the african region.
     Vaccine. 2019 Apr 9. pii: S0264-410X(19)30426.
     PubMed     Text format     Abstract available
     
     
     
301. ODUTOLA A, Ota MOC, Antonio M, Ogundare EO, et al
     Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.
     Vaccine. 2019 Apr 8. pii: S0264-410X(19)30355.
     PubMed     Text format     Abstract available
     
     
     
302. SANDO E, Suzuki M, Furumoto A, Asoh N, et al
     Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE).
     Vaccine. 2019 Apr 8. pii: S0264-410X(19)30447.
     PubMed     Text format     Abstract available
     
     
     
303. KEERSMAEKERS N, Ogunjimi B, Van Damme P, Beutels P, et al
     An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix.
     Vaccine. 2019 Apr 8. pii: S0264-410X(19)30424.
     PubMed     Text format     Abstract available
     
     
     
304. CLARKE RM, Paterson P, Sirota M
     Determinants of satisfaction with information and additional information-seeking behaviour for the pertussis vaccination given during pregnancy.
     Vaccine. 2019 Apr 8. pii: S0264-410X(19)30446.
     PubMed     Text format     Abstract available
     
     
     
305. SCHARTAU S, Heering Holt D, Lutzen T, Rytter D, et al
     On the contextual nature of vaccine safety monitoring: Adverse events reporting after HPV-vaccination in Denmark, 2015.
     Vaccine. 2019 Apr 6. pii: S0264-410X(19)30391.
     PubMed     Text format     Abstract available
     
     
     
306. CHARANIA NA, Gaze N, Kung JY, Brooks S, et al
     Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: A scoping review of published literature, 2006 to 2016.
     Vaccine. 2019 Apr 6. pii: S0264-410X(19)30437.
     PubMed     Text format     Abstract available
     
     
     
307. LECOUTURIER V, Bernard MC, Berry C, Carayol S, et al
     Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice.
     Vaccine. 2019 Apr 6. pii: S0264-410X(19)30451.
     PubMed     Text format     Abstract available
     
     
     
308. CROWCROFT NS, Schwartz KL, Chen C, Johnson C, et al
     Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009-2015.
     Vaccine. 2019 Apr 6. pii: S0264-410X(19)30254.
     PubMed     Text format     Abstract available
     
     
     
309. INOUE M, Yonemura T, de Solom R, Yamaji M, et al
     A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults.
     Vaccine. 2019 Apr 5. pii: S0264-410X(19)30325.
     PubMed     Text format     Abstract available
     
     
     
310. TAUCHER C, Kollaritsch H, Dubischar KL
     Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO(R) in healthy adults: A five year follow-up study.
     Vaccine. 2019 Apr 5. pii: S0264-410X(19)30352.
     PubMed     Text format     Abstract available
     
     
     
311. CHAMBERLAIN AT, Limaye RJ, O'Leary ST, Frew PM, et al
     Development and acceptability of a video-based vaccine promotion tutorial for obstetric care providers.
     Vaccine. 2019 Apr 5. pii: S0264-410X(19)30305.
     PubMed     Text format     Abstract available
     
     
     
312. ECHEVARRIA D, Gutfraind A, Boodram B, Layden J, et al
     Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
     Vaccine. 2019 Apr 5. pii: S0264-410X(19)30319.
     PubMed     Text format     Abstract available
     
     
     
313. KAWADE A, Babji S, Kamath V, Raut A, et al
     Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.
     Vaccine. 2019 Apr 4. pii: S0264-410X(19)30416.
     PubMed     Text format     Abstract available
     
     
     
314. EL SAHLY HM, Atmar RL, Patel SM, Bellamy A, et al
     Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.
     Vaccine. 2019 Apr 4. pii: S0264-410X(19)30420.
     PubMed     Text format     Abstract available
     
     
     
315. LIMA L, Molina MDGF, Pereira BS, Nadaf MLA, et al
     Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
     Vaccine. 2019 Apr 4. pii: S0264-410X(19)30419.
     PubMed     Text format     Abstract available
     
     
     
316. GAGNEUR A, Bergeron J, Gosselin V, Farrands A, et al
     A complementary approach to the vaccination promotion continuum: An immunization-specific motivational-interview training for nurses.
     Vaccine. 2019 Apr 3. pii: S0264-410X(19)30425.
     PubMed     Text format     Abstract available
     
     
     
317. HAVERI A, Ikonen N, Kantele A, Anttila VJ, et al
     Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses.
     Vaccine. 2019 Apr 3. pii: S0264-410X(19)30427.
     PubMed     Text format     Abstract available
     
     
     
318. BRUMMAIER T, Poe Yen Yen S, Keereecharoen D, McGready R, et al
     The natural course of a localized BCG vaccine abscess.
     Vaccine. 2019 Apr 2. pii: S0264-410X(19)30415.
     PubMed     Text format    
     
     
     
319. REGAN AK, Fielding JE, Chilver MB, Carville KS, et al
     Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment.
     Vaccine. 2019 Apr 2. pii: S0264-410X(19)30222.
     PubMed     Text format     Abstract available
     
     
     
320. FERNANDES EG, Sato APS, Vaz-de-Lima LRA, Rodrigues M, et al
     The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: A case-control study.
     Vaccine. 2019 Apr 1. pii: S0264-410X(19)30383.
     PubMed     Text format     Abstract available
     
     
     March 2019
321. MENSAH K, Heraud JM, Takahashi S, Winter AK, et al
     Seasonal gaps in measles vaccination coverage in Madagascar.
     Vaccine. 2019 Mar 30. pii: S0264-410X(19)30276.
     PubMed     Text format     Abstract available
     
     
     
322. PINTO LA, Wilkin TJ, Kemp TJ, Abrahamsen M, et al
     Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men.
     Vaccine. 2019 Mar 30. pii: S0264-410X(19)30356.
     PubMed     Text format     Abstract available
     
     
     
323. LUYTEN J, Bruyneel L, van Hoek AJ
     Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument.
     Vaccine. 2019 Mar 30. pii: S0264-410X(19)30375.
     PubMed     Text format     Abstract available
     
     
     
324. SAWLWIN DC, Graves Jones A, Albano FR
     Modification of the vaccine manufacturing process improves the pyrogenicity profile of inactivated influenza vaccines in young children.
     Vaccine. 2019 Mar 29. pii: S0264-410X(19)30390.
     PubMed     Text format     Abstract available
     
     
     
325. LOPEZ-FAUQUED M, Campora L, Delannois F, El Idrissi M, et al
     Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.
     Vaccine. 2019 Mar 29. pii: S0264-410X(19)30377.
     PubMed     Text format     Abstract available
     
     
     
326. OSTER NV, Williams EC, Unger JM, Newcomb PA, et al
     Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State.
     Vaccine. 2019 Mar 28. pii: S0264-410X(19)30384.
     PubMed     Text format     Abstract available
     
     
     
327. CASHMAN P, Moberley S, Chee K, Stephenson J, et al
     Participant centred safety surveillance of health care workers receiving influenza vaccination.
     Vaccine. 2019 Mar 28. pii: S0264-410X(19)30320.
     PubMed     Text format     Abstract available
     
     
     
328. XIN H, Glee P, Adams A, Mohiuddin F, et al
     Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
     Vaccine. 2019 Mar 28. pii: S0264-410X(19)30407.
     PubMed     Text format     Abstract available
     
     
     
329. POELLABAUER E, Angermayr R, Behre U, Zhang P, et al
     Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
     Vaccine. 2019 Mar 27. pii: S0264-410X(19)30354.
     PubMed     Text format     Abstract available
     
     
     
330. ARNOLD LD, Luong L, Rebmann T, Chang JJ, et al
     Racial disparities in U.S. maternal influenza vaccine uptake: Results from analysis of Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2012-2015.
     Vaccine. 2019 Mar 27. pii: S0264-410X(19)30208.
     PubMed     Text format     Abstract available
     
     
     
331. GODI A, Panwar K, Haque M, Cocuzza CE, et al
     Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix(R) or Gardasil(R) vaccine.
     Vaccine. 2019 Mar 27. pii: S0264-410X(19)30386.
     PubMed     Text format     Abstract available
     
     
     
332. WENTWORTH D, Hampson K, Thumbi SM, Mwatondo A, et al
     A social justice perspective on access to human rabies vaccines.
     Vaccine. 2019 Mar 27. pii: S0264-410X(19)30150.
     PubMed     Text format     Abstract available
     
     
     
333. SARKAR S, Piepenbrink MS, Basu M, Thakar J, et al
     IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine.
     Vaccine. 2019 Mar 26. pii: S0264-410X(19)30378.
     PubMed     Text format     Abstract available
     
     
     
334. LEE BY, Brown ST, Haidari LA, Clark S, et al
     Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya.
     Vaccine. 2019 Mar 25. pii: S0264-410X(19)30307.
     PubMed     Text format     Abstract available
     
     
     
335. XU Y, Ma S, Huang Y, Chen F, et al
     Virus-like particle vaccines for poliovirus types 1, 2, and 3 with enhanced thermostability expressed in insect cells.
     Vaccine. 2019 Mar 25. pii: S0264-410X(19)30353.
     PubMed     Text format     Abstract available
     
     
     
336. TAYLOR E, Banyard AC, Bourhy H, Cliquet F, et al
     Avoiding preventable deaths: The scourge of counterfeit rabies vaccines.
     Vaccine. 2019 Mar 25. pii: S0264-410X(19)30369.
     PubMed     Text format    
     
     
     
337. EVERETT HE, Aramouni M, Coward V, Ramsay A, et al
     Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus.
     Vaccine. 2019 Mar 23. pii: S0264-410X(19)30316.
     PubMed     Text format     Abstract available
     
     
     
338. WEDLOCK PT, Mitgang EA, Oron AP, Hagedorn BL, et al
     Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.
     Vaccine. 2019 Mar 23. pii: S0264-410X(19)30328.
     PubMed     Text format     Abstract available
     
     
     
339. BEKELE Y, Lemma M, Bobosha K, Yibeltal D, et al
     Homing defects of B cells in HIV-1 infected children impair vaccination responses.
     Vaccine. 2019 Mar 23. pii: S0264-410X(19)30349.
     PubMed     Text format     Abstract available
     
     
     
340. CHOUDHARY TS, Reddy NS, Apte A, Sinha B, et al
     Delayed vaccination and its predictors among children under 2years in India: Insights from the national family health survey-4.
     Vaccine. 2019 Mar 23. pii: S0264-410X(19)30371.
     PubMed     Text format     Abstract available
     
     
     
341. TING-HUI-LIN, Chia MY, Lin CY, Yeh YQ, et al
     Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development.
     Vaccine. 2019;37:1897-1903.
     PubMed     Text format     Abstract available
     
     
     
342. DE SOAREZ PC, Silva AB, Randi BA, Azevedo LM, et al
     Systematic review of health economic evaluation studies of dengue vaccines.
     Vaccine. 2019 Mar 22. pii: S0264-410X(19)30348.
     PubMed     Text format     Abstract available
     
     
     
343. DRURY G, Jolliffe S, Mukhopadhyay TK
     Process mapping of vaccines: Understanding the limitations in current response to emerging epidemic threats.
     Vaccine. 2019 Mar 22. pii: S0264-410X(19)30126.
     PubMed     Text format     Abstract available
     
     
     
344. RILEY TV, Lyras D, Douce GR
     Status of vaccine research and development for Clostridium difficile.
     Vaccine. 2019 Mar 19. pii: S0264-410X(19)30259.
     PubMed     Text format     Abstract available
     
     
     
345. ERONDU NA, Ferland L, Haile BH, Abimbola T, et al
     A systematic review of vaccine preventable disease surveillance cost studies.
     Vaccine. 2019 Mar 19. pii: S0264-410X(19)30221.
     PubMed     Text format     Abstract available
     
     
     
346. DUCLOS P, Martinez L, MacDonald N, Asturias E, et al
     Global vaccinology training: Report from an ADVAC workshop.
     Vaccine. 2019 Mar 18. pii: S0264-410X(19)30269.
     PubMed     Text format     Abstract available
     
     
     
347. SELINGER C, Bershteyn A, Dimitrov DT, Adamson BJS, et al
     Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South Africa.
     Vaccine. 2019 Mar 16. pii: S0264-410X(19)30291.
     PubMed     Text format     Abstract available
     
     
     
348. FRITZSCHE C, Bergmann L, Loebermann M, Glass A, et al
     Immune response to hepatitis A vaccine in patients with HIV.
     Vaccine. 2019 Mar 16. pii: S0264-410X(19)30271.
     PubMed     Text format     Abstract available
     
     
     
349. QUIAMBAO BP, Ambas C, Diego S, Bosch Castells V, et al
     Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
     Vaccine. 2019 Mar 16. pii: S0264-410X(19)30335.
     PubMed     Text format     Abstract available
     
     
     
350. ZERVA I, Katsoni E, Simitzi C, Stratakis E, et al
     Laser micro-structured Si scaffold-implantable vaccines against Salmonella Typhimurium.
     Vaccine. 2019 Mar 15. pii: S0264-410X(19)30318.
     PubMed     Text format     Abstract available
     
     
     
351. CRIADO MF, Bertran K, Lee DH, Killmaster L, et al
     Efficacy of novel recombinant fowlpox vaccine against recent Mexican H7N3 highly pathogenic avian influenza virus.
     Vaccine. 2019 Mar 15. pii: S0264-410X(19)30314.
     PubMed     Text format     Abstract available
     
     
     
352. NORMAN DA, Danchin M, Van Buynder P, Moore HC, et al
     Caregiver's attitudes, beliefs, and experiences for influenza vaccination in Australian children with medical comorbidities.
     Vaccine. 2019 Mar 15. pii: S0264-410X(19)30315.
     PubMed     Text format     Abstract available
     
     
     
353. SCHAFFER SJ, Rand CM, Humiston SG, Concannon C, et al
     Practical considerations in developing a successful school-located influenza vaccination (SLIV) program.
     Vaccine. 2019 Mar 13. pii: S0264-410X(19)30290.
     PubMed     Text format    
     
     
     
354. KASEREKA MC, Sawatzky J, Hawkes MT
     Ebola epidemic in war-torn Democratic Republic of Congo, 2018: Acceptability and patient satisfaction of the recombinant Vesicular Stomatitis Virus - Zaire Ebolavirus Vaccine.
     Vaccine. 2019 Mar 13. pii: S0264-410X(19)30304.
     PubMed     Text format     Abstract available
     
     
     
355. BRUNELLI L, Romanese F, Benetollo PP, Iob A, et al
     Management of reduced vaccine coverage due to 6years of failure to vaccinate: The Codroipo case, Italy.
     Vaccine. 2019 Mar 13. pii: S0264-410X(19)30179.
     PubMed     Text format     Abstract available
     
     
     
356. CHEN T, Zhou X, Qi Y, Mi L, et al
     Feline herpesvirus vectored-rabies vaccine in cats: A dual protection.
     Vaccine. 2019 Mar 13. pii: S0264-410X(19)30310.
     PubMed     Text format     Abstract available
     
     
     
357. LAYTON JB, Butler AM, Brookhart MA, Panozzo CA, et al
     Variation in rotavirus vaccination coding in state US medicaid data.
     Vaccine. 2019 Mar 12. pii: S0264-410X(19)30311.
     PubMed     Text format     Abstract available
     
     
     
358. MERCALDO RA, Bellan SE
     Evaluation of alternative endpoints for ZIKV vaccine efficacy trials.
     Vaccine. 2019 Mar 11. pii: S0264-410X(19)30273.
     PubMed     Text format     Abstract available
     
     
     
359. THORRINGTON D, van Leeuwen E, Ramsay M, Pebody R, et al
     Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
     Vaccine. 2019 Mar 11. pii: S0264-410X(19)30293.
     PubMed     Text format     Abstract available
     
     
     
360. JACOBS AAC, Harks F, Hazenberg L, Hoeijmakers MJH, et al
     Efficacy of a novel inactivated Lawsonia intracellularis vaccine in pigs against experimental infection and under field conditions.
     Vaccine. 2019 Mar 11. pii: S0264-410X(19)30274.
     PubMed     Text format     Abstract available
     
     
     
361. YIANNAKOULIAS N, Slavik C, Chase M
     Expressions of pro- and anti-vaccine sentiment on YouTube.
     Vaccine. 2019 Mar 9. pii: S0264-410X(19)30292.
     PubMed     Text format     Abstract available
     
     
     
362. ABAASA A, Nash S, Mayanja Y, Price M, et al
     Simulated vaccine efficacy trials to estimate HIV incidence for actual vaccine clinical trials in key populations in Uganda.
     Vaccine. 2019 Mar 8. pii: S0264-410X(19)30289.
     PubMed     Text format     Abstract available
     
     
     
363. SEKIYA T, Mifsud EJ, Ohno M, Nomura N, et al
     Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
     Vaccine. 2019 Mar 8. pii: S0264-410X(19)30264.
     PubMed     Text format     Abstract available
     
     
     
364. VERELST F, Kessels R, Delva W, Beutels P, et al
     Drivers of vaccine decision-making in South Africa: A discrete choice experiment.
     Vaccine. 2019 Mar 8. pii: S0264-410X(19)30263.
     PubMed     Text format     Abstract available
     
     
     
365. MCCARTY JM, Lock MD, Bennett S, Hunt KM, et al
     Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial.
     Vaccine. 2019;37:1389-1397.
     PubMed     Text format     Abstract available
     
     
     
366. FOTSO KAMDEM A, Vidal C, Pazart L, Leroux F, et al
     A case-control study of risk factors for intussusception among infants in eastern France after the introduction of the rotavirus vaccine.
     Vaccine. 2019 Mar 7. pii: S0264-410X(19)30260.
     PubMed     Text format     Abstract available
     
     
     
367. ZHAN Y, Deng Y, Huang B, Song Q, et al
     Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
     Vaccine. 2019 Mar 6. pii: S0264-410X(19)30270.
     PubMed     Text format     Abstract available
     
     
     
368. MOUCHET J, Begaud B
     Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.
     Vaccine. 2019 Mar 6. pii: S0264-410X(19)30253.
     PubMed     Text format     Abstract available
     
     
     
369. BURNY W, Marchant A, Herve C, Callegaro A, et al
     Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans.
     Vaccine. 2019 Mar 5. pii: S0264-410X(19)30209.
     PubMed     Text format     Abstract available
     
     
     
370. PAN SC, Hsieh SM, Lin CF, Hsu YS, et al
     A randomized, double-blind, controlled clinical trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with adjuvant LTh(alphaK): A phase I study.
     Vaccine. 2019 Mar 2. pii: S0264-410X(19)30189.
     PubMed     Text format     Abstract available
     
     
     
371. AINSLIE KEC, Haber M, Orenstein WA
     Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
     Vaccine. 2019 Mar 1. pii: S0264-410X(19)30241.
     PubMed     Text format     Abstract available
     
     
     February 2019
372. KLEIN NP, Goddard K, Lewis E, Ross P, et al
     Long term risk of developing type 1 diabetes after HPV vaccination in males and females.
     Vaccine. 2019 Feb 28. pii: S0264-410X(19)30258.
     PubMed     Text format     Abstract available
     
     
     
373. SATOH H, Tanaka-Taya K, Shimizu H, Goto A, et al
     Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan.
     Vaccine. 2019 Feb 28. pii: S0264-410X(19)30229.
     PubMed     Text format     Abstract available
     
     
     
374. GIDUTHURI JG, Purohit V, Maire N, Kudale A, et al
     Influenza vaccination of pregnant women: Engaging clinicians to reduce missed opportunities for vaccination.
     Vaccine. 2019 Feb 28. pii: S0264-410X(19)30240.
     PubMed     Text format     Abstract available
     
     
     
375. ZHANG D, Zhang Y, Wang Q, Lock J, et al
     The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18.
     Vaccine. 2019 Feb 28. pii: S0264-410X(19)30207.
     PubMed     Text format     Abstract available
     
     
     
376. ROSSO A, Massimi A, De Vito C, Adamo G, et al
     Knowledge and attitudes on pediatric vaccinations and intention to vaccinate in a sample of pregnant women from the City of Rome.
     Vaccine. 2019 Feb 28. pii: S0264-410X(19)30256.
     PubMed     Text format     Abstract available
     
     
     
377. ZHOU F, Xu J, Black CL, Ding H, et al
     Trends in Tdap vaccination among privately insured pregnant women in the United States, 2009-2016.
     Vaccine. 2019 Feb 27. pii: S0264-410X(19)30249.
     PubMed     Text format     Abstract available
     
     
     
378. PORTH JM, Wagner AL, Teklie H, Abeje Y, et al
     Vaccine non-receipt and refusal in Ethiopia: The expanded program on immunization coverage survey, 2012.
     Vaccine. 2019 Feb 27. pii: S0264-410X(19)30252.
     PubMed     Text format     Abstract available
     
     
     
379. MEYER SB, Violette R, Aggarwal R, Simeoni M, et al
     Vaccine hesitancy and Web 2.0: Exploring how attitudes and beliefs about influenza vaccination are exchanged in online threaded user comments.
     Vaccine. 2019 Feb 27. pii: S0264-410X(19)30223.
     PubMed     Text format     Abstract available
     
     
     
380. ZEPEDA-CERVANTES J, Cruz-Resendiz A, Sampieri A, Carreon-Napoles R, et al
     Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide.
     Vaccine. 2019 Feb 26. pii: S0264-410X(19)30251.
     PubMed     Text format     Abstract available
     
     
     
381. NDAWULA C JR, Sabadin GA, Parizi LF, da Silva Vaz I Jr, et al
     Constituting a glutathione S-transferase-cocktail vaccine against tick infestation.
     Vaccine. 2019 Feb 26. pii: S0264-410X(19)30246.
     PubMed     Text format     Abstract available
     
     
     
382. WALKER EJ, MacDonald NE, Islam N, Le Saux N, et al
     Completeness and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and polio vaccines in young children with chronic health conditions: A systematic review.
     Vaccine. 2019 Feb 25. pii: S0264-410X(19)30226.
     PubMed     Text format     Abstract available
     
     
     
383. LEFEVRE H, Samain S, Ibrahim N, Fourmaux C, et al
     HPV vaccination and sexual health in France: Empowering girls to decide.
     Vaccine. 2019 Feb 23. pii: S0264-410X(19)30215.
     PubMed     Text format     Abstract available
     
     
     
384. MO Z, Ma X, Luo P, Mo Y, et al
     Immunogenicity of pentavalent rotavirus vaccine in Chinese infants.
     Vaccine. 2019 Feb 23. pii: S0264-410X(19)30213.
     PubMed     Text format     Abstract available
     
     
     
385. DOLAN SB, Carnahan E, Shearer JC, Beylerian EN, et al
     Redefining vaccination coverage and timeliness measures using electronic immunization registry data in low- and middle-income countries.
     Vaccine. 2019 Feb 23. pii: S0264-410X(19)30212.
     PubMed     Text format     Abstract available
     
     
     
386. MUNYAKA PM, Kommadath A, Fouhse J, Wilkinson J, et al
     Characterization of whole blood transcriptome and early-life fecal microbiota in high and low responder pigs before, and after vaccination for Mycoplasma hyopneumoniae.
     Vaccine. 2019 Feb 23. pii: S0264-410X(19)30211.
     PubMed     Text format     Abstract available
     
     
     
387. HUANG LM, Chiu CH, Chiu NC, Lin CY, et al
     Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan.
     Vaccine. 2019 Feb 22. pii: S0264-410X(19)30218.
     PubMed     Text format     Abstract available
     
     
     
388. KROGSGAARD LW, Bech BH, Plana-Ripoll O, Thomsen RW, et al
     Hospital contacts and diagnoses five years prior to HPV vaccination among females referred for suspected adverse vaccine effects: A Danish nationwide case-control study.
     Vaccine. 2019 Feb 22. pii: S0264-410X(19)30224.
     PubMed     Text format     Abstract available
     
     
     
389. GETAHUN D, Fassett MJ, Peltier MR, Takhar HS, et al
     Association between seasonal influenza vaccination with pre- and postnatal outcomes.
     Vaccine. 2019 Feb 21. pii: S0264-410X(19)30214.
     PubMed     Text format     Abstract available
     
     
     
390. PERDRIZET JA, Shiau DS, Xie H
     The serological response in dogs inoculated with canine distemper virus vaccine at the acupuncture point governing vessel-14: A randomized controlled trial.
     Vaccine. 2019 Feb 21. pii: S0264-410X(18)31463.
     PubMed     Text format     Abstract available
     
     
     
391. DOENER F, Hong HS, Meyer I, Tadjalli-Mehr K, et al
     RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial.
     Vaccine. 2019 Feb 21. pii: S0264-410X(19)30219.
     PubMed     Text format     Abstract available
     
     
     
392. KENNEDY RB, Ovsyannikova IG, Thomas A, Larrabee BR, et al
     Differential durability of immune responses to measles and mumps following MMR vaccination.
     Vaccine. 2019 Feb 20. pii: S0264-410X(19)30225.
     PubMed     Text format     Abstract available
     
     
     
393. MIKAMO H, Yamagishi Y, Murata S, Yokokawa R, et al
     Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study.
     Vaccine. 2019 Feb 20. pii: S0264-410X(19)30154.
     PubMed     Text format     Abstract available
     
     
     
394. WANG Z, Li Z, Su X, Qiao Y, et al
     Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
     Vaccine. 2019 Feb 20. pii: S0264-410X(19)30206.
     PubMed     Text format     Abstract available
     
     
     
395. HAPPE M, Samuvel DJ, Ohtola JA, Korte JE, et al
     Race-related differences in functional antibody response to pneumococcal vaccination in HIV-infected individuals.
     Vaccine. 2019 Feb 20. pii: S0264-410X(19)30182.
     PubMed     Text format     Abstract available
     
     
     
396. PARVEEN N, Fernandez MC, Haynes AM, Zhang RL, et al
     Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
     Vaccine. 2019 Feb 20. pii: S0264-410X(19)30217.
     PubMed     Text format     Abstract available
     
     
     
397. HARRO C, Louis Bourgeois A, Sack D, Walker R, et al
     Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
     Vaccine. 2019 Feb 20. pii: S0264-410X(19)30220.
     PubMed     Text format     Abstract available
     
     
     
398. WATESKA AR, Nowalk MP, Lin CJ, Harrison LH, et al
     Cost-effectiveness of adult pneumococcal vaccination policies in underserved minorities aged 50-64years compared to the US general population.
     Vaccine. 2019 Feb 20. pii: S0264-410X(19)30012.
     PubMed     Text format     Abstract available
     
     
     
399. ABUBAKAR A, Melhem N, Malik M, Dbaibo G, et al
     Seasonal influenza vaccination policies in the Eastern Mediterranean Region: Current status and the way forward.
     Vaccine. 2019 Feb 19. pii: S0264-410X(19)30163.
     PubMed     Text format     Abstract available
     
     
     
400. ILES RA, Gatumu H, Kagundu S, Draheim C, et al
     Information sharing and willingness-to-pay for CBPP vaccine in rural Kenya.
     Vaccine. 2019 Feb 16. pii: S0264-410X(19)30157.
     PubMed     Text format     Abstract available
     
     
     
401. TAKASHIMA M, Lambert SB, Paynter S, Ware RS, et al
     Relative effectiveness of revaccination with 23-valent pneumococcal polysaccharide vaccine in preventing invasive pneumococcal disease in adult Aboriginal and Torres Strait Islander people, Australia.
     Vaccine. 2019 Feb 16. pii: S0264-410X(19)30183.
     PubMed     Text format     Abstract available
     
     
     
402. DUROUS L, Julien T, Padey B, Traversier A, et al
     SPRi-based hemagglutinin quantitative assay for influenza vaccine production monitoring.
     Vaccine. 2019 Feb 14. pii: S0264-410X(19)30181.
     PubMed     Text format     Abstract available
     
     
     
403. BOUMART Z, Daouam S, Bamouh Z, Jazouli M, et al
     Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12DeltaNSm21/384 vaccine candidate for sheep, goats and calves.
     Vaccine. 2019 Feb 14. pii: S0264-410X(19)30152.
     PubMed     Text format     Abstract available
     
     
     
404. ENCHERY F, Hamers C, Kwiatek O, Gaillardet D, et al
     Development of a PPRV challenge model in goats and its use to assess the efficacy of a PPR vaccine.
     Vaccine. 2019 Feb 13. pii: S0264-410X(19)30133.
     PubMed     Text format     Abstract available
     
     
     
405. FITZWATER SP, Ramachandran P, Kahn GD, Nedunchelian K, et al
     Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India.
     Vaccine. 2019 Feb 13. pii: S0264-410X(19)30166.
     PubMed     Text format     Abstract available
     
     
     
406. ZEIGLER DF, Roque R, Clegg CH
     Optimization of a multivalent peptide vaccine for nicotine addiction.
     Vaccine. 2019 Feb 13. pii: S0264-410X(19)30180.
     PubMed     Text format     Abstract available
     
     
     
407. RAMSAY LC, Anyiwe K, Li M, Macdonald L, et al
     Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
     Vaccine. 2019 Feb 12. pii: S0264-410X(19)30155.
     PubMed     Text format     Abstract available
     
     
     
408. HAMLET A, Jean K, Yactayo S, Benzler J, et al
     POLICI: A web application for visualising and extracting yellow fever vaccination coverage in Africa.
     Vaccine. 2019 Feb 12. pii: S0264-410X(19)30159.
     PubMed     Text format     Abstract available
     
     
     
409. ZHANG T, Cui L, Geng X, Yu X, et al
     Epidemiology study of pediatric primary intussusception aged </=24months in pre-rotavirus vaccine era of Jinan, China.
     Vaccine. 2019 Feb 12. pii: S0264-410X(19)30145.
     PubMed     Text format     Abstract available
     
     
     
410. SHARP A, Coles S, Pegorie M, Harwood C, et al
     Vaccination strategies for control of community outbreaks of hepatitis A: A comparison of two outbreaks in England.
     Vaccine. 2019 Feb 12. pii: S0264-410X(19)30089.
     PubMed     Text format     Abstract available
     
     
     
411. ZENG Y, Yuan Z, Yin J, Han Y, et al
     Factors affecting parental intention to vaccinate kindergarten children against influenza: A cross-sectional survey in China.
     Vaccine. 2019 Feb 12. pii: S0264-410X(19)30156.
     PubMed     Text format     Abstract available
     
     
     
412. AHMED MC, Heukelbach J, Weddih A, Filali-Maltouf A, et al
     Reduction of hospitalizations with diarrhea among children aged 0-5years in Nouakchott, Mauritania, following the introduction of rotavirus vaccine.
     Vaccine. 2019 Feb 11. pii: S0264-410X(19)30164.
     PubMed     Text format     Abstract available
     
     
     
413. HERRERA-RODRIGUEZ J, Signorazzi A, Holtrop M, de Vries-Idema J, et al
     Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
     Vaccine. 2019 Feb 11. pii: S0264-410X(19)30184.
     PubMed     Text format     Abstract available
     
     
     
414. JALLOH MF, Jalloh MB, Albert A, Wolff B, et al
     Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.
     Vaccine. 2019 Feb 9. pii: S0264-410X(19)30122.
     PubMed     Text format     Abstract available
     
     
     
415. ZUK P, Zuk P, Lisiewicz-Jakubaszko J
     The anti-vaccine movement in Poland: The socio-cultural conditions of the opposition to vaccination and threats to public health.
     Vaccine. 2019 Feb 9. pii: S0264-410X(19)30158.
     PubMed     Text format     Abstract available
     
     
     
416. PEPIN S, Samson SI, Alvarez FP, Dupuy M, et al
     Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres.
     Vaccine. 2019 Feb 8. pii: S0264-410X(19)30144.
     PubMed     Text format     Abstract available
     
     
     
417. YOUNG-XU Y, Snider JT, van Aalst R, Mahmud SM, et al
     Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.
     Vaccine. 2019 Feb 8. pii: S0264-410X(19)30148.
     PubMed     Text format     Abstract available
     
     
     
418. WASAN EK, Syeda J, Strom S, Cawthray J, et al
     A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice.
     Vaccine. 2019 Feb 7. pii: S0264-410X(19)30134.
     PubMed     Text format     Abstract available
     
     
     
419. HABER P, Moro PL, Ng C, Dores GM, et al
     Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.
     Vaccine. 2019 Feb 7. pii: S0264-410X(19)30128.
     PubMed     Text format     Abstract available
     
     
     
420. HARAPAN H, Mudatsir M, Yufika A, Nawawi Y, et al
     Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia.
     Vaccine. 2019 Feb 7. pii: S0264-410X(19)30147.
     PubMed     Text format     Abstract available
     
     
     
421. DOORNEKAMP L, de Jong W, Wagener MN, Goeijenbier M, et al
     Dutch healthcare professionals' opinion on vaccination and education to prevent infections in immunocompromised patients: A mixed-method study with recommendations for daily practice.
     Vaccine. 2019 Feb 7. pii: S0264-410X(19)30160.
     PubMed     Text format     Abstract available
     
     
     
422. FORTANIER AC, Venekamp RP, Hoes AW, Schilder AGM, et al
     Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study.
     Vaccine. 2019 Feb 6. pii: S0264-410X(19)30149.
     PubMed     Text format     Abstract available
     
     
     
423. SHEN AK, Groom AV, Leach DL, Bridges CB, et al
     A pathway to developing and testing quality measures aimed at improving adult vaccination rates in the United States.
     Vaccine. 2019 Feb 6. pii: S0264-410X(19)30120.
     PubMed     Text format     Abstract available
     
     
     
424. BORGEY F, Henry L, Lebeltel J, Lescure P, et al
     Effectiveness of an intervention campaign on influenza vaccination of professionals in nursing homes: A cluster-randomized controlled trial.
     Vaccine. 2019 Feb 6. pii: S0264-410X(19)30151.
     PubMed     Text format     Abstract available
     
     
     
425. KESSELS J, Tarantola A, Salahuddin N, Blumberg L, et al
     Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course.
     Vaccine. 2019 Feb 5. pii: S0264-410X(19)30105.
     PubMed     Text format     Abstract available
     
     
     
426. RANDALL H, Kallen LE
     Using advocacy to increase investment in enteric vaccine development.
     Vaccine. 2019 Feb 5. pii: S0264-410X(18)31706.
     PubMed     Text format     Abstract available
     
     
     
427. PARKER AR, Park MA, Harding S, Abraham RS, et al
     The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax(R)23) in a healthy adult population and patients diagnosed with primary immunodeficiencies.
     Vaccine. 2019 Feb 5. pii: S0264-410X(19)30098.
     PubMed     Text format     Abstract available
     
     
     
428. ROY S, Jaeson MI, Li Z, Mahboob S, et al
     Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes.
     Vaccine. 2019 Feb 4. pii: S0264-410X(19)30121.
     PubMed     Text format     Abstract available
     
     
     
429. STASI C, Monnini M, Cellesi V, Salvadori M, et al
     Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study.
     Vaccine. 2019 Feb 4. pii: S0264-410X(19)30125.
     PubMed     Text format     Abstract available
     
     
     
430. SHEIKH S, Biundo E, Courcier S, Damm O, et al
     Corrigendum to 'A report on the status of vaccination in Europe' [Vaccine 36 (2018) 4979-4992].
     Vaccine. 2019 Feb 4. pii: S0264-410X(19)30102.
     PubMed     Text format    
     
     
     
431. NOLAN MB, Schulman ML, Botha AE, Human AM, et al
     Serum antibody immunoreactivity and safety of native porcine and recombinant zona pellucida vaccines formulated with a non-Freund's adjuvant in horses.
     Vaccine. 2019 Feb 4. pii: S0264-410X(19)30129.
     PubMed     Text format     Abstract available
     
     
     
432. DEMPSEY AF, Pyrzanowski J, Campagna EJ, Lockhart S, et al
     Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention.
     Vaccine. 2019 Feb 4. pii: S0264-410X(19)30127.
     PubMed     Text format     Abstract available
     
     
     
433. RAO S, Alishahi M, De Crescenzo L, Dempsey AF, et al
     A population-based study of maternal and infant factors influencing influenza vaccination among young children born in Colorado from 2008 to 2016.
     Vaccine. 2019 Feb 2. pii: S0264-410X(19)30130.
     PubMed     Text format     Abstract available
     
     
     
434. ABENTE EJ, Rajao DS, Gauger PC, Vincent AL, et al
     Alphavirus-vectored hemagglutinin subunit vaccine provides partial protection against heterologous challenge in pigs.
     Vaccine. 2019 Feb 2. pii: S0264-410X(19)30052.
     PubMed     Text format     Abstract available
     
     
     
435. BEARSON SMD, Bearson BL, Sylte MJ, Looft T, et al
     Cross-protective Salmonella vaccine reduces cecal and splenic colonization of multidrug-resistant Salmonella enterica serovar Heidelberg.
     Vaccine. 2019 Feb 1. pii: S0264-410X(19)30027.
     PubMed     Text format     Abstract available
     
     
     January 2019
436. KIM T, Hong JK, Oem JK, Lee KN, et al
     Cross-protective efficacy of the O1 Manisa+O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig.
     Vaccine. 2019 Jan 31. pii: S0264-410X(18)31644.
     PubMed     Text format     Abstract available
     
     
     
437. MONTESINO R, Gutierrez N, Camacho F, Farnos O, et al
     Multi-antigenic recombinant subunit vaccine against Lawsonia intracellularis: The etiological agent of porcine proliferative enteropathy.
     Vaccine. 2019 Jan 30. pii: S0264-410X(19)30092.
     PubMed     Text format     Abstract available
     
     
     
438. MARECHAL C, Lal H, Poder A, Ferguson M, et al
     Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults >/=50years of age: A randomized trial' [Vaccine 36 (2018) 4278-4286].
     Vaccine. 2019 Jan 30. pii: S0264-410X(19)30076.
     PubMed     Text format    
     
     
     
439. BORRAS E, Urbiztondo L, Carmona G, Jane M, et al
     Effectiveness and impact of the hepatitis B vaccination program in preadolescents in Catalonia 21 years after its introduction.
     Vaccine. 2019 Jan 29. pii: S0264-410X(19)30078.
     PubMed     Text format     Abstract available
     
     
     
440. XU S, Newcomer SR, Kulldorff M, Daley MF, et al
     Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule.
     Vaccine. 2019 Jan 29. pii: S0264-410X(19)30104.
     PubMed     Text format     Abstract available
     
     
     
441. MOTTRAM L, Chakraborty S, Cox E, Fleckenstein J, et al
     How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions.
     Vaccine. 2019 Jan 29. pii: S0264-410X(19)30069.
     PubMed     Text format     Abstract available
     
     
     
442. SHAPIRO JR, Hodgins B, Hendin HE, Patel A, et al
     Needle-free delivery of influenza vaccine using the Med-Jet(R) H4 is efficient and elicits the same humoral and cellular responses as standard IM injection: A randomized trial.
     Vaccine. 2019 Jan 29. pii: S0264-410X(19)30103.
     PubMed     Text format     Abstract available
     
     
     
443. PADMANABHA N, Kini JR, Alwani AA, Sardesai A, et al
     Acceptability of human papillomavirus vaccination among medical students in Mangalore, India.
     Vaccine. 2019 Jan 29. pii: S0264-410X(19)30095.
     PubMed     Text format     Abstract available
     
     
     
444. QUINN SC, Jamison AM, An J, Hancock GR, et al
     Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: Results of a national survey of White and African American adults.
     Vaccine. 2019 Jan 29. pii: S0264-410X(19)30096.
     PubMed     Text format     Abstract available
     
     
     
445. AMADOR-MOLINA A, Trejo-Moreno C, Romero-Rodriguez D, Sada-Ovalle I, et al
     Vaccination with human papillomavirus-18 E1 protein plus alpha-galactosyl-ceramide induces CD8(+) cytotoxic response and impairs the growth of E1-expressing tumors.
     Vaccine. 2019 Jan 28. pii: S0264-410X(18)31709.
     PubMed     Text format     Abstract available
     
     
     
446. ADDISON M, Lazzaro T, Crawford N
     Injection site abscess (ISA) following an infant vaccine.
     Vaccine. 2019 Jan 28. pii: S0264-410X(19)30079.
     PubMed     Text format    
     
     
     
447. SURYADEVARA M, Bonville CA, Cibula DA, Domachowske JB, et al
     Associations between population based voting trends during the 2016 US presidential election and adolescent vaccination rates.
     Vaccine. 2019 Jan 25. pii: S0264-410X(19)30099.
     PubMed     Text format     Abstract available
     
     
     
448. WARRELL MJ
     Rabies post-exposure vaccination in 2 visits within a week: A 4-site intradermal regimen.
     Vaccine. 2019 Jan 25. pii: S0264-410X(19)30073.
     PubMed     Text format     Abstract available
     
     
     
449. GHORBANI A, Ngunjiri JM, Xia M, Elaish M, et al
     Heterosubtypic protection against avian influenza virus by live attenuated and chimeric norovirus P-particle-M2e vaccines in chickens.
     Vaccine. 2019 Jan 25. pii: S0264-410X(19)30100.
     PubMed     Text format     Abstract available
     
     
     
450. NOLAN T, Santolaya ME, de Looze F, Marshall H, et al
     Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine.
     Vaccine. 2019 Jan 25. pii: S0264-410X(19)30028.
     PubMed     Text format     Abstract available
     
     
     
451. GARON J, Wuddhika IV, Sreenivasan N, Wannemuehler K, et al
     Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
     Vaccine. 2019 Jan 24. pii: S0264-410X(19)30008.
     PubMed     Text format     Abstract available
     
     
     
452. WILDES TJ, Grippin A, Fasanya H, Dyson KA, et al
     Effect of atorvastatin on humoral immune response to 23-valent pneumococcal polysaccharide vaccination in healthy volunteers: The StatVax randomized clinical trial.
     Vaccine. 2019 Jan 24. pii: S0264-410X(19)30077.
     PubMed     Text format     Abstract available
     
     
     
453. SMITHSON MW, Basinki AJ, Nuismer SL, Bull JJ, et al
     Transmissible vaccines whose dissemination rates vary through time, with applications to wildlife.
     Vaccine. 2019 Jan 24. pii: S0264-410X(19)30072.
     PubMed     Text format     Abstract available
     
     
     
454. VADLAMUDI NK, Parhar K, Altre Malana KL, Kang A, et al
     Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis.
     Vaccine. 2019 Jan 23. pii: S0264-410X(19)30057.
     PubMed     Text format     Abstract available
     
     
     
455. COELHO CH, Gazzinelli-Guimaraes PH, Howard J, Barnafo E, et al
     Chronic helminth infection does not impair immune response to malaria transmission blocking vaccine Pfs230D1-EPA/Alhydrogel(R) in mice.
     Vaccine. 2019 Jan 23. pii: S0264-410X(19)30090.
     PubMed     Text format     Abstract available
     
     
     
456. SAHIN Z, Neeleman R, Haines J, Kayser V, et al
     Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines.
     Vaccine. 2019 Jan 23. pii: S0264-410X(19)30050.
     PubMed     Text format     Abstract available
     
     
     
457. MILUCKY J, Carvalho MG, Rouphael N, Bennett NM, et al
     Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016.
     Vaccine. 2019 Jan 23. pii: S0264-410X(19)30070.
     PubMed     Text format     Abstract available
     
     
     
458. JENDROSSEK M, Edmunds WJ, Rohan H, Clifford S, et al
     Health care worker vaccination against Ebola: Vaccine acceptance and employment duration in Sierra Leone.
     Vaccine. 2019 Jan 23. pii: S0264-410X(19)30029.
     PubMed     Text format     Abstract available
     
     
     
459. LYONS NA, Knight-Jones TJD, Bartels C, Paton DJ, et al
     Considerations for design and implementation of vaccine field trials for novel foot-and-mouth disease vaccines.
     Vaccine. 2019 Jan 23. pii: S0264-410X(19)30043.
     PubMed     Text format     Abstract available
     
     
     
460. LU J, Luo M, Yee AZH, Sheldenkar A, et al
     Do superstitious beliefs affect influenza vaccine uptake through shaping health beliefs?
     Vaccine. 2019 Jan 22. pii: S0264-410X(19)30071.
     PubMed     Text format     Abstract available
     
     
     
461. TORISU H, Okada K
     Vaccination-associated acute disseminated encephalomyelitis.
     Vaccine. 2019 Jan 22. pii: S0264-410X(19)30075.
     PubMed     Text format     Abstract available
     
     
     
462. SHEN AK, Warnock R, Selna W, MaCurdy TE, et al
     Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017.
     Vaccine. 2019 Jan 22. pii: S0264-410X(19)30041.
     PubMed     Text format     Abstract available
     
     
     
463. ZHANG D, Jiang N, Chen Q
     Vaccination with recombinant adenoviruses expressing Toxoplasma gondii MIC3, ROP9, and SAG2 provide protective immunity against acute toxoplasmosis in mice.
     Vaccine. 2019 Jan 19. pii: S0264-410X(18)31729.
     PubMed     Text format     Abstract available
     
     
     
464. ROBERTSON CA, Hedrick J, Bassily E, Greenberg DP, et al
     Persistence of bactericidal antibodies 4years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D).
     Vaccine. 2019 Jan 19. pii: S0264-410X(19)30039.
     PubMed     Text format     Abstract available
     
     
     
465. LEDOV VA, Golovina ME, Markina AA, Knirel YA, et al
     Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.
     Vaccine. 2019 Jan 19. pii: S0264-410X(19)30048.
     PubMed     Text format     Abstract available
     
     
     
466. WOUTERS I, Desmet S, Van Heirstraeten L, Blaizot S, et al
     Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium.
     Vaccine. 2019 Jan 19. pii: S0264-410X(19)30049.
     PubMed     Text format     Abstract available
     
     
     
467. WOODS CW, Sanchez AM, Swamy GK, McClain MT, et al
     An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults.
     Vaccine. 2019 Jan 18. pii: S0264-410X(18)31699.
     PubMed     Text format     Abstract available
     
     
     
468. MARLOW R, Finn A, Rodrigues F
     Lack of impact of rotavirus vaccination on childhood seizure hospital attendances in Portugal - An interrupted time series analysis.
     Vaccine. 2019 Jan 17. pii: S0264-410X(19)30055.
     PubMed     Text format    
     
     
     
469. YUNG BS, Pugh H, Generotti AA, Phanhthilath N, et al
     Novel IFN-gamma ELISpot reveals robust T cell responses elicited after influenza nucleoprotein DNA vaccination in New Zealand White rabbits.
     Vaccine. 2019 Jan 17. pii: S0264-410X(19)30037.
     PubMed     Text format     Abstract available
     
     
     
470. KOLE S, Qadiri SSN, Shin SM, Kim WS, et al
     PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes.
     Vaccine. 2019 Jan 17. pii: S0264-410X(19)30042.
     PubMed     Text format     Abstract available
     
     
     
471. LALSIAMTHARA J, Senevirathne A, Lee JH
     Partial protection induced by Salmonella based Brucella vaccine candidate in pregnant guinea pigs.
     Vaccine. 2019 Jan 17. pii: S0264-410X(19)30074.
     PubMed     Text format     Abstract available
     
     
     
472. STRIJBOS E, Tannemaat MR, Alleman I, de Meel RHP, et al
     A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis.
     Vaccine. 2019 Jan 16. pii: S0264-410X(19)30038.
     PubMed     Text format     Abstract available
     
     
     
473. LANDAZABAL CS, Moro PL, Lewis P, Omer SB, et al
     Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017.
     Vaccine. 2019 Jan 16. pii: S0264-410X(18)31641.
     PubMed     Text format     Abstract available
     
     
     
474. DEGAREGE A, Krupp K, Fennie K, Srinivas V, et al
     An integrative behavior theory derived model to assess factors affecting HPV vaccine acceptance using structural equation modeling.
     Vaccine. 2019 Jan 14. pii: S0264-410X(19)30046.
     PubMed     Text format     Abstract available
     
     
     
475. BIANCO A, Mascaro V, Zucco R, Pavia M, et al
     Parent perspectives on childhood vaccination: How to deal with vaccine hesitancy and refusal?
     Vaccine. 2019 Jan 14. pii: S0264-410X(19)30033.
     PubMed     Text format     Abstract available
     
     
     
476. XU L, Li Z, Su Z, Yang Y, et al
     Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
     Vaccine. 2019 Jan 14. pii: S0264-410X(19)30054.
     PubMed     Text format     Abstract available
     
     
     
477. SMITH GP, Jain-Gupta N, Alqublan H, Dorneles EMS, et al
     Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH.
     Vaccine. 2019 Jan 14. pii: S0264-410X(19)30051.
     PubMed     Text format     Abstract available
     
     
     
478. BOCCALINI S, Tacconi FM, Lai PL, Bechini A, et al
     Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy.
     Vaccine. 2019 Jan 14. pii: S0264-410X(19)30026.
     PubMed     Text format     Abstract available
     
     
     
479. MUNIRA SL, Hendriks JT, Atmosukarto II, Friede MH, et al
     A cost analysis of producing vaccines in developing countries.
     Vaccine. 2019 Jan 14. pii: S0264-410X(18)31575.
     PubMed     Text format     Abstract available
     
     
     
480. WALLACE AS, Wannemuehler K, Bonsu G, Wardle M, et al
     Development of a valid and reliable scale to assess parents' beliefs and attitudes about childhood vaccines and their association with vaccination uptake and delay in Ghana.
     Vaccine. 2019 Jan 11. pii: S0264-410X(19)30024.
     PubMed     Text format     Abstract available
     
     
     
481. WANG X, Tang Q, Qiu L, Yang Z, et al
     Penton-dodecahedron of fowl adenovirus serotype 4 as a vaccine candidate for the control of related diseases.
     Vaccine. 2019 Jan 11. pii: S0264-410X(18)31714.
     PubMed     Text format     Abstract available
     
     
     
482. JALLOH MF, Bennett SD, Alam D, Kouta P, et al
     Rapid behavioral assessment of barriers and opportunities to improve vaccination coverage among displaced Rohingyas in Bangladesh, January 2018.
     Vaccine. 2019 Jan 11. pii: S0264-410X(18)31715.
     PubMed     Text format     Abstract available
     
     
     
483. SOUTO FJD, de Brito WI, Fontes CJF
     Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil.
     Vaccine. 2019 Jan 10. pii: S0264-410X(19)30010.
     PubMed     Text format     Abstract available
     
     
     
484. VANNICE KS, Cassetti MC, Eisinger RW, Hombach J, et al
     Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates.
     Vaccine. 2019 Jan 10. pii: S0264-410X(18)31713.
     PubMed     Text format     Abstract available
     
     
     
485. SHEN A, Khavjou O, King G, Bates L, et al
     Provider time and costs to vaccinate adult patients: Impact of time counseling without vaccination.
     Vaccine. 2019 Jan 10. pii: S0264-410X(19)30001.
     PubMed     Text format     Abstract available
     
     
     
486. KHAN AI, Islam MS, Islam MT, Ahmed A, et al
     Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
     Vaccine. 2019 Jan 10. pii: S0264-410X(19)30004.
     PubMed     Text format     Abstract available
     
     
     
487. LUSVAN ME, Debellut F, Clark A, Demberelsuren S, et al
     Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia.
     Vaccine. 2019 Jan 10. pii: S0264-410X(19)30025.
     PubMed     Text format     Abstract available
     
     
     
488. BAKER SM, Pociask D, Clements JD, McLachlan JB, et al
     Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.
     Vaccine. 2019 Jan 9. pii: S0264-410X(19)30009.
     PubMed     Text format     Abstract available
     
     
     
489. POLKOWSKA A, Skoczynska A, Paradowska-Stankiewicz I, Stefanoff P, et al
     Pneumococcal meningitis before the introduction of 10-valent pneumococcal conjugate vaccine into the National Childhood Immunization Program in Poland.
     Vaccine. 2019 Jan 9. pii: S0264-410X(18)31701.
     PubMed     Text format     Abstract available
     
     
     
490. CHEN W, Zhao Y, Xie X, Liu J, et al
     Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90months of follow-up.
     Vaccine. 2019 Jan 9. pii: S0264-410X(18)31703.
     PubMed     Text format     Abstract available
     
     
     
491. XIAN TH, Parasuraman S, Sinniah K, Ravichandran M, et al
     Repeated dose toxicity evaluation of a cold chain-free, live, attenuated oral cholera vaccine in Sprague Dawley rats.
     Vaccine. 2019 Jan 7. pii: S0264-410X(18)31700.
     PubMed     Text format     Abstract available
     
     
     
492. PENG X, Hu X, Salazar MA
     First case in China of vaccine-associated poliomyelitis after sequential Inactivated and bivalent oral polio vaccination.
     Vaccine. 2019 Jan 7. pii: S0264-410X(18)31693.
     PubMed     Text format     Abstract available
     
     
     
493. NAILI I, Vinot J, Baudner BC, Bernalier-Donadille A, et al
     Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota.
     Vaccine. 2019;37:314-324.
     PubMed     Text format     Abstract available
     
     
     
494. PANOZZO CA, Pourmalek F, Brauchli Pernus Y, Pileggi GS, et al
     Arthritis and arthralgia as an adverse event following immunization: A systematic literature review.
     Vaccine. 2019;37:372-383.
     PubMed     Text format     Abstract available
     
     
     
495. WORLD HEALTH ORGANIZATION
     Measles vaccines: WHO position paper, April 2017 - Recommendations.
     Vaccine. 2019;37:219-222.
     PubMed     Text format     Abstract available
     
     
     
496. VU M, Luu M, Haardorfer R, Berg CJ, et al
     A multilevel analysis of factors influencing the inaccuracy of parental reports of adolescent HPV vaccination status.
     Vaccine. 2019 Jan 6. pii: S0264-410X(18)31705.
     PubMed     Text format     Abstract available
     
     
     
497. MCDONALD P, Limaye RJ, Omer SB, Buttenheim AM, et al
     Exploring California's new law eliminating personal belief exemptions to childhood vaccines and vaccine decision-making among homeschooling mothers in California.
     Vaccine. 2019 Jan 6. pii: S0264-410X(18)31678.
     PubMed     Text format     Abstract available
     
     
     
498. WANG Y, Zade J, Moon SS, Weldon W, et al
     Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species.
     Vaccine. 2019 Jan 6. pii: S0264-410X(18)31716.
     PubMed     Text format     Abstract available
     
     
     
499. MORAN A, Agaliotis M, Seale H
     The views of key stakeholders around mandatory influenza vaccination of hospital and aged care staff: Examining the current climate in Australia.
     Vaccine. 2019 Jan 6. pii: S0264-410X(18)31702.
     PubMed     Text format     Abstract available
     
     
     
500. HEALY SA, Fried M, Richie T, Bok K, et al
     Malaria vaccine trials in pregnant women: An imperative without precedent.
     Vaccine. 2019 Jan 6. pii: S0264-410X(18)31698.
     PubMed     Text format     Abstract available
     
     
     
501. PRASERT K, Patumanond J, Praphasiri P, Siriluk S, et al
     Effectiveness of trivalent inactivated influenza vaccine among community-dwelling older adults in Thailand: A two-year prospective cohort study.
     Vaccine. 2019 Jan 4. pii: S0264-410X(19)30003.
     PubMed     Text format     Abstract available
     
     
     
502. ATTWELL K, Dube E, Gagneur A, Omer SB, et al
     Vaccine acceptance: Science, policy, and practice in a 'post-fact' world.
     Vaccine. 2019 Jan 4. pii: S0264-410X(18)31674.
     PubMed     Text format     Abstract available
     
     
     
503. TOIZUMI M, Vo HM, Dang DA, Moriuchi H, et al
     Clinical manifestations of congenital rubella syndrome: A review of our experience in Vietnam.
     Vaccine. 2019;37:202-209.
     PubMed     Text format     Abstract available
     
     
     
504. VERMA SK, Gupta A, Batra L, Tuteja U, et al
     Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection.
     Vaccine. 2019;37:19-24.
     PubMed     Text format     Abstract available
     
     
     
505. BEN-SHIMOL S, Givon-Lavi N, Leibovitz E, Greenberg D, et al
     Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis.
     Vaccine. 2019;37:1-6.
     PubMed     Text format     Abstract available
     
     
     
506. WEHBI NK, Wani RJ, Klepser DG, Murry J, et al
     Impact of implementing a technology platform in community pharmacies to increase adult immunizations rates.
     Vaccine. 2019;37:56-60.
     PubMed     Text format     Abstract available
     
     
     
507. KIM SJ, Seon SH, Luong TT, Ghosh P, et al
     Immunization with attenuated non-transformable pneumococcal pep27 and comD mutant provides serotype-independent protection against pneumococcal infection.
     Vaccine. 2019;37:90-98.
     PubMed     Text format     Abstract available
     
     
     
508. BEN FRAJ I, Smaoui H, Zghal M, Sassi O, et al
     Seroprevalence of pertussis among healthcare workers: A cross-sectional study from Tunisia.
     Vaccine. 2019;37:109-112.
     PubMed     Text format     Abstract available
     
     
     
509. NAGAI K, Domon H, Maekawa T, Hiyoshi T, et al
     Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection.
     Vaccine. 2019;37:160-168.
     PubMed     Text format     Abstract available
     
     
     
510. ARORA G, Lehman D, Charlu S, Ross N, et al
     Vaccine health beliefs and educational influences among pediatric residents.
     Vaccine. 2019 Jan 2. pii: S0264-410X(18)31711.
     PubMed     Text format     Abstract available
     
     
     
511. NAWA N, Fujiwara T
     Association between social capital and second dose of measles vaccination in Japan: Results from the A-CHILD study.
     Vaccine. 2019 Jan 2. pii: S0264-410X(18)31710.
     PubMed     Text format     Abstract available
     
     
     
512. YAN Z, Cui Y, Zhou W, Li W, et al
     Molecular characterization of Streptococcus pneumoniae in children living in southwest China and assessment of a potential protein vaccine, rPfbA.
     Vaccine. 2019 Jan 2. pii: S0264-410X(18)31692.
     PubMed     Text format     Abstract available
     
     
     December 2018
513. QUINTEL BK, Thomas A, Poer DeRaad DE, Slifka MK, et al
     Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine.
     Vaccine. 2018 Dec 31. pii: S0264-410X(18)31691.
     PubMed     Text format     Abstract available
     
     
     
514. REGAN AK, Gibbs R, Bloomfield L, Effler PV, et al
     Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records.
     Vaccine. 2018 Dec 29. pii: S0264-410X(18)31651.
     PubMed     Text format     Abstract available
     
     
     
515. EDLER M, Fernandez A, Anderson K, Pierce JY, et al
     HPV vaccination, knowledge, and attitudes among young cervical cancer survivors in the Deep South.
     Vaccine. 2018 Dec 28. pii: S0264-410X(18)31712.
     PubMed     Text format     Abstract available
     
     
     
516. HURLEY LP, Allison MA, Kim L, O'Leary ST, et al
     Primary care physicians' perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults.
     Vaccine. 2018 Dec 28. pii: S0264-410X(18)31704.
     PubMed     Text format     Abstract available
     
     
     
517. WAGNER AL, Shenton LM, Gillespie BW, Mathew JL, et al
     Assessing the timeliness of vaccine administration in children under five years in India, 2013.
     Vaccine. 2018 Dec 27. pii: S0264-410X(18)31708.
     PubMed     Text format     Abstract available
     
     
     
518. LIN X, Shrader L, Rodgers L, Stokley S, et al
     Increasing human papillomavirus vaccination at the recommended age.
     Vaccine. 2018 Dec 24. pii: S0264-410X(18)31694.
     PubMed     Text format     Abstract available
     
     
     
519. VAN MULDER TJS, Withanage K, Beyers KCL, Vankerckhoven VVJ, et al
     Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID.
     Vaccine. 2018 Dec 23. pii: S0264-410X(18)31676.
     PubMed     Text format     Abstract available
     
     
     
520. BASTA NE, Becker AB, Li Q, Nederhoff D, et al
     Parental awareness of Meningococcal B vaccines and willingness to vaccinate their teens.
     Vaccine. 2018 Dec 23. pii: S0264-410X(18)31642.
     PubMed     Text format     Abstract available
     
     
     
521. KRISHNAMOORTHY Y, Eliyas SK, Nair NP, Sakthivel M, et al
     Impact and cost effectiveness of pneumococcal conjugate vaccine in India.
     Vaccine. 2018 Dec 23. pii: S0264-410X(18)31649.
     PubMed     Text format     Abstract available
     
     
     
522. HIRTH JM, Fuchs EL, Chang M, Fernandez ME, et al
     Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008-2016).
     Vaccine. 2018 Dec 21. pii: S0264-410X(18)31677.
     PubMed     Text format     Abstract available
     
     
     
523. ROCHANATHIMOKE O, Riewpaiboon A, Tharmaphornpilas P, Jiamsiri S, et al
     Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination.
     Vaccine. 2018 Dec 19. pii: S0264-410X(18)31673.
     PubMed     Text format     Abstract available
     
     
     
524. HANSON CM, Mirza I, Kumapley R, Ogbuanu I, et al
     Response to comments on "Enhancing immunization during second year of life by reducing missed opportunities for vaccinations in 46 countries".
     Vaccine. 2018;36:7908.
     PubMed     Text format    
     
     
     
525. THYSEN SM, Fisker AB
     Reducing missed opportunities for vaccinations should be done with eyes wide open.
     Vaccine. 2018;36:7907.
     PubMed     Text format    
     
     
     
526. WEDLOCK PT, Mitgang EA, Elsheikh F, Leonard J, et al
     The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
     Vaccine. 2018 Dec 18. pii: S0264-410X(18)31653.
     PubMed     Text format     Abstract available
     
     
     
527. FISHER H, Harding S, Hickman M, Macleod J, et al
     Barriers and enablers to adolescent self-consent for vaccination: A mixed-methods evidence synthesis.
     Vaccine. 2018 Dec 17. pii: S0264-410X(18)31652.
     PubMed     Text format     Abstract available
     
     
     
528. TAK CR, Gunning K, Kim J, Sherwin CM, et al
     The effect of a prescription order requirement for pharmacist-administered vaccination on herpes zoster vaccination rates.
     Vaccine. 2018 Dec 15. pii: S0264-410X(18)31648.
     PubMed     Text format     Abstract available
     
     
     
529. PEPIN S, Dupuy M, Borja-Tabora CFC, Montellano M, et al
     Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.
     Vaccine. 2018 Dec 14. pii: S0264-410X(18)31637.
     PubMed     Text format     Abstract available
     
     
     
530. MILLER PDE, de Silva TI, Leonard H, Anthias C, et al
     A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoieti
     Vaccine. 2018 Dec 13. pii: S0264-410X(18)31586.
     PubMed     Text format     Abstract available
     
     
     
531. BAHRI P, Rago L
     CIOMS Guide To Vaccine Safety Communication - Executive summary.
     Vaccine. 2018 Dec 13. pii: S0264-410X(18)31646.
     PubMed     Text format     Abstract available
     
     
     
532. KIMOTO T, Kim H, Sakai S, Takahashi E, et al
     Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity i
     Vaccine. 2018 Dec 13. pii: S0264-410X(18)31647.
     PubMed     Text format     Abstract available
     
     
     
533. OSHANSKY CM, Zhou J, Gao Y, Schweinle JE, et al
     Safety and immunogenicity of influenza A(H5N1) vaccine stored up to twelve years in the National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS).
     Vaccine. 2018 Dec 12. pii: S0264-410X(18)31632.
     PubMed     Text format     Abstract available
     
     
     
534. HOOK LM, Awasthi S, Dubin J, Flechtner J, et al
     A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection.
     Vaccine. 2018 Dec 12. pii: S0264-410X(18)31639.
     PubMed     Text format     Abstract available
     
     
     
535. BROTHERTON JM, Hawkes D, Sultana F, Malloy MJ, et al
     Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact.
     Vaccine. 2018 Dec 11. pii: S0264-410X(18)31638.
     PubMed     Text format     Abstract available
     
     
     
536. DENIS M, Knezevic I, Wilde H, Hemachudha T, et al
     An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route.
     Vaccine. 2018 Dec 11. pii: S0264-410X(18)31635.
     PubMed     Text format     Abstract available
     
     
     
537. VAN ZANDVOORT K, Howard N, Mounier-Jack S, Jit M, et al
     Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries.
     Vaccine. 2018 Dec 10. pii: S0264-410X(18)31633.
     PubMed     Text format     Abstract available
     
     
     
538. POLLOCK KG, Wallace LA, Wrigglesworth S, McMaster D, et al
     HPV vaccine uptake in men who have sex with men in Scotland.
     Vaccine. 2018 Dec 10. pii: S0264-410X(18)31645.
     PubMed     Text format     Abstract available
     
     
     
539. CATTAPAN A, Browne K, Halperin DM, Di Castri A, et al
     Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
     Vaccine. 2018 Dec 6. pii: S0264-410X(18)31527.
     PubMed     Text format     Abstract available
     
     
     
540. LEIDNER AJ, Murthy N, Chesson HW, Biggerstaff M, et al
     Cost-effectiveness of adult vaccinations: A systematic review.
     Vaccine. 2018 Dec 4. pii: S0264-410X(18)31581.
     PubMed     Text format     Abstract available
     
     
     
541. YANG YT, Huang AL, Zhao Y
     The prevalence of hepatitis B core antibody in vaccinated Chinese children: A hospital-based study.
     Vaccine. 2018 Dec 4. pii: S0264-410X(18)31630.
     PubMed     Text format     Abstract available
     
     
     
542. O'NEILL J, Newall F, Antolovich G, Lima S, et al
     The uptake of adolescent vaccinations through the School Immunisation Program in specialist schools in Victoria, Australia.
     Vaccine. 2018 Dec 3. pii: S0264-410X(18)31557.
     PubMed     Text format     Abstract available
     
     
     
543. VALENCIA S, Gill RB, Dowdell KC, Wang Y, et al
     Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model.
     Vaccine. 2018 Dec 3. pii: S0264-410X(18)31172.
     PubMed     Text format     Abstract available
     
     
     November 2018
544. SHIBLI R, Rishpon S, Cohen-Dar M, Kandlik Y, et al
     What affects pediatric healthcare providers to encourage receipt of routine childhood vaccinations? Results from the Northern District of Israel, 2016.
     Vaccine. 2018 Nov 30. pii: S0264-410X(18)31576.
     PubMed     Text format     Abstract available
     
     
     
545. CIRUELA P, Izquierdo C, Broner S, Munoz-Almagro C, et al
     The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.
     Vaccine. 2018;36:7744-7752.
     PubMed     Text format     Abstract available
     
     
     
546. BRESEE JS, McKinlay MA, Abramson J, Klugman KP, et al
     Global Funders Consortium for Universal Influenza Vaccine Development.
     Vaccine. 2018 Nov 29. pii: S0264-410X(18)31560.
     PubMed     Text format    
     
     
     
547. FREW PM, Murden R, Mehta CC, Chamberlain AT, et al
     Development of a US trust measure to assess and monitor parental confidence in the vaccine system.
     Vaccine. 2018 Nov 29. pii: S0264-410X(18)31312.
     PubMed     Text format     Abstract available
     
     
     
548. NAKAYAMA T
     Causal relationship between immunological responses and adverse reactions following vaccination.
     Vaccine. 2018 Nov 29. pii: S0264-410X(18)31568.
     PubMed     Text format     Abstract available
     
     
     
549. DUSZYNSKI KM, Pratt NL, Lynch JW, Berry JG, et al
     Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and t
     Vaccine. 2018 Nov 28. pii: S0264-410X(18)31548.
     PubMed     Text format     Abstract available
     
     
     
550. FLAXMAN A, Yamaguchi Y, van Diemen PM, Rollier C, et al
     Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination.
     Vaccine. 2018 Nov 28. pii: S0264-410X(18)31588.
     PubMed     Text format     Abstract available
     
     
     
551. JRADI H, Bawazir A
     Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine.
     Vaccine. 2018 Nov 28. pii: S0264-410X(18)31590.
     PubMed     Text format     Abstract available
     
     
     
552. FABER MT, Duun-Henriksen AK, Dehlendorff C, Tatla MK, et al
     Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy.
     Vaccine. 2018 Nov 28. pii: S0264-410X(18)31553.
     PubMed     Text format     Abstract available
     
     
     
553. LANGEDIJK AC, van Aalst M, Meek B, van Leeuwen EMM, et al
     Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation.
     Vaccine. 2018 Nov 27. pii: S0264-410X(18)31578.
     PubMed     Text format     Abstract available
     
     
     
554. DAWA J, Chaves SS, Ba Nguz A, Kalani R, et al
     Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG).
     Vaccine. 2018 Nov 27. pii: S0264-410X(18)31587.
     PubMed     Text format     Abstract available
     
     
     
555. JEONG JH, Kim EH, Lloren KKS, Kwon JJ, et al
     Preclinical evaluation of the efficacy of an H5N8 vaccine candidate (IDCDC-RG43A) in mouse and ferret models for pandemic preparedness.
     Vaccine. 2018 Nov 27. pii: S0264-410X(18)31589.
     PubMed     Text format     Abstract available
     
     
     
556. SATZKE C, Dunne EM, Choummanivong M, Ortika BD, et al
     Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine.
     Vaccine. 2018 Nov 27. pii: S0264-410X(18)31464.
     PubMed     Text format     Abstract available
     
     
     
557. ELSHINA E, Allen ER, Flaxman A, van Diemen PM, et al
     Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease.
     Vaccine. 2018 Nov 27. pii: S0264-410X(18)31559.
     PubMed     Text format     Abstract available
     
     
     
558. ABI JAOUDE J, Khair D, Dagher H, Saad H, et al
     Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study.
     Vaccine. 2018;36:7562-7567.
     PubMed     Text format     Abstract available
     
     
     
559. NAPOLITANO F, Gualdieri L, Santagati G, Angelillo IF, et al
     Knowledge and attitudes toward HPV infection and vaccination among immigrants and refugees in Italy.
     Vaccine. 2018;36:7536-7541.
     PubMed     Text format     Abstract available
     
     
     
560. REN S, Holliday E, Hure A, Peel R, et al
     Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions: Experience from the Hunter Community Study.
     Vaccine. 2018;36:7520-7524.
     PubMed     Text format     Abstract available
     
     
     
561. PASTOR Y, Camacho AI, Zuniga-Ripa A, Merchan A, et al
     Towards a subunit vaccine from a Shigella flexneri DeltatolR mutant.
     Vaccine. 2018;36:7509-7519.
     PubMed     Text format     Abstract available
     
     
     
562. VAN DE BURGWAL LHM, Ribeiro CDS, Van der Waal MB, Claassen E, et al
     Towards improved process efficiency in vaccine innovation: The Vaccine Innovation Cycle as a validated, conceptual stage-gate model.
     Vaccine. 2018;36:7496-7508.
     PubMed     Text format     Abstract available
     
     
     
563. PECENKA C, Debellut F, Bar-Zeev N, Anwari P, et al
     Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
     Vaccine. 2018;36:7472-7478.
     PubMed     Text format     Abstract available
     
     
     
564. KARTHIGESU SP, Chisholm JS, Coall DA
     Do grandparents influence parents' decision to vaccinate their children? A systematic review.
     Vaccine. 2018;36:7456-7462.
     PubMed     Text format     Abstract available
     
     
     
565. VAJO Z, Kalabay L, Vajo P, Balaton G, et al
     Licensing the first reduced, 6microg dose whole virion, aluminum adjuvanted seasonal influenza vaccine - A randomized-controlled multicenter trial.
     Vaccine. 2018 Nov 26. pii: S0264-410X(18)31562.
     PubMed     Text format     Abstract available
     
     
     
566. YU W, Lee LA, Liu Y, Scherpbier RW, et al
     Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
     Vaccine. 2018 Nov 26. pii: S0264-410X(18)31357.
     PubMed     Text format     Abstract available
     
     
     
567. HEGAZY-HASSAN W, Zepeda-Escobar JA, Ochoa-Garcia L, Contreras-Ortiz JME, et al
     TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
     Vaccine. 2018 Nov 26. pii: S0264-410X(18)31564.
     PubMed     Text format     Abstract available
     
     
     
568. KOCHHAR S, Excler JL, Bok K, Gurwith M, et al
     Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines.
     Vaccine. 2018 Nov 26. pii: S0264-410X(18)31235.
     PubMed     Text format     Abstract available
     
     
     
569. QUEENAN AM, Dowling DJ, Cheng WK, Fae K, et al
     Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
     Vaccine. 2018 Nov 23. pii: S0264-410X(18)31551.
     PubMed     Text format     Abstract available
     
     
     
570. CAMPBELL ZA, Otieno L, Shirima GM, Marsh TL, et al
     Drivers of vaccination preferences to protect a low-value livestock resource: Willingness to pay for Newcastle disease vaccines by smallholder households.
     Vaccine. 2018 Nov 23. pii: S0264-410X(18)31583.
     PubMed     Text format     Abstract available
     
     
     
571. MCCLURE DL, Jacobsen SJ, Klein NP, Naleway AL, et al
     Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.
     Vaccine. 2018 Nov 23. pii: S0264-410X(18)31561.
     PubMed     Text format     Abstract available
     
     
     
572. PEZZOTTI P, Bellino S, Riccardo F, Lucaroni F, et al
     Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016.
     Vaccine. 2018 Nov 23. pii: S0264-410X(18)31572.
     PubMed     Text format     Abstract available
     
     
     
573. MATYSIAK-KLOSE D, Santibanez S, Schwerdtfeger C, Koch J, et al
     Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany.
     Vaccine. 2018 Nov 23. pii: S0264-410X(18)31455.
     PubMed     Text format     Abstract available
     
     
     
574. RIDDELL CA, Bhat N, Bont LJ, Dupont WD, et al
     Informing randomized clinical trials of respiratory syncytial virus vaccination during pregnancy to prevent recurrent childhood wheezing: A sample size analysis.
     Vaccine. 2018 Nov 22. pii: S0264-410X(18)31407.
     PubMed     Text format     Abstract available
     
     
     
575. AKHTAR M, Chowdhury MI, Bhuiyan TR, Kaim J, et al
     Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELI
     Vaccine. 2018 Nov 22. pii: S0264-410X(18)31563.
     PubMed     Text format     Abstract available
     
     
     
576. TARANTOLA A, Tejiokem MC, Briggs DJ
     Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines.
     Vaccine. 2018 Nov 21. pii: S0264-410X(18)31542.
     PubMed     Text format     Abstract available
     
     
     
577. BOLLAERTS K, Verstraeten T, Cohet C
     Observational studies of non-specific effects of Diphtheria-Tetanus-Pertussis vaccines in low-income countries: Assessing the potential impact of study characteristics, bias and confounding through meta-regression.
     Vaccine. 2018 Nov 21. pii: S0264-410X(18)31574.
     PubMed     Text format     Abstract available
     
     
     
578. MCMORROW ML, Tempia S, Walaza S, Treurnicht FK, et al
     Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa.
     Vaccine. 2018 Nov 21. pii: S0264-410X(18)31573.
     PubMed     Text format     Abstract available
     
     
     
579. BERNSTEIN DI, Pullum DA, Cardin RD, Bravo FJ, et al
     The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
     Vaccine. 2018 Nov 21. pii: S0264-410X(18)31565.
     PubMed     Text format     Abstract available
     
     
     
580. VESIKARI T, Borrow R, Da Costa X, Thomas S, et al
     Concomitant administration of a fully liquid ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal ACWY conjugate vaccine in toddlers.
     Vaccine. 2018 Nov 21. pii: S0264-410X(18)31497.
     PubMed     Text format     Abstract available
     
     
     
581. STEAD M, Critchlow N, Eadie D, Sullivan F, et al
     Mandatory policies for influenza vaccination: Views of managers and healthcare workers in England.
     Vaccine. 2018 Nov 20. pii: S0264-410X(18)31556.
     PubMed     Text format     Abstract available
     
     
     
582. CHEN J, Yu X, Zheng Q, Hou L, et al
     The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
     Vaccine. 2018 Nov 20. pii: S0264-410X(18)31523.
     PubMed     Text format     Abstract available
     
     
     
583. KOVACS E, Sahin-Toth J, Tothpal A, Kristof K, et al
     Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.
     Vaccine. 2018 Nov 20. pii: S0264-410X(18)31549.
     PubMed     Text format     Abstract available
     
     
     
584. LOPEZ AL, Harris JB, Raguindin PF, Aldaba J, et al
     Introduction of inactivated poliovirus vaccine in the Philippines: Effect on health care provider and infant caregiver attitudes and practices.
     Vaccine. 2018;36:7399-7407.
     PubMed     Text format     Abstract available
     
     
     
585. CROWCROFT NS, Klein NP
     A framework for research on vaccine effectiveness.
     Vaccine. 2018;36:7286-7293.
     PubMed     Text format     Abstract available
     
     
     
586. HURLEY LP, Allison MA, Dooling KL, O'Leary ST, et al
     Primary care physicians' experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV).
     Vaccine. 2018;36:7408-7414.
     PubMed     Text format     Abstract available
     
     
     
587. DEMEURE CE, Derbise A, Guillas C, Gerke C, et al
     Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.
     Vaccine. 2018 Nov 19. pii: S0264-410X(18)31545.
     PubMed     Text format     Abstract available
     
     
     
588. DE SERRES G, Billard MN, Gariepy MC, Rouleau I, et al
     Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada.
     Vaccine. 2018 Nov 19. pii: S0264-410X(18)31492.
     PubMed     Text format     Abstract available
     
     
     
589. DENG Y, Cai W, Li J, Li Y, et al
     Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing.
     Vaccine. 2018 Nov 19. pii: S0264-410X(18)31543.
     PubMed     Text format     Abstract available
     
     
     
590. DIAMOS AG, Larios D, Brown L, Kilbourne J, et al
     Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen.
     Vaccine. 2018 Nov 17. pii: S0264-410X(18)31544.
     PubMed     Text format     Abstract available
     
     
     
591. SEPPALA EM, Lopez-Perea N, Torres de Mier MV, Echevarria JE, et al
     Last cases of rubella and congenital rubella syndrome in Spain, 1997-2016: The success of a vaccination program.
     Vaccine. 2018 Nov 16. pii: S0264-410X(18)31539.
     PubMed     Text format     Abstract available
     
     
     
592. TUCKERMAN J, Misan S, Salih S, Joseph Xavier B, et al
     Influenza vaccination: Uptake and associations in a cross-sectional study of children with special risk medical conditions.
     Vaccine. 2018 Nov 16. pii: S0264-410X(18)31299.
     PubMed     Text format     Abstract available
     
     
     
593. DONG B, Wang L, Nie S, Li X, et al
     Anti-glioma effect of intracranial vaccination with tumor cell lysate plus flagellin in mice.
     Vaccine. 2018 Nov 15. pii: S0264-410X(18)30550.
     PubMed     Text format     Abstract available
     
     
     
594. NAGASHIMA S, Yamamoto C, Ko K, Chuon C, et al
     Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination.
     Vaccine. 2018 Nov 15. pii: S0264-410X(18)31541.
     PubMed     Text format     Abstract available
     
     
     
595. MILLIGAN GN, Schnierle BS, McAuley AJ, Beasley DWC, et al
     Defining a correlate of protection for chikungunya virus vaccines.
     Vaccine. 2018 Nov 15. pii: S0264-410X(18)31399.
     PubMed     Text format     Abstract available
     
     
     
596. BIELECKI K, Kirolos A, Willocks LJ, Pollock KG, et al
     Low uptake of nasal influenza vaccine in polish and other ethnic minority children in Edinburgh, Scotland.
     Vaccine. 2018 Nov 15. pii: S0264-410X(18)31552.
     PubMed     Text format     Abstract available
     
     
     
597. ESPOSITO D, Titievsky L, Beachler DC, Hawes JCL, et al
     Incidence of outcomes relevant to vaccine safety monitoring in a US commercially-insured population.
     Vaccine. 2018 Nov 15. pii: S0264-410X(18)31418.
     PubMed     Text format     Abstract available
     
     
     
598. KUROVA N, Timofeeva EV, Guiso N, Macina D, et al
     A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
     Vaccine. 2018 Nov 15. pii: S0264-410X(18)31516.
     PubMed     Text format     Abstract available
     
     
     
599. YUE X, Black CL, Williams WW, Lu PJ, et al
     Influenza vaccination among adults living with persons at high-risk for complications from influenza during early 2016-17 influenza season.
     Vaccine. 2018 Nov 14. pii: S0264-410X(18)31499.
     PubMed     Text format     Abstract available
     
     
     
600. VALENTINI S, Santoro G, Baffetta F, Franceschi S, et al
     Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
     Vaccine. 2018 Nov 14. pii: S0264-410X(18)31469.
     PubMed     Text format     Abstract available
     
     
     
601. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
     Association between patient reminders and influenza vaccination status among children.
     Vaccine. 2018 Nov 14. pii: S0264-410X(18)31395.
     PubMed     Text format     Abstract available
     
     
     
602. WON SY, Hunt K, Guak H, Hasaj B, et al
     Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.
     Vaccine. 2018 Nov 14. pii: S0264-410X(18)31496.
     PubMed     Text format     Abstract available
     
     
     
603. BACCI JL, Hansen R, Ree C, Reynolds MJ, et al
     The effects of vaccination forecasts and value-based payment on adult immunizations by community pharmacists.
     Vaccine. 2018 Nov 13. pii: S0264-410X(18)31540.
     PubMed     Text format     Abstract available
     
     
     
604. PAN WK, Seidman JC, Ali A, Hoest C, et al
     Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
     Vaccine. 2018 Nov 12. pii: S0264-410X(18)30746.
     PubMed     Text format     Abstract available
     
     
     
605. GIORGAKOUDI K, O'Sullivan C, Heath PT, Ladhani S, et al
     Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
     Vaccine. 2018;36:7033-7042.
     PubMed     Text format     Abstract available
     
     
     
606. 
     Dengue vaccine: WHO position paper, September 2018 - Recommendations.
     Vaccine. 2018 Nov 10. pii: S0264-410X(18)31339.
     PubMed     Text format     Abstract available
     
     
     
607. SHANG M, Chung JR, Jackson ML, Jackson LA, et al
     Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016.
     Vaccine. 2018 Nov 9. pii: S0264-410X(18)31490.
     PubMed     Text format     Abstract available
     
     
     
608. HUANG H, Gao P, Gao Z, Wang L, et al
     A big pertussis outbreak in a primary school with high vaccination coverage in northern China: An evidence of the emerging of the disease in China.
     Vaccine. 2018 Nov 9. pii: S0264-410X(18)31518.
     PubMed     Text format     Abstract available
     
     
     
609. CHEN S, Lin F, Chen S, Hu Q, et al
     Development of a live attenuated vaccine against Muscovy duck reovirus infection.
     Vaccine. 2018 Nov 9. pii: S0264-410X(18)31502.
     PubMed     Text format     Abstract available
     
     
     
610. RATHI N, Desai S, Kawade A, Venkatramanan P, et al
     A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
     Vaccine. 2018 Nov 9. pii: S0264-410X(18)31515.
     PubMed     Text format     Abstract available
     
     
     
611. HOEVE CE, van Haren A, Sturkenboom MCJM, Straus SMJM, et al
     Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study.
     Vaccine. 2018 Nov 8. pii: S0264-410X(18)31501.
     PubMed     Text format     Abstract available
     
     
     
612. MUNOZ FM, Jackson LA, Swamy GK, Edwards KM, et al
     Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.
     Vaccine. 2018 Nov 8. pii: S0264-410X(18)31475.
     PubMed     Text format     Abstract available
     
     
     
613. ADETIFA IMO, Karia B, Mutuku A, Bwanaali T, et al
     Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.
     Vaccine. 2018 Nov 8. pii: S0264-410X(18)31504.
     PubMed     Text format     Abstract available
     
     
     
614. MACIAS PARRA M, Gentile A, Vazquez Narvaez JA, Capdevila A, et al
     Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial.
     Vaccine. 2018 Nov 7. pii: S0264-410X(18)31493.
     PubMed     Text format     Abstract available
     
     
     
615. BURNETT E, Van Trang N, Rayamajhi A, Yousafzai MT, et al
     Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2years of age in four Asian countries.
     Vaccine. 2018 Nov 7. pii: S0264-410X(18)31500.
     PubMed     Text format     Abstract available
     
     
     
616. WOOD ME, Griebel P, Huizenga ML, Lockwood S, et al
     Accelerated onset of chronic wasting disease in elk (Cervus canadensis) vaccinated with a PrP(Sc)-specific vaccine and housed in a prion contaminated environment.
     Vaccine. 2018 Nov 7. pii: S0264-410X(18)31425.
     PubMed     Text format     Abstract available
     
     
     
617. WILCOX CR, Bottrell K, Paterson P, Schulz WS, et al
     Influenza and pertussis vaccination in pregnancy: Portrayal in online media articles and perceptions of pregnant women and healthcare professionals.
     Vaccine. 2018 Nov 3. pii: S0264-410X(18)31489.
     PubMed     Text format     Abstract available
     
     
     
618. WANG X, Li M, Lin Z, Pan H, et al
     Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.
     Vaccine. 2018 Nov 2. pii: S0264-410X(18)31486.
     PubMed     Text format     Abstract available
     
     
     
619. HAATVEIT HM, Hodneland K, Braaen S, Hansen EF, et al
     DNA vaccine expressing the non-structural proteins of Piscine orthoreovirus delay the kinetics of PRV infection and induces moderate protection against heart -and skeletal muscle inflammation in Atlantic salmon (Salmo salar).
     Vaccine. 2018 Nov 2. pii: S0264-410X(18)31491.
     PubMed     Text format     Abstract available
     
     
     
620. POLLOCK KG, Tait B, Tait J, Bielecki K, et al
     Evidence of decreased HPV vaccine acceptance in Polish communities within Scotland.
     Vaccine. 2018 Nov 2. pii: S0264-410X(18)31494.
     PubMed     Text format     Abstract available
     
     
     
621. DESAI S, Schanzer DL, Silva A, Rotondo J, et al
     Trends in Canadian infant pertussis hospitalizations in the pre- and post-acellular vaccine era, 1981-2016.
     Vaccine. 2018 Nov 1. pii: S0264-410X(18)31413.
     PubMed     Text format     Abstract available
     
     
     
622. TRUMBO SP, Silver D, Domenti O, Gasoyan H, et al
     Strengthening legal frameworks for vaccination: The experiences of Armenia, Georgia, and Moldova.
     Vaccine. 2018 Nov 1. pii: S0264-410X(18)31454.
     PubMed     Text format     Abstract available
     
     
     October 2018
623. BOCQUIER A, Fressard L, Cortaredona S, Zaytseva A, et al
     Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: A nationwide cross-sectional study.
     Vaccine. 2018 Oct 31. pii: S0264-410X(18)31472.
     PubMed     Text format     Abstract available
     
     
     
624. YANG X, Zhang D, Ou W
     Pneumococcal vaccination patterns among persons aged 65years or older in the United States: A retrospective database analysis.
     Vaccine. 2018 Oct 31. pii: S0264-410X(18)31367.
     PubMed     Text format     Abstract available
     
     
     
625. SHEDRAWY J, Henriksson M, Hergens MP, Askling HH, et al
     Estimating costs and health outcomes of publicly funded tick-born encephalitis vaccination: A cost-effectiveness analysis.
     Vaccine. 2018 Oct 30. pii: S0264-410X(18)31473.
     PubMed     Text format     Abstract available
     
     
     
626. GILBERT BE, Patel N, Lu H, Liu Y, et al
     Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
     Vaccine. 2018 Oct 30. pii: S0264-410X(18)31458.
     PubMed     Text format     Abstract available
     
     
     
627. MARTIRE B, Azzari C, Badolato R, Canessa C, et al
     Corrigendum to: "Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET)" [Vaccine 36 (2018) Pages 3541-3542].
     Vaccine. 2018 Oct 30. pii: S0264-410X(18)31424.
     PubMed     Text format    
     
     
     
628. AHMED N, Quinn SC, Hancock GR, Freimuth VS, et al
     Social media use and influenza vaccine uptake among White and African American adults.
     Vaccine. 2018 Oct 30. pii: S0264-410X(18)31415.
     PubMed     Text format     Abstract available
     
     
     
629. WILLAME C, Lin L, Vetter V, Baril L, et al
     Reply to Lee et al.'s letter to the editor pertaining to our publication entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
     Vaccine. 2018;36:6589-6590.
     PubMed     Text format    
     
     
     
630. LEE AW, Saldutti LP, Wolfson LJ, Stek JE, et al
     To the editor: Response to Willame, et al., published in Vaccine 35 (2017) 5551-5558, entitled "Pain caused by measles, mumps, and rubella vaccines: A systematic literature review".
     Vaccine. 2018;36:6587-6588.
     PubMed     Text format    
     
     
     
631. DATEY A, Shreenivas M, Chandrasekharan G, Joseph J, et al
     Rewiring of one carbon metabolism in Salmonella serves as an excellent live vaccine against systemic salmonellosis.
     Vaccine. 2018 Oct 29. pii: S0264-410X(18)31466.
     PubMed     Text format     Abstract available
     
     
     
632. GIUFRE M, Fabiani M, Cardines R, Riccardo F, et al
     Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012-2016.
     Vaccine. 2018;36:6615-6622.
     PubMed     Text format     Abstract available
     
     
     
633. ARAUJO IL, Dummer LA, Rodrigues PRC, Dos Santos AG Jr, et al
     Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
     Vaccine. 2018 Oct 28. pii: S0264-410X(18)31467.
     PubMed     Text format     Abstract available
     
     
     
634. MOSAHEB M, Wetzler LM
     Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
     Vaccine. 2018 Oct 28. pii: S0264-410X(18)31459.
     PubMed     Text format     Abstract available
     
     
     
635. SCHURINK-VAN 'T KLOOSTER TM, Donken R, Schepp RM, van der Klis FRM, et al
     Persistence of immune response following bivalent HPV vaccination: A follow-up study among girls routinely vaccinated with a two-dose schedule.
     Vaccine. 2018 Oct 27. pii: S0264-410X(18)31370.
     PubMed     Text format     Abstract available
     
     
     
636. BOIGARD H, Cimica V, Galarza JM
     Dengue-2 virus-like particle (VLP) based vaccine elicits the highest titers of neutralizing antibodies when produced at reduced temperature.
     Vaccine. 2018 Oct 27. pii: S0264-410X(18)31457.
     PubMed     Text format     Abstract available
     
     
     
637. HIRTH J, McGrath CJ, Kuo YF, Rupp RE, et al
     Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26year old females in the U.S.
     Vaccine. 2018 Oct 27. pii: S0264-410X(18)31462.
     PubMed     Text format     Abstract available
     
     
     
638. PERCIACCANTE A, Coralli A, Bianucci R
     Vaccines: The oxymoron of Italian health policy.
     Vaccine. 2018 Oct 23. pii: S0264-410X(18)31404.
     PubMed     Text format    
     
     
     
639. BERKLEY S
     Political will and vaccine legislation.
     Vaccine. 2018 Oct 23. pii: S0264-410X(18)31402.
     PubMed     Text format    
     
     
     
640. LOVRIC MAKARIC Z, Kolaric B, Tomljenovic M, Posavec M, et al
     Attitudes and beliefs related to childhood vaccinations among parents of 6years old children in Zagreb, Croatia.
     Vaccine. 2018 Oct 23. pii: S0264-410X(18)31421.
     PubMed     Text format     Abstract available
     
     
     
641. IKILEZI G, Zlavog B, Augusto OJ, Sherr K, et al
     Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
     Vaccine. 2018 Oct 23. pii: S0264-410X(18)31430.
     PubMed     Text format     Abstract available
     
     
     
642. CALO WA, Gilkey MB, Malo TL, Robichaud M, et al
     A content analysis of HPV vaccination messages available online.
     Vaccine. 2018 Oct 23. pii: S0264-410X(18)31419.
     PubMed     Text format     Abstract available
     
     
     
643. BEKKAT-BERKANI R, Romano-Mazzotti L
     Understanding the unique characteristics of seasonal influenza illness to improve vaccine uptake in the US.
     Vaccine. 2018 Oct 23. pii: S0264-410X(18)31393.
     PubMed     Text format     Abstract available
     
     
     
644. ZHANG H, Wen W, Zhao Z, Wang J, et al
     Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-gamma as immunoadjuvant in weaning piglets.
     Vaccine. 2018 Oct 23. pii: S0264-410X(18)31396.
     PubMed     Text format     Abstract available
     
     
     
645. GAGNEUR A, Gosselin V, Dube E
     Motivational interviewing: A promising tool to address vaccine hesitancy.
     Vaccine. 2018;36:6553-6555.
     PubMed     Text format    
     
     
     
646. ZHAI Y, Santibanez TA, Kahn KE, Black CL, et al
     Paid sick leave benefits, influenza vaccination, and taking sick days due to influenza-like illness among U.S. workers.
     Vaccine. 2018 Oct 22. pii: S0264-410X(18)31405.
     PubMed     Text format     Abstract available
     
     
     
647. LOEB M, Russell ML, Neupane B, Thanabalan V, et al
     A randomized, blinded, placebo-controlled trial comparing antibody responses to homeopathic and conventional vaccines in university students.
     Vaccine. 2018 Oct 20. pii: S0264-410X(18)31232.
     PubMed     Text format     Abstract available
     
     
     
648. HEINSBROEK E, Tafatatha T, Phiri A, Swarthout TD, et al
     Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination.
     Vaccine. 2018 Oct 20. pii: S0264-410X(18)31387.
     PubMed     Text format     Abstract available
     
     
     
649. VAUGHN AR, Johnson ML
     Communicating and enhancing teachers' attitudes and understanding of influenza using refutational text.
     Vaccine. 2018 Oct 17. pii: S0264-410X(18)31406.
     PubMed     Text format     Abstract available
     
     
     
650. WANG Q, Yue N, Zheng M, Wang D, et al
     Influenza vaccination coverage of population and the factors influencing influenza vaccination in mainland China: A meta-analysis.
     Vaccine. 2018 Oct 16. pii: S0264-410X(18)31411.
     PubMed     Text format     Abstract available
     
     
     
651. D'ALESSIO F, Koopman G, Houard S, Remarque EJ, et al
     Workshop report: Experimental animal models for universal influenza vaccines.
     Vaccine. 2018 Oct 16. pii: S0264-410X(18)31390.
     PubMed     Text format     Abstract available
     
     
     
652. THOMAS LF, Bellet C, Rushton J
     Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology.
     Vaccine. 2018 Oct 16. pii: S0264-410X(18)31410.
     PubMed     Text format     Abstract available
     
     
     
653. MCGAVIN ZA, Wagner AL, Carlson BF, Power LE, et al
     Childhood full and under-vaccination in Nigeria, 2013.
     Vaccine. 2018 Oct 16. pii: S0264-410X(18)31409.
     PubMed     Text format     Abstract available
     
     
     
654. ZHANG L, Durr E, Galli JD, Cosmi S, et al
     Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability.
     Vaccine. 2018 Oct 16. pii: S0264-410X(18)31398.
     PubMed     Text format     Abstract available
     
     
     
655. SANTIBANEZ TA, Kahn KE, Bridges CB
     Do parents prefer inactivated or live attenuated influenza vaccine for their children?
     Vaccine. 2018 Oct 16. pii: S0264-410X(18)31408.
     PubMed     Text format     Abstract available
     
     
     
656. CANNON JW, Jack S, Wu Y, Zhang J, et al
     An economic case for a vaccine to prevent group A streptococcus skin infections.
     Vaccine. 2018 Oct 16. pii: S0264-410X(18)31352.
     PubMed     Text format     Abstract available
     
     
     
657. CHIDO-AMAJUOYI OG, Wonodi C, Mantey D, Perez A, et al
     Prevalence and correlates of never vaccinated Nigerian children, aged 1-5years.
     Vaccine. 2018 Oct 16. pii: S0264-410X(18)31358.
     PubMed     Text format     Abstract available
     
     
     
658. HRABER P, Bradfute S, Clarke E, Ye C, et al
     Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus.
     Vaccine. 2018 Oct 15. pii: S0264-410X(18)31388.
     PubMed     Text format     Abstract available
     
     
     
659. SALAT J, Formanova P, Hunady M, Eyer L, et al
     Development and testing of a new tick-borne encephalitis virus vaccine candidate for veterinary use.
     Vaccine. 2018 Oct 15. pii: S0264-410X(18)31400.
     PubMed     Text format     Abstract available
     
     
     
660. THANG HV, Huong VM, Victor JC, Van CB, et al
     Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam.
     Vaccine. 2018 Oct 15. pii: S0264-410X(18)31365.
     PubMed     Text format     Abstract available
     
     
     
661. ATTWELL K, Navin MC, Lopalco PL, Jestin C, et al
     Recent vaccine mandates in the United States, Europe and Australia: A comparative study.
     Vaccine. 2018 Oct 15. pii: S0264-410X(18)31371.
     PubMed     Text format     Abstract available
     
     
     
662. HAQUE W, Haque J, Barai D, Rahman S, et al
     Distribution of rotavirus genotypes in Dhaka, Bangladesh, 2012-2016: Re-emergence of G3P[8] after over a decade of interval.
     Vaccine. 2018;36:6393-6400.
     PubMed     Text format     Abstract available
     
     
     
663. TOKARS JI, Rolfes MA, Foppa IM, Reed C, et al
     An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States.
     Vaccine. 2018 Oct 13. pii: S0264-410X(18)31392.
     PubMed     Text format     Abstract available
     
     
     
664. BARRERA J, Brake DA, Schutta C, Ettyreddy D, et al
     Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
     Vaccine. 2018 Oct 13. pii: S0264-410X(18)31397.
     PubMed     Text format     Abstract available
     
     
     
665. NUGENT G, Yockney IJ, Cross ML, Buddle BM, et al
     Low-dose BCG vaccination protects free-ranging cattle against naturally-acquired bovine tuberculosis.
     Vaccine. 2018 Oct 13. pii: S0264-410X(18)31391.
     PubMed     Text format     Abstract available
     
     
     
666. YEOLEKAR LR, Ganguly M, Tyagi P, Ingle NB, et al
     Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
     Vaccine. 2018 Oct 12. pii: S0264-410X(18)31354.
     PubMed     Text format     Abstract available
     
     
     
667. GERRETSEN HE, Capone S, Vitelli A, Reyes LS, et al
     Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.
     Vaccine. 2018 Oct 11. pii: S0264-410X(18)31351.
     PubMed     Text format     Abstract available
     
     
     
668. SASAKI E, Momose H, Hiradate Y, Mizukami T, et al
     Establishment of a novel safety assessment method for vaccine adjuvant development.
     Vaccine. 2018 Oct 11. pii: S0264-410X(18)31361.
     PubMed     Text format     Abstract available
     
     
     
669. PIRCON JY, Talarico CA, Bollaerts K, Hausdorff WP, et al
     The choice of analytical methodology can alter conclusions regarding herd effects of paediatric pneumococcal vaccination programmes.
     Vaccine. 2018 Oct 10. pii: S0264-410X(18)31355.
     PubMed     Text format     Abstract available
     
     
     
670. ZHANG Z, Dong Z, Wang Q, Carr MJ, et al
     Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
     Vaccine. 2018 Oct 10. pii: S0264-410X(18)31350.
     PubMed     Text format     Abstract available
     
     
     
671. GILCA V, Sauvageau C, Panicker G, De Serres G, et al
     Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial.
     Vaccine. 2018 Oct 9. pii: S0264-410X(18)31326.
     PubMed     Text format     Abstract available
     
     
     
672. ODEVALL L, Hong D, Digilio L, Sahastrabuddhe S, et al
     The Euvichol story - Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships.
     Vaccine. 2018 Oct 9. pii: S0264-410X(18)31276.
     PubMed     Text format     Abstract available
     
     
     
673. SCHAEFERS MM, Duan B, Mizrahi B, Lu R, et al
     PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia.
     Vaccine. 2018 Oct 9. pii: S0264-410X(18)31362.
     PubMed     Text format     Abstract available
     
     
     
674. BOCKSTAL V, Tiemessen MM, Achterberg R, Van Wordragen C, et al
     An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6(R) cell culture platform is immunogenic and safe in a non-human primate model.
     Vaccine. 2018 Oct 9. pii: S0264-410X(18)31349.
     PubMed     Text format     Abstract available
     
     
     
675. HADDISON EC, Ngono D, Kouamen GT, Kagina BM, et al
     Successful polio supplementary immunisation activities in a security compromised zone - Experiences from the Southwest region of Cameroon.
     Vaccine. 2018 Oct 9. pii: S0264-410X(18)31356.
     PubMed     Text format     Abstract available
     
     
     
676. CHANGALUCHA J, Steenson R, Grieve E, Cleaveland S, et al
     The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania.
     Vaccine. 2018 Oct 8. pii: S0264-410X(18)31243.
     PubMed     Text format     Abstract available
     
     
     
677. WUTZLER P, Casabona G, Cnops J, Akpo EIH, et al
     Herpes zoster in the context of varicella vaccination - An equation with several variables.
     Vaccine. 2018 Oct 8. pii: S0264-410X(18)31262.
     PubMed     Text format     Abstract available
     
     
     
678. AKSULAR M, Calvo-Pinilla E, Marin-Lopez A, Ortego J, et al
     A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model.
     Vaccine. 2018 Oct 8. pii: S0264-410X(18)31341.
     PubMed     Text format     Abstract available
     
     
     
679. LEE VY, Booy R, Skinner SR, Fong J, et al
     The effect of exercise on local and systemic adverse reactions after vaccinations - Outcomes of two randomized controlled trials.
     Vaccine. 2018 Oct 6. pii: S0264-410X(18)31345.
     PubMed     Text format     Abstract available
     
     
     
680. ABEBE A, Getahun M, Mapaseka SL, Beyene B, et al
     Impact of rotavirus vaccine introduction and genotypic characteristics of rotavirus strains in children less than 5years of age with gastroenteritis in Ethiopia: 2011-2016.
     Vaccine. 2018 Oct 6. pii: S0264-410X(18)31317.
     PubMed     Text format     Abstract available
     
     
     
681. MUGO NR, Eckert L, Magaret AS, Cheng A, et al
     Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.
     Vaccine. 2018 Oct 5. pii: S0264-410X(18)31328.
     PubMed     Text format     Abstract available
     
     
     
682. GROMIS A, Liu K
     The roles of neighborhood composition and autism prevalence on vaccination exemption pockets: A population-wide study.
     Vaccine. 2018 Oct 5. pii: S0264-410X(18)31298.
     PubMed     Text format     Abstract available
     
     
     
683. IBRAHIM R, Ali SA, Kazi AM, Rizvi A, et al
     Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting.
     Vaccine. 2018 Oct 5. pii: S0264-410X(18)31314.
     PubMed     Text format     Abstract available
     
     
     
684. BARTSCH SM, Taitel MS, DePasse JV, Cox SN, et al
     Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
     Vaccine. 2018 Oct 5. pii: S0264-410X(18)31300.
     PubMed     Text format     Abstract available
     
     
     
685. HUNGERFORD D, Vivancos R, Read JM, Bonnett LJ, et al
     Mitigating bias in observational vaccine effectiveness studies using simulated comparator populations: Application to rotavirus vaccination in the UK.
     Vaccine. 2018 Oct 4. pii: S0264-410X(18)31320.
     PubMed     Text format     Abstract available
     
     
     
686. TIFREA DF, Pal S, Le Bon C, Giusti F, et al
     Co-delivery of amphipol-conjugated adjuvant with antigen, and adjuvant combinations, enhance immune protection elicited by a membrane protein-based vaccine against a mucosal challenge with Chlamydia.
     Vaccine. 2018 Oct 4. pii: S0264-410X(18)31324.
     PubMed     Text format     Abstract available
     
     
     
687. SALMONS B, Lim PY, Djurup R, Cardosa J, et al
     Non-clinical safety assessment of repeated intramuscular administration of an EV-A71 VLP vaccine in rabbits.
     Vaccine. 2018 Oct 4. pii: S0264-410X(18)31331.
     PubMed     Text format     Abstract available
     
     
     
688. MUKERJI R, Hendrickson C, Genschmer KR, Park SS, et al
     The diversity of the proline-rich domain of pneumococcal surface protein A (PspA): Potential relevance to a broad-spectrum vaccine.
     Vaccine. 2018 Oct 4. pii: S0264-410X(18)31174.
     PubMed     Text format     Abstract available
     
     
     
689. TSUZUKI S, Schwehm M, Eichner M
     Corrigendum to "Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination" [Vaccine 36 (2018) 624-630].
     Vaccine. 2018 Oct 3. pii: S0264-410X(18)31315.
     PubMed     Text format    
     
     
     
690. ROBISON SG, Thomas AR
     Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
     Vaccine. 2018 Oct 1. pii: S0264-410X(18)31319.
     PubMed     Text format     Abstract available
     
     
     
691. ZHANG C, Huang X, Chen S, Li Y, et al
     Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid.
     Vaccine. 2018 Oct 1. pii: S0264-410X(18)31295.
     PubMed     Text format     Abstract available
     
     
     
692. RAGONNAUD E, Schroedel S, Mariya S, Iskandriati D, et al
     Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques.
     Vaccine. 2018;36:6212-6222.
     PubMed     Text format     Abstract available
     
     
     September 2018
693. BORG K, Sutton K, Beasley M, Tull F, et al
     Communication-based interventions for increasing influenza vaccination rates among Aboriginal children: A randomised controlled trial.
     Vaccine. 2018 Sep 29. pii: S0264-410X(18)31269.
     PubMed     Text format     Abstract available
     
     
     
694. GORDON CL, Hutchings CL, Highton AJ, Colston JM, et al
     Memory inflation following adenoviral vaccination depends on IL-21.
     Vaccine. 2018 Sep 29. pii: S0264-410X(18)31330.
     PubMed     Text format     Abstract available
     
     
     
695. MIYAMOTO N, Mochizuki S, Kobiyama K, Ishii KJ, et al
     Corrigendum to "Designing an immunocyte-targeting delivery system by use of beta-glucan" [Vaccine 36 (2018) 186-189].
     Vaccine. 2018 Sep 29. pii: S0264-410X(18)31316.
     PubMed     Text format    
     
     
     
696. HAYASHI T, Lynch HE, Geyer S, Yoshida K, et al
     Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.
     Vaccine. 2018 Sep 28. pii: S0264-410X(18)31323.
     PubMed     Text format     Abstract available
     
     
     
697. HAN Y, Peng X, Li K, Jiang X, et al
     Potent effect of KISS1-54 DNA vaccine compared with KISS1-10 DNA vaccine in inhibiting the fertility of female rats.
     Vaccine. 2018 Sep 28. pii: S0264-410X(18)31322.
     PubMed     Text format     Abstract available
     
     
     
698. FERLITO C, Biselli R, Mariotti S, von Hunolstein C, et al
     Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1 *01.
     Vaccine. 2018 Sep 27. pii: S0264-410X(18)31301.
     PubMed     Text format     Abstract available
     
     
     
699. LAIRD RM, Ma Z, Dorabawila N, Pequegnat B, et al
     Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella.
     Vaccine. 2018 Sep 27. pii: S0264-410X(18)31321.
     PubMed     Text format     Abstract available
     
     
     
700. HARRIS SL, Tan C, Andrew L, Hao L, et al
     The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci.
     Vaccine. 2018 Sep 27. pii: S0264-410X(18)30747.
     PubMed     Text format     Abstract available
     
     
     
701. KIELY M, Billard MN, Toth E, Zafack JG, et al
     Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa(R)) and MMRV (ProQuad(R)) at 18months of age.
     Vaccine. 2018 Sep 27. pii: S0264-410X(18)31318.
     PubMed     Text format     Abstract available
     
     
     
702. SCHNEIDER K, Gronhoj C, Hahn CH, von Buchwald C, et al
     Therapeutic human papillomavirus vaccines in head and neck cancer: A systematic review of current clinical trials.
     Vaccine. 2018 Sep 26. pii: S0264-410X(18)31277.
     PubMed     Text format     Abstract available
     
     
     
703. TENG Z, Sun S, Chen H, Huang J, et al
     Golden-star nanoparticles as adjuvant effectively promotes immune response to foot-and-mouth disease virus-like particles vaccine.
     Vaccine. 2018 Sep 26. pii: S0264-410X(18)31290.
     PubMed     Text format     Abstract available
     
     
     
704. GOLDFARB IT, Jaffe E, James K, Drapkin Lyerly A, et al
     Pregnant women's attitudes toward Zika virus vaccine trial participation.
     Vaccine. 2018 Sep 26. pii: S0264-410X(18)31311.
     PubMed     Text format     Abstract available
     
     
     
705. JUAN-GINER A, Tchaton M, Jemmy JP, Soumah A, et al
     Safety of the rVSV ZEBOV vaccine against Ebola Zaire among frontline workers in Guinea.
     Vaccine. 2018 Sep 25. pii: S0264-410X(18)31246.
     PubMed     Text format     Abstract available
     
     
     
706. SAYEDAHMED EE, Kumari R, Shukla S, Hassan AO, et al
     Longevity of adenovirus vector immunity in mice and its implications for vaccine efficacy.
     Vaccine. 2018 Sep 25. pii: S0264-410X(18)31291.
     PubMed     Text format     Abstract available
     
     
     
707. DOKE K, Fitzgerald SA, Barral RL, Griffin P, et al
     Concomitant HPV and MenACWY vaccination among sixth and seventh graders receiving Tdap.
     Vaccine. 2018 Sep 25. pii: S0264-410X(18)31216.
     PubMed     Text format     Abstract available
     
     
     
708. STUURMAN AL, Riera M, Lamprianou S, Perez-Vilar S, et al
     Vaccine safety surveillance in pregnancy in low- and middle-income countries using GAIA case definitions: A feasibility assessment.
     Vaccine. 2018 Sep 25. pii: S0264-410X(18)31293.
     PubMed     Text format     Abstract available
     
     
     
709. TILEY KS, White JM, Andrews N, Ramsay M, et al
     Inequalities in childhood vaccination timing and completion in London.
     Vaccine. 2018 Sep 25. pii: S0264-410X(18)31292.
     PubMed     Text format     Abstract available
     
     
     
710. REN Z, Zhao Y, Liu J, Ji X, et al
     Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.
     Vaccine. 2018;36:5990-5998.
     PubMed     Text format     Abstract available
     
     
     
711. SURAGH TA, Lamprianou S, MacDonald NE, Loharikar AR, et al
     Cluster anxiety-related adverse events following immunization (AEFI): An assessment of reports detected in social media and those identified using an online search engine.
     Vaccine. 2018;36:5949-5954.
     PubMed     Text format     Abstract available
     
     
     
712. BURKHARDT M, Reiter K, Nguyen V, Suzuki M, et al
     Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A.
     Vaccine. 2018 Sep 24. pii: S0264-410X(18)31297.
     PubMed     Text format     Abstract available
     
     
     
713. WANG Y, Resch T, Esona MD, Moon SS, et al
     A DS-1 like G9P[6] human strain CDC-6 as a new rotavirus vaccine candidate.
     Vaccine. 2018 Sep 24. pii: S0264-410X(18)31184.
     PubMed     Text format     Abstract available
     
     
     
714. MCCOY JD, Painter JE, Jacobsen KH
     Perceptions of vaccination within a Christian homeschooling community in Pennsylvania.
     Vaccine. 2018 Sep 22. pii: S0264-410X(18)31296.
     PubMed     Text format     Abstract available
     
     
     
715. CHU K, Ying Z, Wang L, Hu Y, et al
     Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial.
     Vaccine. 2018 Sep 21. pii: S0264-410X(18)31272.
     PubMed     Text format     Abstract available
     
     
     
716. GREENBERG D, Hoover PA, Vesikari T, Peltier C, et al
     Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.
     Vaccine. 2018 Sep 20. pii: S0264-410X(18)30323.
     PubMed     Text format     Abstract available
     
     
     
717. FISCHER T, Spohn M, Olearo F, Zinser ME, et al
     Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV.
     Vaccine. 2018 Sep 20. pii: S0264-410X(18)31265.
     PubMed     Text format     Abstract available
     
     
     
718. HENRY O, Brzostek J, Czajka H, Leviniene G, et al
     Corrigendum to "One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life" [Vaccine 36 (2018) 381-387].
     Vaccine. 2018 Sep 20. pii: S0264-410X(18)31271.
     PubMed     Text format    
     
     
     
719. SCHURINK-VAN'T KLOOSTER TM, Kemmeren JM, van der Maas NAT, van de Putte EM, et al
     No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
     Vaccine. 2018 Sep 19. pii: S0264-410X(18)31268.
     PubMed     Text format     Abstract available
     
     
     
720. MOMOSE H, Sasaki E, Kuramitsu M, Hamaguchi I, et al
     Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan.
     Vaccine. 2018 Sep 19. pii: S0264-410X(18)31270.
     PubMed     Text format     Abstract available
     
     
     
721. DEHLENDORFF C, Sparen P, Baldur-Felskov B, Herweijer E, et al
     Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
     Vaccine. 2018 Sep 18. pii: S0264-410X(18)31258.
     PubMed     Text format     Abstract available
     
     
     
722. BERTRAN K, Lee DH, Criado MF, Balzli CL, et al
     Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
     Vaccine. 2018 Sep 18. pii: S0264-410X(18)31264.
     PubMed     Text format     Abstract available
     
     
     
723. ALI M, Chang BA, Johnson KW, Morris SK, et al
     Incidence and aetiology of bacterial meningitis among children aged 1-59months in South Asia: systematic review and meta-analysis.
     Vaccine. 2018;36:5846-5857.
     PubMed     Text format     Abstract available
     
     
     
724. WISE LD, Wolf JJ, Plitnick LM
     Evaluation of a 9-valent HPV vaccine in Sprague-Dawley rats: Nonclinical studies assessing general, reproductive, and developmental toxicity.
     Vaccine. 2018 Sep 17. pii: S0264-410X(18)31211.
     PubMed     Text format     Abstract available
     
     
     
725. HOSSAIN A, Politi C, Mandalia N, Cohen AL, et al
     Expenditures on vaccine-preventable disease surveillance: Analysis and evaluation of comprehensive multi-year plans (cMYPs) for immunization.
     Vaccine. 2018 Sep 17. pii: S0264-410X(18)31077.
     PubMed     Text format     Abstract available
     
     
     
726. EDOUARD S, Al-Tawfiq JA, Memish ZA, Yezli S, et al
     Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines.
     Vaccine. 2018 Sep 17. pii: S0264-410X(18)31266.
     PubMed     Text format     Abstract available
     
     
     
727. RICHARDSON JS, Messonnier ML, Prosser LA
     Preferences for health economics presentations among vaccine policymakers and researchers.
     Vaccine. 2018 Sep 17. pii: S0264-410X(18)31178.
     PubMed     Text format     Abstract available
     
     
     
728. VERMA A, Burns DL
     Improving the stability of recombinant anthrax protective antigen vaccine.
     Vaccine. 2018 Sep 15. pii: S0264-410X(18)31261.
     PubMed     Text format     Abstract available
     
     
     
729. MARIA DE SOUZA MORAIS S, Ferreira Rodigues N, Ingrid Oliveira da Silva N, Aparecido Salvador E, et al
     Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.
     Vaccine. 2018 Sep 15. pii: S0264-410X(18)31210.
     PubMed     Text format     Abstract available
     
     
     
730. SMITH MA, Hall M, Lew JB, Canfell K, et al
     Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand.
     Vaccine. 2018 Sep 14. pii: S0264-410X(18)31202.
     PubMed     Text format     Abstract available
     
     
     
731. DIALLO A, Victor JC, Feser J, Ortiz JR, et al
     Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naive children in a randomized clinical trial in rural Senegal.
     Vaccine. 2018 Sep 14. pii: S0264-410X(18)31158.
     PubMed     Text format     Abstract available
     
     
     
732. DEDIEGO ML, Chiem K, Topham DJ
     Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.
     Vaccine. 2018 Sep 14. pii: S0264-410X(18)31240.
     PubMed     Text format     Abstract available
     
     
     
733. TOEPP A, Larson M, Wilson G, Grinnage-Pulley T, et al
     Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis.
     Vaccine. 2018 Sep 12. pii: S0264-410X(18)31245.
     PubMed     Text format     Abstract available
     
     
     
734. MIYAZAKI A, Kandasamy S, Michael H, Langel SN, et al
     Protein deficiency reduces efficacy of oral attenuated human rotavirus vaccine in a human infant fecal microbiota transplanted gnotobiotic pig model.
     Vaccine. 2018 Sep 12. pii: S0264-410X(18)31244.
     PubMed     Text format     Abstract available
     
     
     
735. FORTNER KB, Swamy GK, Broder KR, Jimenez-Truque N, et al
     Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women.
     Vaccine. 2018 Sep 12. pii: S0264-410X(18)30942.
     PubMed     Text format     Abstract available
     
     
     
736. CARRELL RK, Stanton RA, Ethier SP, LaRue AC, et al
     ICOSL-augmented adenoviral-based vaccination induces a bipolar Th17/Th1 T cell response against unglycosylated MUC1 antigen.
     Vaccine. 2018 Sep 12. pii: S0264-410X(18)31257.
     PubMed     Text format     Abstract available
     
     
     
737. DENDLE C, Stuart RL, Mulley WR, Holdsworth SR, et al
     Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence.
     Vaccine. 2018 Sep 11. pii: S0264-410X(18)31209.
     PubMed     Text format     Abstract available
     
     
     
738. KHATOON N, Ojha R, Mishra A, Prajapati VK, et al
     Examination of antigenic proteins of Trypanosoma cruzi to fabricate an epitope-based subunit vaccine by exploiting epitope mapping mechanism.
     Vaccine. 2018 Sep 11. pii: S0264-410X(18)31239.
     PubMed     Text format     Abstract available
     
     
     
739. CAO Z, Chen D, Yang Y, Zhang D, et al
     Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: An analysis of three-year surveillance data.
     Vaccine. 2018;36:5754-5759.
     PubMed     Text format     Abstract available
     
     
     
740. KHAN MN, Pryharski K, Pichichero ME
     Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection.
     Vaccine. 2018;36:5701-5708.
     PubMed     Text format     Abstract available
     
     
     
741. CHEN C, Beutels P, Wood J, Menzies R, et al
     Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia.
     Vaccine. 2018 Sep 10. pii: S0264-410X(18)31234.
     PubMed     Text format     Abstract available
     
     
     
742. BARTHOLOMEUS E, De Neuter N, Meysman P, Suls A, et al
     Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders.
     Vaccine. 2018 Sep 8. pii: S0264-410X(18)31236.
     PubMed     Text format     Abstract available
     
     
     
743. THOMSON A, Vallee-Tourangeau G, Suggs LS
     Strategies to increase vaccine acceptance and uptake: From behavioral insights to context-specific, culturally-appropriate, evidence-based communications and interventions.
     Vaccine. 2018 Sep 7. pii: S0264-410X(18)31140.
     PubMed     Text format    
     
     
     
744. ULENDORF JACOBSEN S, Valentiner-Branth P, Molbak K
     Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark.
     Vaccine. 2018 Sep 7. pii: S0264-410X(18)31190.
     PubMed     Text format     Abstract available
     
     
     
745. ZHANG C, Li LH, Wang J, Zhao Z, et al
     Enhanced protective immunity against spring viremia of carp virus infection can be induced by recombinant subunit vaccine conjugated to single-walled carbon nanotubes.
     Vaccine. 2018 Sep 7. pii: S0264-410X(18)31110.
     PubMed     Text format     Abstract available
     
     
     
746. PNIEWSKI T, Milczarek M, Wojas-Turek J, Pajtasz-Piasecka E, et al
     Plant lyophilisate carrying S-HBsAg as an oral booster vaccine against HBV.
     Vaccine. 2018 Sep 6. pii: S0264-410X(18)31241.
     PubMed     Text format     Abstract available
     
     
     
747. ALBANESE GA, Lee DH, Cheng IN, Hilt DA, et al
     Biological and molecular characterization of ArkGA: A novel Arkansas serotype vaccine that is highly attenuated, efficacious, and protective against homologous challenge.
     Vaccine. 2018 Sep 6. pii: S0264-410X(18)31228.
     PubMed     Text format     Abstract available
     
     
     
748. BRANDON D, Kimmel M, Kuriyakose SO, Kostanyan L, et al
     Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
     Vaccine. 2018 Sep 6. pii: S0264-410X(18)31180.
     PubMed     Text format     Abstract available
     
     
     
749. PEZZOTTI P, Bellino S, Prestinaci F, Iacchini S, et al
     Reply to letters to the Editor: Bellavite P. Factors that influenced the historical trends of tetanus and diphtheria. Donzelli A, Duca P. More than 70,000 deaths prevented by vaccination against three diseases in about 75years? The estimation seems ex
     Vaccine. 2018;36:5508-5509.
     PubMed     Text format    
     
     
     
750. DONZELLI A, Duca P
     More than 70,000 deaths prevented by vaccination against three diseases in about 75years? The estimation seems exaggerated.
     Vaccine. 2018;36:5507.
     PubMed     Text format    
     
     
     
751. SU QD, He SH, Yi Y, Qiu F, et al
     Intranasal vaccination with ebola virus GP amino acids 258-601 protects mice against lethal challenge.
     Vaccine. 2018 Sep 5. pii: S0264-410X(18)31238.
     PubMed     Text format     Abstract available
     
     
     
752. MATTHEWS I, Lu X, Dawson H, Bricout H, et al
     Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
     Vaccine. 2018 Sep 5. pii: S0264-410X(18)31166.
     PubMed     Text format     Abstract available
     
     
     
753. MUHSEN IN, Aljurf M, Wingard JR, Poland GA, et al
     Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives.
     Vaccine. 2018 Sep 5. pii: S0264-410X(18)31173.
     PubMed     Text format     Abstract available
     
     
     
754. FISKER AB, Thysen SM
     Non-live pentavalent vaccines after live measles vaccine may increase mortality.
     Vaccine. 2018 Sep 5. pii: S0264-410X(18)31233.
     PubMed     Text format     Abstract available
     
     
     
755. MCGRATH LJ, Layton JB, Krueger WS, Kshirsagar AV, et al
     High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013.
     Vaccine. 2018 Sep 5. pii: S0264-410X(18)31229.
     PubMed     Text format     Abstract available
     
     
     
756. HORSINGTON J, Nfon C, Gonzales JL, Singanallur N, et al
     Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
     Vaccine. 2018 Sep 5. pii: S0264-410X(18)31213.
     PubMed     Text format     Abstract available
     
     
     
757. MOKADDAS EM, Shibl AM, Elgouhary A, Elsobky M, et al
     Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
     Vaccine. 2018 Sep 5. pii: S0264-410X(18)31076.
     PubMed     Text format     Abstract available
     
     
     
758. MORGENSTERN K, Xie Y, Palladino G, Barr JR, et al
     Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination.
     Vaccine. 2018 Sep 4. pii: S0264-410X(18)31204.
     PubMed     Text format     Abstract available
     
     
     
759. GROOM HC, Irving SA, Koppolu P, Smith N, et al
     Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.
     Vaccine. 2018 Sep 4. pii: S0264-410X(18)31214.
     PubMed     Text format     Abstract available
     
     
     
760. TAM YH, Ng TWY, Chu DKW, Fang VJ, et al
     The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17.
     Vaccine. 2018 Sep 3. pii: S0264-410X(18)31215.
     PubMed     Text format     Abstract available
     
     
     
761. NZOLO D, Engo Biongo A, Kuemmerle A, Lusakibanza M, et al
     Safety profile of fractional dosing of the 17DD Yellow Fever Vaccine among males and females: Experience of a community-based pharmacovigilance in Kinshasa, DR Congo.
     Vaccine. 2018 Sep 3. pii: S0264-410X(18)31181.
     PubMed     Text format     Abstract available
     
     
     
762. SOUZA CK, Rajao DS, Sandbulte MR, Lopes S, et al
     The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.
     Vaccine. 2018 Sep 1. pii: S0264-410X(18)31212.
     PubMed     Text format     Abstract available
     
     
     
763. ROOZBEHANI M, Falak R, Mohammadi M, Hemphill A, et al
     Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection.
     Vaccine. 2018 Sep 1. pii: S0264-410X(18)31208.
     PubMed     Text format     Abstract available
     
     
     
764. MOMBELLI M, Rettby N, Perreau M, Pascual M, et al
     Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
     Vaccine. 2018 Sep 1. pii: S0264-410X(18)31186.
     PubMed     Text format     Abstract available
     
     
     August 2018
765. CHIU HT, Shen LJ, Chen YC, Lin JH, et al
     Effect of statin use on the risk of medically attended acute respiratory illness among influenza vaccinated elderly.
     Vaccine. 2018 Aug 30. pii: S0264-410X(18)31206.
     PubMed     Text format     Abstract available
     
     
     
766. WESTFALL J, Yates JL, Van Slyke G, Ehrbar D, et al
     Thermal stability and epitope integrity of a lyophilized ricin toxin subunit vaccine.
     Vaccine. 2018 Aug 29. pii: S0264-410X(18)31188.
     PubMed     Text format     Abstract available
     
     
     
767. MOHANTY S, Leader AE, Gibeau E, Johnson C, et al
     Using Facebook to reach adolescents for human papillomavirus (HPV) vaccination.
     Vaccine. 2018 Aug 29. pii: S0264-410X(18)31189.
     PubMed     Text format     Abstract available
     
     
     
768. BRUXELLE JF, Tsapis N, Hoys S, Collignon A, et al
     Protection against Clostridium difficile infection in a hamster model by oral vaccination using flagellin FliC-loaded pectin beads.
     Vaccine. 2018 Aug 29. pii: S0264-410X(18)31122.
     PubMed     Text format     Abstract available
     
     
     
769. ESPOSITO S, Pugni L, Mosca F, Principi N, et al
     Rotarix(R) and RotaTeq(R) administration to preterm infants in the neonatal intensive care unit: Review of available evidence.
     Vaccine. 2018;36:5430-5434.
     PubMed     Text format     Abstract available
     
     
     
770. VILCA LM, Esposito S
     The crucial role of maternal care providers as vaccinators for pregnant women.
     Vaccine. 2018;36:5379-5384.
     PubMed     Text format     Abstract available
     
     
     
771. BONANNI P, Bonaccorsi G, Lorini C, Santomauro F, et al
     Focusing on the implementation of 21st century vaccines for adults.
     Vaccine. 2018;36:5358-5365.
     PubMed     Text format     Abstract available
     
     
     
772. MAVER PJ, Poljak M
     Progress in prophylactic human papillomavirus (HPV) vaccination in 2016: A literature review.
     Vaccine. 2018;36:5416-5423.
     PubMed     Text format     Abstract available
     
     
     
773. ESPOSITO S, Principi N
     Herpes zoster prevention: A difficult problem to solve.
     Vaccine. 2018;36:5442-5448.
     PubMed     Text format     Abstract available
     
     
     
774. VENKATRAMAN N, Silman D, Folegatti PM, Hill AVS, et al
     Vaccines against Ebola virus.
     Vaccine. 2018;36:5454-5459.
     PubMed     Text format     Abstract available
     
     
     
775. WILKINS AL, Snape MD
     Emerging clinical experience with vaccines against group B meningococcal disease.
     Vaccine. 2018;36:5470-5476.
     PubMed     Text format     Abstract available
     
     
     
776. POLAND GA, Ovsyannikova IG, Kennedy RB
     Personalized vaccinology: A review.
     Vaccine. 2018;36:5350-5357.
     PubMed     Text format     Abstract available
     
     
     
777. KOWALZIK F, Faber J, Knuf M
     MMR and MMRV vaccines.
     Vaccine. 2018;36:5402-5407.
     PubMed     Text format     Abstract available
     
     
     
778. OBANDO-PACHECO P, Rivero-Calle I, Gomez-Rial J, Rodriguez-Tenreiro Sanchez C, et al
     New perspectives for hexavalent vaccines.
     Vaccine. 2018;36:5485-5494.
     PubMed     Text format     Abstract available
     
     
     
779. LUCERO Y, Vidal R, O'Ryan G M
     Norovirus vaccines under development.
     Vaccine. 2018;36:5435-5441.
     PubMed     Text format     Abstract available
     
     
     
780. DATTA SS, O'Connor PM, Jankovic D, Muscat M, et al
     Progress and challenges in measles and rubella elimination in the WHO European Region.
     Vaccine. 2018;36:5408-5415.
     PubMed     Text format     Abstract available
     
     
     
781. BONANNI P, Zanella B, Santomauro F, Lorini C, et al
     Safety and perception: What are the greatest enemies of HPV vaccination programmes?
     Vaccine. 2018;36:5424-5429.
     PubMed     Text format     Abstract available
     
     
     
782. PRYMULA R, Shaw J, Chlibek R, Urbancikova I, et al
     Vaccination in newly arrived immigrants to the European Union.
     Vaccine. 2018;36:5385-5390.
     PubMed     Text format     Abstract available
     
     
     
783. BEN-SHIMOL S, Givon-Lavi N, Grisaru-Soen G, Megged O, et al
     Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
     Vaccine. 2018;36:5477-5484.
     PubMed     Text format     Abstract available
     
     
     
784. MORINO S, Tanaka-Taya K, Satoh H, Arai S, et al
     Descriptive epidemiology of varicella based on national surveillance data before and after the introduction of routine varicella vaccination with two doses in Japan, 2000-2017.
     Vaccine. 2018 Aug 27. pii: S0264-410X(18)31177.
     PubMed     Text format     Abstract available
     
     
     
785. FOOKS AR, Banyard AC, Ertl HCJ
     New human rabies vaccines in the pipeline.
     Vaccine. 2018 Aug 25. pii: S0264-410X(18)31168.
     PubMed     Text format     Abstract available
     
     
     
786. SHIMIZU H, Seki K, Shiga K, Nakayama T, et al
     Safety and efficacy of DTaP-IPV vaccine use in healthcare workers for prevention of pertussis.
     Vaccine. 2018 Aug 25. pii: S0264-410X(18)31176.
     PubMed     Text format     Abstract available
     
     
     
787. WHITAKER JA, von Itzstein MS, Poland GA
     Strategies to maximize influenza vaccine impact in older adults.
     Vaccine. 2018 Aug 25. pii: S0264-410X(18)31169.
     PubMed     Text format     Abstract available
     
     
     
788. GONGAL G, Sampath G
     Introduction of intradermal rabies vaccination - A paradigm shift in improving post-exposure prophylaxis in Asia.
     Vaccine. 2018 Aug 24. pii: S0264-410X(18)31163.
     PubMed     Text format     Abstract available
     
     
     
789. STONE K, Akpalu Y, Horney J
     Use of the Community Assessment for Public Health Response (CASPER) method to assess influenza vaccination and activity in Brazos County, Texas.
     Vaccine. 2018 Aug 24. pii: S0264-410X(18)31139.
     PubMed     Text format     Abstract available
     
     
     
790. PACI JT, Paci I
     The time has come for a Phase 3 trial of an Epstein-Barr virus vaccine.
     Vaccine. 2018 Aug 24. pii: S0264-410X(18)31164.
     PubMed     Text format    
     
     
     
791. POULOS C, Standaert B, Sloesen B, Stryjewska I, et al
     Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary.
     Vaccine. 2018 Aug 24. pii: S0264-410X(18)31108.
     PubMed     Text format     Abstract available
     
     
     
792. WEDLOCK PT, Mitgang EA, Siegmund S, DePasse J, et al
     Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
     Vaccine. 2018 Aug 23. pii: S0264-410X(18)31135.
     PubMed     Text format     Abstract available
     
     
     
793. NEWALL AT, Chen C, Wood JG, Stockwell MS, et al
     Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States.
     Vaccine. 2018 Aug 23. pii: S0264-410X(18)31114.
     PubMed     Text format     Abstract available
     
     
     
794. RIVADENEIRA MF, Bassanesi SL, Fuchs SC
     Socioeconomic inequalities and measles immunization coverage in Ecuador: A spatial analysis.
     Vaccine. 2018;36:5251-5257.
     PubMed     Text format     Abstract available
     
     
     
795. VORSTERS A, Van Damme P
     HPV immunization programs: Ensuring their sustainability and resilience.
     Vaccine. 2018;36:5219-5221.
     PubMed     Text format    
     
     
     
796. HADJ MB, Bouguerra H, Saffar F, Chelly S, et al
     Observational study of vaccine effectiveness 20years after the introduction of universal hepatitis B vaccination in Tunisia.
     Vaccine. 2018 Aug 22. pii: S0264-410X(18)31167.
     PubMed     Text format     Abstract available
     
     
     
797. COWLEY D, Nirwati H, Donato CM, Bogdanovic-Sakran N, et al
     Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.
     Vaccine. 2018 Aug 22. pii: S0264-410X(18)31136.
     PubMed     Text format     Abstract available
     
     
     
798. KILPI TM, Jokinen J, Puumalainen T, Nieminen H, et al
     Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.
     Vaccine. 2018 Aug 22. pii: S0264-410X(18)31129.
     PubMed     Text format     Abstract available
     
     
     
799. ESPOSITO S, Principi N, Rezza G, Bonanni P, et al
     Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward.
     Vaccine. 2018 Aug 21. pii: S0264-410X(18)31170.
     PubMed     Text format     Abstract available
     
     
     
800. PATTERSON J, Kagina BM, Gold M, Hussey GD, et al
     Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: A systematic review.
     Vaccine. 2018 Aug 21. pii: S0264-410X(18)31131.
     PubMed     Text format     Abstract available
     
     
     
801. SHONO A, Hoshi SL, Kondo M
     The impact on vaccination coverage following introduction of a routine pneumococcal vaccination programme for the elderly in Japan.
     Vaccine. 2018 Aug 21. pii: S0264-410X(18)31132.
     PubMed     Text format     Abstract available
     
     
     
802. FU H, Lin HH, Hallett TB, Arinaminpathy N, et al
     Modelling the effect of discontinuing universal Bacillus Calmette-Guerin vaccination in an intermediate tuberculosis burden setting.
     Vaccine. 2018 Aug 21. pii: S0264-410X(18)31128.
     PubMed     Text format     Abstract available
     
     
     
803. PRINCIPI N, Esposito S
     Aluminum in vaccines: Does it create a safety problem?
     Vaccine. 2018 Aug 20. pii: S0264-410X(18)31165.
     PubMed     Text format     Abstract available
     
     
     
804. GVOZDENOVIC E, Vetter V, Willame C, Rosillon D, et al
     Impact of history of febrile convulsions on the risk difference of febrile convulsions with the tetravalent measles-mumps-rubella-varicella vaccine: Post-hoc exploratory analysis of results from a matched-cohort study.
     Vaccine. 2018 Aug 18. pii: S0264-410X(18)31127.
     PubMed     Text format     Abstract available
     
     
     
805. COHEN AL, Aliabadi N, Serhan F, Tate JE, et al
     Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction.
     Vaccine. 2018 Aug 18. pii: S0264-410X(18)30672.
     PubMed     Text format     Abstract available
     
     
     
806. CHICHESTER JA, Green BJ, Jones RM, Shoji Y, et al
     Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.
     Vaccine. 2018 Aug 17. pii: S0264-410X(18)31159.
     PubMed     Text format     Abstract available
     
     
     
807. VAN AALST M, Langedijk AC, Spijker R, de Bree GJ, et al
     The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis.
     Vaccine. 2018 Aug 16. pii: S0264-410X(18)31008.
     PubMed     Text format     Abstract available
     
     
     
808. CUI A, Zhu Z, Mao N, Si Y, et al
     Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
     Vaccine. 2018 Aug 16. pii: S0264-410X(18)31137.
     PubMed     Text format     Abstract available
     
     
     
809. WEIBEL D, Sturkenboom M, Black S, de Ridder M, et al
     Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
     Vaccine. 2018 Aug 16. pii: S0264-410X(18)31115.
     PubMed     Text format     Abstract available
     
     
     
810. WEI L, Xie X, Liu J, Zhao Y, et al
     Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up.
     Vaccine. 2018 Aug 16. pii: S0264-410X(18)31116.
     PubMed     Text format     Abstract available
     
     
     
811. SUGA S, Ishiwada N, Sasaki Y, Akeda H, et al
     A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
     Vaccine. 2018 Aug 16. pii: S0264-410X(18)31138.
     PubMed     Text format     Abstract available
     
     
     
812. PHAM TT, Le HM, Nguyen DT, Maertens K, et al
     Assessment of the timely administration of the hepatitis B and BCG birth dose and the primary infant vaccination schedule in 2015-2016 in the Mekong Delta, Viet Nam.
     Vaccine. 2018 Aug 16. pii: S0264-410X(18)31109.
     PubMed     Text format     Abstract available
     
     
     
813. HARA M, Nakagomi O
     Role of rotavirus vaccination on an emerging G8P[8] rotavirus strain causing an outbreak in central Japan.
     Vaccine. 2018;36:5109.
     PubMed     Text format    
     
     
     
814. HADJIPANAYIS A, Efstathiou E, Michaelidou K, Papaevangelou V, et al
     Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
     Vaccine. 2018 Aug 13. pii: S0264-410X(18)31130.
     PubMed     Text format     Abstract available
     
     
     
815. SHI H, Dong S, Zhang X, Chen X, et al
     Phage vaccines displaying YGKDVKDLFDYAQE epitope induce protection against systemic candidiasis in mouse model.
     Vaccine. 2018 Aug 13. pii: S0264-410X(18)31120.
     PubMed     Text format     Abstract available
     
     
     
816. AMDISEN L, Kristensen ML, Rytter D, Molbak K, et al
     Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark.
     Vaccine. 2018 Aug 12. pii: S0264-410X(18)31113.
     PubMed     Text format     Abstract available
     
     
     
817. LEE SH, Kang HJ, Lee DH, Kang SM, et al
     Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection.
     Vaccine. 2018 Aug 11. pii: S0264-410X(18)31125.
     PubMed     Text format     Abstract available
     
     
     
818. CHOE YJ, Park K, Park E, Kong I, et al
     School entry vaccination requirement program: Experience from the Republic of Korea.
     Vaccine. 2018 Aug 11. pii: S0264-410X(18)30943.
     PubMed     Text format    
     
     
     
819. NOUCHIKIAN L, Roque C, Song JY, Rahman N, et al
     An intrinsic fluorescence method for the determination of protein concentration in vaccines containing aluminum salt adjuvants.
     Vaccine. 2018 Aug 11. pii: S0264-410X(18)31112.
     PubMed     Text format     Abstract available
     
     
     
820. MCLEAN HQ, Fiebelkorn AP, Ogee-Nwankwo A, Hao L, et al
     Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
     Vaccine. 2018 Aug 11. pii: S0264-410X(18)31117.
     PubMed     Text format     Abstract available
     
     
     
821. WORLD HEALTH ORGANIZATION
     Rabies vaccines: WHO position paper, April 2018 - Recommendations.
     Vaccine. 2018 Aug 11. pii: S0264-410X(18)30902.
     PubMed     Text format     Abstract available
     
     
     
822. HOLMGREN J, Nordqvist S, Blomquist M, Jeverstam F, et al
     Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
     Vaccine. 2018 Aug 10. pii: S0264-410X(18)31082.
     PubMed     Text format     Abstract available
     
     
     
823. 
     Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15months: A phase III, randomized, non-inferiority trial.
     Vaccine. 2018 Aug 10. pii: S0264-410X(18)31096.
     PubMed     Text format     Abstract available
     
     
     
824. LONCOMAN CA, Hartley CA, Coppo MJC, Browning GF, et al
     Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
     Vaccine. 2018 Aug 10. pii: S0264-410X(18)31121.
     PubMed     Text format     Abstract available
     
     
     
825. DAMJANOVIC D, He L, Symes J, Gajewska B, et al
     In vitro assessment of biological activity and stability of the ALVAC-HIV vaccine.
     Vaccine. 2018 Aug 10. pii: S0264-410X(18)31003.
     PubMed     Text format     Abstract available
     
     
     
826. DESAI S, Rathi N, Kawade A, Venkatramanan P, et al
     Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL(R) with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
     Vaccine. 2018 Aug 10. pii: S0264-410X(18)31073.
     PubMed     Text format     Abstract available
     
     
     
827. PAN X, Shu M, Ma R, Fang T, et al
     Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China.
     Vaccine. 2018 Aug 10. pii: S0264-410X(18)30632.
     PubMed     Text format     Abstract available
     
     
     
828. NADARZYNSKI T, Smith H, Richardson D, Bremner S, et al
     Men who have sex with men who do not access sexual health clinics nor disclose sexual orientation are unlikely to receive the HPV vaccine in the UK.
     Vaccine. 2018;36:5065-5070.
     PubMed     Text format     Abstract available
     
     
     
829. SHI W, Kou Y, Xiao J, Zhang L, et al
     Comparison of immunogenicity, efficacy and transcriptome changes of inactivated rabies virus vaccine with different adjuvants.
     Vaccine. 2018;36:5020-5029.
     PubMed     Text format     Abstract available
     
     
     
830. SHEIKH S, Biundo E, Courcier S, Damm O, et al
     A report on the status of vaccination in Europe.
     Vaccine. 2018;36:4979-4992.
     PubMed     Text format     Abstract available
     
     
     
831. AYRLE H, Mevissen M, Kaske M, Vogtlin A, et al
     Colostral transmission of BTV-8 antibodies from dairy cows six years after vaccination.
     Vaccine. 2018 Aug 9. pii: S0264-410X(18)31124.
     PubMed     Text format     Abstract available
     
     
     
832. QIN J, Zhang Y, Shen X, Gong L, et al
     H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice.
     Vaccine. 2018;36:5030-5036.
     PubMed     Text format     Abstract available
     
     
     
833. ELWOOD JM, Ameratunga R
     Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).
     Vaccine. 2018 Aug 9. pii: S0264-410X(18)31094.
     PubMed     Text format     Abstract available
     
     
     
834. PATRICIA D'SOUZA M, Allen MA, Baumblatt JAG, Boggiano C, et al
     Innovative approaches to track lymph node germinal center responses to evaluate development of broadly neutralizing antibodies in human HIV vaccine trials.
     Vaccine. 2018 Aug 7. pii: S0264-410X(18)31080.
     PubMed     Text format     Abstract available
     
     
     
835. HASAN AZ, Saha S, Saha SK, Sahakyan G, et al
     Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia.
     Vaccine. 2018;36.
     PubMed     Text format     Abstract available
     
     
     
836. YU Y, Guo J, Li D, Liu Y, et al
     Development of a human papillomavirus type 6/11 vaccine candidate for the prevention of condyloma acuminatum.
     Vaccine. 2018;36.
     PubMed     Text format     Abstract available
     
     
     
837. GILBERT A, Johnson S, Walker N, Wickham C, et al
     Efficacy of Ontario Rabies Vaccine Baits (ONRAB) against rabies infection in raccoons.
     Vaccine. 2018;36.
     PubMed     Text format     Abstract available
     
     
     
838. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
     Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen.
     Vaccine. 2018;36.
     PubMed     Text format     Abstract available
     
     
     
839. COLEY S, Hoefer D, Rausch-Phung E
     A population-based reminder intervention to improve human papillomavirus vaccination rates among adolescents at routine vaccination age.
     Vaccine. 2018;36.
     PubMed     Text format     Abstract available
     
     
     
840. FRENCK RW JR, Baqar S, Alexander W, Dickey M, et al
     A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.
     Vaccine. 2018;36.
     PubMed     Text format     Abstract available
     
     
     
841. HU H, Roth JP, Yu Q
     Generation of a recombinant Newcastle disease virus expressing two foreign genes for use as a multivalent vaccine and gene therapy vector.
     Vaccine. 2018;36.
     PubMed     Text format     Abstract available
     
     
     
842. SHINJOH M, Sugaya N, Yamaguchi Y, Iibuchi N, et al
     Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.
     Vaccine. 2018 Aug 6. pii: S0264-410X(18)31074.
     PubMed     Text format     Abstract available
     
     
     
843. AGUDELO CI, DeAntonio R, Castaneda E
     Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean 2010-2015: A systematic review and a time series analysis.
     Vaccine. 2018;36.
     PubMed     Text format     Abstract available
     
     
     
844. CASTANEDA-ORJUELA C, De la Hoz-Restrepo F
     How cost effective is switching universal vaccination from PCV10 to PCV13? A case study from a developing country.
     Vaccine. 2018 Aug 4. pii: S0264-410X(18)31098.
     PubMed     Text format     Abstract available
     
     
     
845. ITELL HL, McGuire EP, Muresan P, Cunningham CK, et al
     Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines.
     Vaccine. 2018 Aug 4. pii: S0264-410X(18)31017.
     PubMed     Text format     Abstract available
     
     
     
846. PUGLIESE-GARCIA M, Heyerdahl L, Mwamba C, Nkwemu S, et al
     Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia.
     Vaccine. 2018 Aug 4. pii: S0264-410X(18)31011.
     PubMed     Text format     Abstract available
     
     
     
847. WU S, Pan Y, Zhang X, Zhang L, et al
     Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season.
     Vaccine. 2018 Aug 4. pii: S0264-410X(18)31097.
     PubMed     Text format     Abstract available
     
     
     
848. DOBRICA MO, Lazar C, Paruch L, van Eerde A, et al
     Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
     Vaccine. 2018 Aug 3. pii: S0264-410X(18)31081.
     PubMed     Text format     Abstract available
     
     
     
849. YEUNG KHT, Tarrant M, Chan KCC, Tam WH, et al
     Increasing influenza vaccine uptake in children: A randomised controlled trial.
     Vaccine. 2018 Aug 2. pii: S0264-410X(18)31075.
     PubMed     Text format     Abstract available
     
     
     
850. UCAKAR V, Fafangel M, Kraigher A
     Vaccine confidence among mothers of young children, Slovenia, 2016.
     Vaccine. 2018 Aug 1. pii: S0264-410X(18)31071.
     PubMed     Text format     Abstract available
     
     
     
851. DE WALS P
     Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children.
     Vaccine. 2018 Aug 1. pii: S0264-410X(18)31078.
     PubMed     Text format    
     
     
     
852. THOMPSON MG, Pierse N, Sue Huang Q, Prasad N, et al
     Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
     Vaccine. 2018 Aug 1. pii: S0264-410X(18)30997.
     PubMed     Text format     Abstract available
     
     
     July 2018
853. NEMOTO M, Inagaki M, Tamura N, Bannai H, et al
     Evaluation of inactivated vaccines against equine group A rotaviruses by use of a suckling mouse model.
     Vaccine. 2018 Jul 31. pii: S0264-410X(18)31064.
     PubMed     Text format     Abstract available
     
     
     
854. GAYTHORPE KAM, Trotter CL, Conlan AJK
     Modelling norovirus transmission and vaccination.
     Vaccine. 2018 Jul 31. pii: S0264-410X(18)31049.
     PubMed     Text format     Abstract available
     
     
     
855. ORTQVIST A, Brytting M, Leval A, Hergens MP, et al
     Impact of repeated influenza vaccinations in persons over 65years of age: A large population-based cohort study of severe influenza over six consecutive seasons, 2011/12-2016/17.
     Vaccine. 2018 Jul 31. pii: S0264-410X(18)31046.
     PubMed     Text format     Abstract available
     
     
     
856. HOWARD N, Walls H, Bell S, Mounier-Jack S, et al
     The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda.
     Vaccine. 2018 Jul 31. pii: S0264-410X(18)31072.
     PubMed     Text format     Abstract available
     
     
     
857. WELSCH JA, Senders S, Essink B, Klein T, et al
     Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
     Vaccine. 2018 Jul 27. pii: S0264-410X(18)30946.
     PubMed     Text format     Abstract available
     
     
     
858. KOUTOUZIS EI, Daikos GL, Chatzichristou P, Michos AG, et al
     Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986-2015.
     Vaccine. 2018 Jul 27. pii: S0264-410X(18)31062.
     PubMed     Text format     Abstract available
     
     
     
859. DOMEK GJ, O'Leary ST, Bull S, Bronsert M, et al
     Measuring vaccine hesitancy: Field testing the WHO SAGE Working Group on Vaccine Hesitancy survey tool in Guatemala.
     Vaccine. 2018 Jul 27. pii: S0264-410X(18)31015.
     PubMed     Text format     Abstract available
     
     
     
860. RAVEN S, Urbanus A, de Gee A, Hoebe C, et al
     Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination.
     Vaccine. 2018 Jul 27. pii: S0264-410X(18)31014.
     PubMed     Text format     Abstract available
     
     
     
861. PALLIVATHUCAL LB, Noymer A
     Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
     Vaccine. 2018 Jul 26. pii: S0264-410X(18)30999.
     PubMed     Text format     Abstract available
     
     
     
862. NOH JY, Choi WS, Song JY, Lee HS, et al
     Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014.
     Vaccine. 2018 Jul 26. pii: S0264-410X(18)30987.
     PubMed     Text format     Abstract available
     
     
     
863. STATLER VA, Albano FR, Airey J, Sawlwin DC, et al
     Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59months of age: A phase 3, randomized, noninferiority study.
     Vaccine. 2018 Jul 26. pii: S0264-410X(18)31005.
     PubMed     Text format     Abstract available
     
     
     
864. SUN B, Yu S, Zhao D, Guo S, et al
     Polysaccharides as vaccine adjuvants.
     Vaccine. 2018 Jul 26. pii: S0264-410X(18)31009.
     PubMed     Text format     Abstract available
     
     
     
865. PANOVSKA-GRIFFITHS J, Crowe S, Pagel C, Shiri T, et al
     A method for evaluating and comparing immunisation schedules that cover multiple diseases: Illustrative application to the UK routine childhood vaccine schedule.
     Vaccine. 2018 Jul 25. pii: S0264-410X(18)30749.
     PubMed     Text format     Abstract available
     
     
     
866. FORD AJ, Alwan NA
     Use of social networking sites and women's decision to receive vaccinations during pregnancy: A cross-sectional study in the UK.
     Vaccine. 2018 Jul 25. pii: S0264-410X(18)30988.
     PubMed     Text format     Abstract available
     
     
     
867. POLJAK M
     Editorial: Progress in vaccines and vaccination - Best of ECCMID 2016.
     Vaccine. 2018 Jul 25. pii: S0264-410X(18)31019.
     PubMed     Text format    
     
     
     
868. FERDMAN J, Palladino G, Liao HX, Moody MA, et al
     Intra-seasonal antibody repertoire analysis of a subject immunized with an MF59(R)-adjuvanted pandemic 2009 H1N1 vaccine.
     Vaccine. 2018 Jul 25. pii: S0264-410X(18)30895.
     PubMed     Text format     Abstract available
     
     
     
869. SKUFCA J, Ollgren J, Artama M, Ruokokoski E, et al
     The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
     Vaccine. 2018 Jul 25. pii: S0264-410X(18)30925.
     PubMed     Text format     Abstract available
     
     
     
870. BOUKHVALOVA MS, Mbaye A, Kovtun S, Yim KC, et al
     Improving ability of RSV microneutralization assay to detect G-specific and cross-reactive neutralizing antibodies through immortalized cell line selection.
     Vaccine. 2018;36:4657-4662.
     PubMed     Text format     Abstract available
     
     
     
871. PENNINGTON SH, Ferreira DM, Reine J, Nyirenda TS, et al
     Longevity of duodenal and peripheral T-cell and humoral responses to live-attenuated Salmonella Typhi strain Ty21a.
     Vaccine. 2018;36:4725-4733.
     PubMed     Text format     Abstract available
     
     
     
872. YEZLI S, Gautret P, Assiri AM, Gessner BD, et al
     Prevention of meningococcal disease at mass gatherings: Lessons from the Hajj and Umrah.
     Vaccine. 2018;36:4603-4609.
     PubMed     Text format     Abstract available
     
     
     
873. RIAZ A, Husain S, Yousafzai MT, Nisar I, et al
     Reasons for non-vaccination and incomplete vaccinations among children in Pakistan.
     Vaccine. 2018 Jul 24. pii: S0264-410X(18)30993.
     PubMed     Text format     Abstract available
     
     
     
874. JAYESHBHAI C, Hajam IA, Verma AK, Bhanuprakash V, et al
     Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA 206 adjuvanted foot-and-mouth disease vaccine in mice model.
     Vaccine. 2018 Jul 24. pii: S0264-410X(18)30933.
     PubMed     Text format     Abstract available
     
     
     
875. MARTINEZ AC, Prymula R, Valdivieso MM, Del Carmen Otero Reigada M, et al
     Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.
     Vaccine. 2018 Jul 24. pii: S0264-410X(18)30989.
     PubMed     Text format     Abstract available
     
     
     
876. MACHADO A, Kislaya I, Santos AJ, Gaio V, et al
     Factors associated to repeated influenza vaccination in the Portuguese adults with chronic conditions.
     Vaccine. 2018 Jul 24. pii: S0264-410X(18)31010.
     PubMed     Text format     Abstract available
     
     
     
877. WERNIKE K, Mundt A, Link EK, Aebischer A, et al
     N-terminal domain of Schmallenberg virus envelope protein Gc delivered by recombinant equine herpesvirus type 1 and modified vaccinia virus Ankara: Immunogenicity and protective efficacy in cattle.
     Vaccine. 2018 Jul 23. pii: S0264-410X(18)31016.
     PubMed     Text format     Abstract available
     
     
     
878. KASPER AK, Pallotta AM, Kovacs CS, Spinner ML, et al
     Infectious diseases consult improves vaccination adherence in kidney transplant candidates.
     Vaccine. 2018 Jul 23. pii: S0264-410X(18)30899.
     PubMed     Text format     Abstract available
     
     
     
879. DANOVARO-HOLLIDAY MC, Dansereau E, Rhoda DA, Brown DW, et al
     Collecting and using reliable vaccination coverage survey estimates: Summary and recommendations from the "Meeting to share lessons learnt from the roll-out of the updated WHO Vaccination Coverage Cluster Survey Reference Manual and to set an operatio
     Vaccine. 2018 Jul 21. pii: S0264-410X(18)30949.
     PubMed     Text format     Abstract available
     
     
     
880. HOSHI SL, Seposo X, Okubo I, Kondo M, et al
     Cost-effectiveness analysis of pertussis vaccination during pregnancy in Japan.
     Vaccine. 2018 Jul 21. pii: S0264-410X(18)30995.
     PubMed     Text format     Abstract available
     
     
     
881. HU WG, Steigerwald R, Kalla M, Volkmann A, et al
     Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.
     Vaccine. 2018 Jul 20. pii: S0264-410X(18)30905.
     PubMed     Text format     Abstract available
     
     
     
882. ARAKI K, Hara M, Tsugawa T, Shimanoe C, et al
     Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.
     Vaccine. 2018 Jul 20. pii: S0264-410X(18)30937.
     PubMed     Text format     Abstract available
     
     
     
883. GESUALDO F, Zamperini N, Tozzi AE
     To talk better about vaccines, we should talk less about vaccines.
     Vaccine. 2018 Jul 19. pii: S0264-410X(18)30994.
     PubMed     Text format    
     
     
     
884. MUANGCHANA C, Thanormwat Y, Kongsiang A
     Workshops advocating ASEAN Vaccine Security and Self-Reliance (AVSSR): A regional initiative.
     Vaccine. 2018 Jul 19. pii: S0264-410X(18)30624.
     PubMed     Text format     Abstract available
     
     
     
885. HARVEY MJ, Denton BT, Prosser LA, Hutton DW, et al
     Determining the optimal strategy for the herpes zoster vaccine in adults.
     Vaccine. 2018 Jul 18. pii: S0264-410X(18)30900.
     PubMed     Text format     Abstract available
     
     
     
886. GRIFFIN JB, Yu L, Watson D, Turner N, et al
     Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine.
     Vaccine. 2018 Jul 18. pii: S0264-410X(18)30941.
     PubMed     Text format     Abstract available
     
     
     
887. SHENTON LM, Wagner AL, Carlson BF, Mubarak MY, et al
     Vaccination status of children aged 1-4years in Afghanistan and associated factors, 2015.
     Vaccine. 2018 Jul 17. pii: S0264-410X(18)30986.
     PubMed     Text format     Abstract available
     
     
     
888. RISALDE MA, Lopez V, Contreras M, Mateos-Hernandez L, et al
     Control of mycobacteriosis in zebrafish (Danio rerio) mucosally vaccinated with heat-inactivated Mycobacterium bovis.
     Vaccine. 2018;36:4447-4453.
     PubMed     Text format     Abstract available
     
     
     
889. SAITOH A, Okabe N
     Progress and challenges for the Japanese immunization program: Beyond the "vaccine gap".
     Vaccine. 2018;36:4582-4588.
     PubMed     Text format     Abstract available
     
     
     
890. LE MEUR JB, Ayukawa H, Proulx JF, De Wals P, et al
     Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada.
     Vaccine. 2018 Jul 16. pii: S0264-410X(18)30938.
     PubMed     Text format     Abstract available
     
     
     
891. ALQAHTANI AS, Tashani M, Ridda I, Gamil A, et al
     Burden of clinical infections due to S. pneumoniae during Hajj: A systematic review.
     Vaccine. 2018;36:4440-4446.
     PubMed     Text format     Abstract available
     
     
     
892. MACINTYRE CR, Kpozehouen E, Kunasekaran M, Harriman K, et al
     Measles control in Australia - threats, opportunities and future needs.
     Vaccine. 2018;36:4393-4398.
     PubMed     Text format     Abstract available
     
     
     
893. MAKARKOV AI, Patel AR, Bainov V, Ward BJ, et al
     A novel serological assay for influenza based on DiD fluorescence dequenching that is free from observer bias and potentially automatable - A proof of concept study.
     Vaccine. 2018;36:4485-4493.
     PubMed     Text format     Abstract available
     
     
     
894. MOORE BD, New RRC, Butcher W, Mahood R, et al
     Dual route vaccination for plague with emergency use applications.
     Vaccine. 2018 Jul 14. pii: S0264-410X(18)30867.
     PubMed     Text format     Abstract available
     
     
     
895. WOLFF E, Elfstrom KM, Haugen Cange H, Larsson S, et al
     Cost-effectiveness of sex-neutral HPV-vaccination in Sweden, accounting for herd-immunity and sexual behaviour.
     Vaccine. 2018 Jul 14. pii: S0264-410X(18)30948.
     PubMed     Text format     Abstract available
     
     
     
896. ZHANG L, Pan Y, Hackert V, van der Hoek W, et al
     The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
     Vaccine. 2018 Jul 14. pii: S0264-410X(18)30947.
     PubMed     Text format     Abstract available
     
     
     
897. CURRAN D, Patterson B, Varghese L, Van Oorschot D, et al
     Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
     Vaccine. 2018 Jul 13. pii: S0264-410X(18)30935.
     PubMed     Text format     Abstract available
     
     
     
898. ZHAO X, Liang S, Dai Q, Jia R, et al
     Regulated delayed attenuation enhances the immunogenicity and protection provided by recombinant Salmonellaenterica serovar Typhimurium vaccines expressing serovar Choleraesuis O-polysaccharides.
     Vaccine. 2018 Jul 12. pii: S0264-410X(18)30939.
     PubMed     Text format     Abstract available
     
     
     
899. ONUIGBO E, Iseghohimhen J, Chah K, Gyang M, et al
     Chitosan/alginate microparticles for the oral delivery of fowl typhoid vaccine: Innate and acquired immunity.
     Vaccine. 2018 Jul 12. pii: S0264-410X(18)30753.
     PubMed     Text format     Abstract available
     
     
     
900. RHEINGANS R, Anderson JD 4th, Bagamian KH, Laytner LA, et al
     Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
     Vaccine. 2018 Jul 12. pii: S0264-410X(18)30172.
     PubMed     Text format     Abstract available
     
     
     
901. HATTA Y, Boltz D, Sarawar S, Kawaoka Y, et al
     Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
     Vaccine. 2018 Jul 12. pii: S0264-410X(18)30894.
     PubMed     Text format     Abstract available
     
     
     
902. RHEINGANS R, Anderson JD 4th, Bagamian KH, Pecenka CJ, et al
     Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
     Vaccine. 2018 Jul 11. pii: S0264-410X(18)30173.
     PubMed     Text format     Abstract available
     
     
     
903. DUNSCH D, Wicker S
     Visual Vaccinology: Changing public perception.
     Vaccine. 2018 Jul 11. pii: S0264-410X(18)30944.
     PubMed     Text format    
     
     
     
904. MARTINEZ CPD, Linares-Perez N, Toledo-Romani ME, Delgado YR, et al
     Safety and immunogenicity of the Cuban heptavalent pneumococcal conjugate vaccine in healthy infants. Results from a double-blind randomized control trial Phase I.
     Vaccine. 2018 Jul 10. pii: S0264-410X(18)30634.
     PubMed     Text format     Abstract available
     
     
     
905. THANGSUPANIMITCHAI N, Edwards AD
     Mixing is required for uniform reconstitution of filter-dried protein antigens in a single-injection vaccine formulation.
     Vaccine. 2018 Jul 10. pii: S0264-410X(18)30929.
     PubMed     Text format     Abstract available
     
     
     
906. RAILEY AF, Lembo T, Palmer GH, Shirima GM, et al
     Spatial and temporal risk as drivers for adoption of foot and mouth disease vaccination.
     Vaccine. 2018 Jul 6. pii: S0264-410X(18)30910.
     PubMed     Text format     Abstract available
     
     
     
907. MARECHAL C, Lal H, Poder A, Ferguson M, et al
     Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults >/=50years of age: A randomized trial.
     Vaccine. 2018;36:4278-4286.
     PubMed     Text format     Abstract available
     
     
     
908. PAIGE LAKE BA, Kasting ML, Malo T, Giuliano AR, et al
     An environmental scan to examine stakeholder perspectives on human papillomavirus vaccination: A mixed methods study.
     Vaccine. 2018 Jul 5. pii: S0264-410X(18)30924.
     PubMed     Text format     Abstract available
     
     
     
909. KURONUMA K, Honda H, Mikami T, Saito A, et al
     Response to pneumococcal vaccine in interstitial lung disease patients: Influence of systemic immunosuppressive treatment.
     Vaccine. 2018 Jul 5. pii: S0264-410X(18)30903.
     PubMed     Text format     Abstract available
     
     
     
910. APAYDIN KZ, Fontenot HB, Borba CPC, Shtasel DL, et al
     Three-dose HPV vaccine completion among sexual and gender minority young adults at a Boston community health center.
     Vaccine. 2018 Jul 5. pii: S0264-410X(18)30898.
     PubMed     Text format     Abstract available
     
     
     
911. PUSHKO P, Tretyakova I, Hidajat R, Sun X, et al
     Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.
     Vaccine. 2018;36:4346-4353.
     PubMed     Text format     Abstract available
     
     
     
912. GAMAOUN R
     National cervical cancer prevention program in the Arab States: Strategies and cost-minimization study of the Tunisian case.
     Vaccine. 2018 Jul 5. pii: S0264-410X(18)30921.
     PubMed     Text format     Abstract available
     
     
     
913. HARRISON N, Poeppl W, Miksch M, Machold K, et al
     Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseases.
     Vaccine. 2018 Jul 3. pii: S0264-410X(18)30906.
     PubMed     Text format     Abstract available
     
     
     
914. HABER M, Lopman BA, Tate JE, Shi M, et al
     A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness.
     Vaccine. 2018 Jul 3. pii: S0264-410X(18)30923.
     PubMed     Text format     Abstract available
     
     
     
915. RODRIGUEZ SA, Savas LS, Baumler E, Nyitray AG, et al
     Parental predictors of HPV vaccine initiation among low-income Hispanic females aged 11-17years.
     Vaccine. 2018 Jul 3. pii: S0264-410X(18)30922.
     PubMed     Text format     Abstract available
     
     
     
916. FARAG NH, Mansour Z, Torossian L, Said R, et al
     Feasibility of jet injector use during inactivated poliovirus vaccine house-to-house vaccination campaigns.
     Vaccine. 2018 Jul 3. pii: S0264-410X(18)30826.
     PubMed     Text format     Abstract available
     
     
     June 2018
917. MASSOT E, Epaulard O
     Midwives' perceptions of vaccines and their role as vaccinators: The emergence of a new immunization corps.
     Vaccine. 2018 Jun 30. pii: S0264-410X(18)30891.
     PubMed     Text format     Abstract available
     
     
     
918. AUTA A, Adewuyi EO, Kureh GT, Onoviran N, et al
     Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis.
     Vaccine. 2018 Jun 30. pii: S0264-410X(18)30871.
     PubMed     Text format     Abstract available
     
     
     
919. BRADY RC, Jackson LA, Frey SE, Shane AL, et al
     Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.
     Vaccine. 2018 Jun 28. pii: S0264-410X(18)30864.
     PubMed     Text format     Abstract available
     
     
     
920. GRASSE M, Meryk A, Miggitsch C, Grubeck-Loebenstein B, et al
     GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine.
     Vaccine. 2018 Jun 28. pii: S0264-410X(18)30861.
     PubMed     Text format     Abstract available
     
     
     
921. LIU W, Wong YC, Chen SMY, Tang J, et al
     DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses.
     Vaccine. 2018 Jun 28. pii: S0264-410X(18)30888.
     PubMed     Text format     Abstract available
     
     
     
922. JARZAB A, Witkowska D, Ziomek E, Setner B, et al
     Cyclic OmpC peptidic epitope conjugated to tetanus toxoid as a potential vaccine candidate against shigellosis.
     Vaccine. 2018 Jun 27. pii: S0264-410X(18)30865.
     PubMed     Text format     Abstract available
     
     
     
923. RIVERA L, Schwarz TF, Kim KH, Kim YK, et al
     Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized
     Vaccine. 2018 Jun 27. pii: S0264-410X(18)30517.
     PubMed     Text format     Abstract available
     
     
     
924. RERMRUAY R, Rungmaitree S, Chatpornvorarux S, Brukesawan C, et al
     Clinical features and outcomes of Bacille Calmette-Guerin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization.
     Vaccine. 2018;36:4046-4053.
     PubMed     Text format     Abstract available
     
     
     
925. DURRHEIM DN, Orenstein WA, Schluter WW
     Assessing population immunity for measles elimination - The promise and peril of serosurveys.
     Vaccine. 2018;36:4001-4003.
     PubMed     Text format    
     
     
     
926. PING X, Hu W, Xiong R, Zhang X, et al
     Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.
     Vaccine. 2018 Jun 27. pii: S0264-410X(18)30889.
     PubMed     Text format     Abstract available
     
     
     
927. YOU JHS, Ming WK, Lee CF, Tsang OT, et al
     Potential cost-effectiveness of adjuvanted herpes zoster subunit vaccine for older adults in Hong Kong.
     Vaccine. 2018 Jun 26. pii: S0264-410X(18)30890.
     PubMed     Text format     Abstract available
     
     
     
928. STEELFISHER GK, Blendon RJ, Haydarov R, Lodge W 2nd, et al
     Threats to oral polio vaccine acceptance in Somalia: Polling in an outbreak.
     Vaccine. 2018 Jun 26. pii: S0264-410X(18)30814.
     PubMed     Text format     Abstract available
     
     
     
929. HECHTER RC, Qian L, Luo Y, Ling Grant DS, et al
     Impact of an electronic medical record reminder on hepatitis B vaccine initiation and completion rates among insured adults with diabetes mellitus.
     Vaccine. 2018 Jun 26. pii: S0264-410X(18)30863.
     PubMed     Text format     Abstract available
     
     
     
930. LIU X, Zhao D, Jia L, Xu H, et al
     Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
     Vaccine. 2018 Jun 25. pii: S0264-410X(18)30868.
     PubMed     Text format     Abstract available
     
     
     
931. BOHM K, Krause G, Sievers C
     Response to comment on: Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
     Vaccine. 2018;36:3885.
     PubMed     Text format    
     
     
     
932. HERZOG C, Mayorga O
     Serologic differential diagnosis of hepatitis A virus (HAV) infected and vaccinated individuals: How long persist antibodies to non-structural HAV proteins?
     Vaccine. 2018;36:3883-3884.
     PubMed     Text format    
     
     
     
933. SCHELTEMA NM, Kavelaars XM, Thorburn K, Hennus MP, et al
     Potential impact of maternal vaccination on life-threatening respiratory syncytial virus infection during infancy.
     Vaccine. 2018 Jun 22. pii: S0264-410X(18)30837.
     PubMed     Text format     Abstract available
     
     
     
934. SCHLAUDECKER EP, Ambroggio L, McNeal MM, Finkelman FD, et al
     Declining responsiveness to influenza vaccination with progression of human pregnancy.
     Vaccine. 2018 Jun 22. pii: S0264-410X(18)30796.
     PubMed     Text format     Abstract available
     
     
     
935. KARA PD, Mather AS, Pretorius A, Chetty T, et al
     Characterisation of putative immunomodulatory gene knockouts of lumpy skin disease virus in cattle towards an improved vaccine.
     Vaccine. 2018 Jun 22. pii: S0264-410X(18)30833.
     PubMed     Text format     Abstract available
     
     
     
936. RIVERA L, Chanthavanich P, Poder A, Suryakiran PV, et al
     MenACWY-TT is immunogenic when co-administered with Tdap and AS04-HPV16/18 in girls and young women: Results from a phase III randomized trial.
     Vaccine. 2018;36:3967-3975.
     PubMed     Text format     Abstract available
     
     
     
937. HINCAPIE-PALACIO D, Hoyos MC, Ochoa J, Montoya N, et al
     Effect of maternal immunization against pertussis in Medellin and the metropolitan area, Colombia, 2016-2017.
     Vaccine. 2018;36:3984-3991.
     PubMed     Text format     Abstract available
     
     
     
938. DEMCZUK WHB, Martin I, Desai S, Griffith A, et al
     Serotype distribution of invasive Streptococcus pneumoniae in adults 65years of age and over after the introduction of childhood 13-valent pneumococcal conjugate vaccination programs in Canada, 2010-2016.
     Vaccine. 2018 Jun 21. pii: S0264-410X(18)30834.
     PubMed     Text format     Abstract available
     
     
     
939. BRANDAO LGP, Santoro-Lopes G, Oliveira SS, da Silva EE, et al
     Seroprevalence of antibodies against the three serotypes of poliovirus and IPV vaccine response in adult solid organ transplant candidates.
     Vaccine. 2018 Jun 21. pii: S0264-410X(18)30859.
     PubMed     Text format     Abstract available
     
     
     
940. BIGGART R, Finn A, Marlow R
     Lack of impact of rotavirus vaccination on childhood seizure hospitalizations in England - An interrupted time series analysis.
     Vaccine. 2018 Jun 21. pii: S0264-410X(18)30857.
     PubMed     Text format     Abstract available
     
     
     
941. RAMANATHAN R, Voigt EA, Kennedy RB, Poland GA, et al
     Knowledge gaps persist and hinder progress in eliminating mumps.
     Vaccine. 2018;36:3721-3726.
     PubMed     Text format     Abstract available
     
     
     
942. ROSENBERG DANZIGER C, Anis E, Gordon ES, Grotto I, et al
     Reintroducing OPV in Israel on the journey to global polio eradication - Estimation at a low rate of contraindicated population.
     Vaccine. 2018;36:3717-3720.
     PubMed     Text format     Abstract available
     
     
     
943. HOENIG LJ, Jackson AC, Dickinson GM
     The early use of Pasteur's rabies vaccine in the United States.
     Vaccine. 2018 Jun 16. pii: S0264-410X(18)30623.
     PubMed     Text format     Abstract available
     
     
     
944. PANDEY RK, Ali M, Ojha R, Bhatt TK, et al
     Development of multi-epitope driven subunit vaccine in secretory and membrane protein of Plasmodium falciparum to convey protection against malaria infection.
     Vaccine. 2018 Jun 16. pii: S0264-410X(18)30748.
     PubMed     Text format     Abstract available
     
     
     
945. FINNEGAN G, Holt D, English PM, Glismann S, et al
     Lessons from an online vaccine communication project.
     Vaccine. 2018 Jun 16. pii: S0264-410X(18)30612.
     PubMed     Text format     Abstract available
     
     
     
946. MWENDA JM, Parashar UD, Cohen AL, Tate JE, et al
     Impact of rotavirus vaccines in Sub-Saharan African countries.
     Vaccine. 2018 Jun 15. pii: S0264-410X(18)30854.
     PubMed     Text format     Abstract available
     
     
     
947. JIAO H, Yang H, Zhao D, Chen J, et al
     Design and immune characterization of a novel Neisseria gonorrhoeae DNA vaccine using bacterial ghosts as vector and adjuvant.
     Vaccine. 2018 Jun 15. pii: S0264-410X(18)30817.
     PubMed     Text format     Abstract available
     
     
     
948. GILLAM F, Zhang C
     Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen.
     Vaccine. 2018 Jun 15. pii: S0264-410X(18)30831.
     PubMed     Text format     Abstract available
     
     
     
949. VUJADINOVIC M, Khan S, Oosterhuis K, Uil TG, et al
     Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responses.
     Vaccine. 2018 Jun 15. pii: S0264-410X(18)30840.
     PubMed     Text format     Abstract available
     
     
     
950. KOUL PA, Mir H
     The biggest barrier to influenza vaccination in pregnant females in India: Poor sensitization of the care providers.
     Vaccine. 2018;36:3569-3570.
     PubMed     Text format    
     
     
     
951. YAN Q, Cheng Z, Liu H, Shan W, et al
     Enhancement of Ag85B DNA vaccine immunogenicity against tuberculosis by dissolving microneedles in mice.
     Vaccine. 2018 Jun 14. pii: S0264-410X(18)30841.
     PubMed     Text format     Abstract available
     
     
     
952. ORTIZ JR
     Implementation of maternal influenza immunization programs.
     Vaccine. 2018;36:3571.
     PubMed     Text format    
     
     
     
953. LEAL KS, de Oliveira Silva MT, de Fatima Silva Rezende A, Bezerra FSB, et al
     Recombinant M. bovis BCG expressing the PLD protein promotes survival in mice challenged with a C. pseudotuberculosis virulent strain.
     Vaccine. 2018;36:3578-3583.
     PubMed     Text format     Abstract available
     
     
     
954. OZAWA S, Yemeke TT, Thompson KM
     Systematic review of the incremental costs of interventions that increase immunization coverage.
     Vaccine. 2018;36:3641-3649.
     PubMed     Text format     Abstract available
     
     
     
955. KUMAR L, Puliyel J
     New pentavalent rotavirus vaccine shows little efficacy against diarrhea.
     Vaccine. 2018 Jun 13. pii: S0264-410X(18)30772.
     PubMed     Text format    
     
     
     
956. TRANTHAM L, Kurosky SK, Zhang D, Johnson KD, et al
     Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States.
     Vaccine. 2018 Jun 13. pii: S0264-410X(18)30788.
     PubMed     Text format     Abstract available
     
     
     
957. ZHANG J, Wang M, Zhou N, Shen Y, et al
     Evaluation of carbopol as an adjuvant on the effectiveness of progressive atrophic rhinitis vaccine.
     Vaccine. 2018 Jun 13. pii: S0264-410X(18)30839.
     PubMed     Text format     Abstract available
     
     
     
958. ZIMMERMANN P, Curtis N
     The influence of the intestinal microbiome on vaccine responses.
     Vaccine. 2018 Jun 13. pii: S0264-410X(18)30563.
     PubMed     Text format     Abstract available
     
     
     
959. KOWALEWICZ-KULBAT M, Szpakowski P, Locht C, Biet F, et al
     Tuberculin skin test reaction is related to memory, but not naive CD4(+) T cell responses to mycobacterial stimuli in BCG-vaccinated young adults.
     Vaccine. 2018 Jun 13. pii: S0264-410X(18)30708.
     PubMed     Text format     Abstract available
     
     
     
960. SHEN AK, Warnock R, Chu S, Kelman JA, et al
     Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015.
     Vaccine. 2018 Jun 13. pii: S0264-410X(18)30836.
     PubMed     Text format     Abstract available
     
     
     
961. CATALDI JR, Dempsey AF, Allison MA, O'Leary ST, et al
     Impact of publicly available vaccination rates on parental school and child care choice.
     Vaccine. 2018 Jun 13. pii: S0264-410X(18)30828.
     PubMed     Text format     Abstract available
     
     
     
962. WALLACE AS, Krey K, Hustedt J, Burnett E, et al
     Assessment of vaccine wastage rates, missed opportunities, and related knowledge, attitudes and practices during introduction of a second dose of measles-containing vaccine into Cambodia's national immunization program.
     Vaccine. 2018 Jun 12. pii: S0264-410X(18)30821.
     PubMed     Text format     Abstract available
     
     
     
963. STRASSBERG ER, Power M, Schulkin J, Stark LM, et al
     Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
     Vaccine. 2018 Jun 12. pii: S0264-410X(18)30800.
     PubMed     Text format     Abstract available
     
     
     
964. SIMWAKA JC, Mpabalwani EM, Seheri M, Peenze I, et al
     Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015.
     Vaccine. 2018 Jun 12. pii: S0264-410X(18)30380.
     PubMed     Text format     Abstract available
     
     
     
965. FOUGERE Y, El Houss S, Suris JC, Rouvenaz-Defago S, et al
     High coverage of hepatitis B vaccination and low prevalence of chronic hepatitis B in migrant children dictate a new catch-up vaccination strategy.
     Vaccine. 2018 Jun 12. pii: S0264-410X(18)30825.
     PubMed     Text format     Abstract available
     
     
     
966. PEZZOTTI P, Miglietta A, Neri A, Fazio C, et al
     Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
     Vaccine. 2018 Jun 9. pii: S0264-410X(18)30813.
     PubMed     Text format     Abstract available
     
     
     
967. ENGELHARDT OG, Edge C, Dunleavy U, Guilfoyle K, et al
     Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen.
     Vaccine. 2018 Jun 9. pii: S0264-410X(18)30742.
     PubMed     Text format     Abstract available
     
     
     
968. HENKE J, Carlson J, Zani L, Leidenberger S, et al
     Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
     Vaccine. 2018 Jun 9. pii: S0264-410X(18)30830.
     PubMed     Text format     Abstract available
     
     
     
969. DOBROVOLSKIENE N, Pasukoniene V, Darinskas A, Krasko JA, et al
     Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines.
     Vaccine. 2018 Jun 9. pii: S0264-410X(18)30832.
     PubMed     Text format     Abstract available
     
     
     
970. RUSSO P, Ligsay AD, Olveda R, Choi SK, et al
     A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol(R), a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines.
     Vaccine. 2018 Jun 9. pii: S0264-410X(18)30769.
     PubMed     Text format     Abstract available
     
     
     
971. JOYCE C, Scallan CD, Mateo R, Belshe RB, et al
     Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats.
     Vaccine. 2018 Jun 9. pii: S0264-410X(18)30789.
     PubMed     Text format     Abstract available
     
     
     
972. HILL S, Entwisle C, Pang Y, Joachim M, et al
     Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae.
     Vaccine. 2018 Jun 9. pii: S0264-410X(18)30801.
     PubMed     Text format     Abstract available
     
     
     
973. ZHANG Y, Huang S, Zeng Y, Xue C, et al
     Rapid development and evaluation of a live-attenuated QX-like infectious bronchitis virus vaccine.
     Vaccine. 2018 Jun 8. pii: S0264-410X(18)30820.
     PubMed     Text format     Abstract available
     
     
     
974. WALKER WL, Hills SL, Miller ER, Fischer M, et al
     Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016.
     Vaccine. 2018 Jun 8. pii: S0264-410X(18)30521.
     PubMed     Text format     Abstract available
     
     
     
975. LIN YL, Cheng PY, Chin CL, Huang LM, et al
     Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine.
     Vaccine. 2018 Jun 8. pii: S0264-410X(18)30756.
     PubMed     Text format     Abstract available
     
     
     
976. TAN N, Sharma M, Winer R, Galloway D, et al
     Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa.
     Vaccine. 2018 Jun 8. pii: S0264-410X(18)30197.
     PubMed     Text format     Abstract available
     
     
     
977. LABASTIDA-CONDE RG, Ramirez-Pliego O, Peleteiro-Olmedo M, Lopez-Guerrero DV, et al
     Flagellin is a Th1 polarizing factor for human CD4(+) T cells and induces protection in a murine neonatal vaccination model of rotavirus infection.
     Vaccine. 2018 Jun 8. pii: S0264-410X(18)30816.
     PubMed     Text format     Abstract available
     
     
     
978. LI Q, Xu Z, Wu T, Peng O, et al
     A flagellin-adjuvanted PED subunit vaccine improved protective efficiency against PEDV variant challenge in pigs.
     Vaccine. 2018 Jun 8. pii: S0264-410X(18)30822.
     PubMed     Text format     Abstract available
     
     
     
979. VALKENBURG SA, Li OTW, Li A, Bull M, et al
     Protection by universal influenza vaccine is mediated by memory CD4 T cells.
     Vaccine. 2018 Jun 7. pii: S0264-410X(18)30818.
     PubMed     Text format     Abstract available
     
     
     
980. CHESSON HW, Meites E, Ekwueme DU, Saraiya M, et al
     Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26years in the United States.
     Vaccine. 2018 Jun 7. pii: S0264-410X(18)30578.
     PubMed     Text format     Abstract available
     
     
     
981. DYDA A, McIntyre P, Karki S, MacIntyre CR, et al
     Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program.
     Vaccine. 2018 Jun 7. pii: S0264-410X(18)30786.
     PubMed     Text format     Abstract available
     
     
     
982. GILCA V, Salmeron-Castro J, Sauvageau C, Ogilvie G, et al
     Early use of the HPV 2-dose vaccination schedule: Leveraging evidence to support policy for accelerated impact.
     Vaccine. 2018 Jun 7. pii: S0264-410X(18)30168.
     PubMed     Text format     Abstract available
     
     
     
983. KIELY M, Boulianne N, Talbot D, Ouakki M, et al
     Impact of the addition of new vaccines in the early childhood schedule on vaccine coverage by 24months of age from 2006 to 2016 in Quebec, Canada.
     Vaccine. 2018 Jun 7. pii: S0264-410X(18)30463.
     PubMed     Text format     Abstract available
     
     
     
984. BENNETT A, Pollock L, Jere KC, Pitzer VE, et al
     Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.
     Vaccine. 2018 Jun 7. pii: S0264-410X(18)30513.
     PubMed     Text format     Abstract available
     
     
     
985. HU K, Fu M, Guan X, Zhang D, et al
     Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses.
     Vaccine. 2018 Jun 7. pii: S0264-410X(18)30797.
     PubMed     Text format     Abstract available
     
     
     
986. BAAY M, Bollaerts K, Verstraeten T
     A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adults.
     Vaccine. 2018 Jun 6. pii: S0264-410X(18)30815.
     PubMed     Text format     Abstract available
     
     
     
987. PHILLIPS DE, Dieleman JL, Shearer JC, Lim SS, et al
     Childhood vaccines in Uganda and Zambia: Determinants and barriers to vaccine coverage.
     Vaccine. 2018 Jun 6. pii: S0264-410X(18)30795.
     PubMed     Text format     Abstract available
     
     
     
988. MODI RN, King C, Bar-Zeev N, Colbourn T, et al
     Caregiver recall in childhood vaccination surveys: Systematic review of recall quality and use in low- and middle-income settings.
     Vaccine. 2018 Jun 6. pii: S0264-410X(18)30755.
     PubMed     Text format     Abstract available
     
     
     
989. MCGREGOR S, Saulo D, Brotherton J, Liu B, et al
     Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
     Vaccine. 2018 Jun 4. pii: S0264-410X(18)30771.
     PubMed     Text format     Abstract available
     
     
     
990. FOSTER M, Pandey A, Kreimeyer K, Botsis T, et al
     Generation of an annotated reference standard for vaccine adverse event reports.
     Vaccine. 2018 Jun 4. pii: S0264-410X(18)30745.
     PubMed     Text format     Abstract available
     
     
     
991. TASHANI M, Alfelali M, Barasheed O, Alqahtani AS, et al
     Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj p
     Vaccine. 2018 Jun 4. pii: S0264-410X(18)30516.
     PubMed     Text format     Abstract available
     
     
     
992. RUSSO R, Bozzola E, Villani A
     Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society.
     Vaccine. 2018 Jun 4. pii: S0264-410X(18)30794.
     PubMed     Text format    
     
     
     
993. PRINCIPI N, Esposito S
     Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome.
     Vaccine. 2018 Jun 4. pii: S0264-410X(18)30798.
     PubMed     Text format     Abstract available
     
     
     
994. FAN X, Su Q, Qiu F, Yi Y, et al
     Intranasal inoculate of influenza virus vaccine against lethal virus challenge.
     Vaccine. 2018 Jun 4. pii: S0264-410X(18)30739.
     PubMed     Text format     Abstract available
     
     
     
995. BRANCHE AR, Yang H, Java J, Wiltse-Holden J, et al
     Effect of prior vaccination on carriage rates of Streptococcus pneumoniae in older adults: A longitudinal surveillance study.
     Vaccine. 2018 Jun 2. pii: S0264-410X(18)30774.
     PubMed     Text format     Abstract available
     
     
     
996. MULYANI NS, Prasetyo D, Karyana IPG, Sukardi W, et al
     Diarrhea among hospitalized children under five: A call for inclusion of rotavirus vaccine to the national immunization program in Indonesia.
     Vaccine. 2018 Jun 1. pii: S0264-410X(18)30649.
     PubMed     Text format     Abstract available
     
     
     
997. HENDRIKS J, Hutubessy RCW, Grohmann G, Torelli G, et al
     Quadrivalent influenza vaccines in low and middle income countries: Cost-effectiveness, affordability and availability.
     Vaccine. 2018 Jun 1. pii: S0264-410X(18)30766.
     PubMed     Text format     Abstract available
     
     
     
998. MULLIGAN K, Snider JT, Arthur P, Frank G, et al
     Examination of universal purchase programs as a driver of vaccine uptake among US States, 1995-2014.
     Vaccine. 2018 Jun 1. pii: S0264-410X(18)30770.
     PubMed     Text format     Abstract available
     
     
     May 2018
999. FISHER DG, Coppock GM, Lopez CB
     Virus-derived immunostimulatory RNA induces type I IFN-dependent antibodies and T-cell responses during vaccination.
     Vaccine. 2018 May 31. pii: S0264-410X(18)30767.
     PubMed     Text format     Abstract available
     
     
     
1000. BEESLAAR J, Absalon J, Balmer P, Srivastava A, et al
      Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults.
      Vaccine. 2018 May 31. pii: S0264-410X(18)30680.
      PubMed     Text format     Abstract available
      
      
      
1001. MOORE HC, Fathima P, Gidding HF, de Klerk N, et al
      Assessment of on-time vaccination coverage in population subgroups: A record linkage cohort study.
      Vaccine. 2018 May 31. pii: S0264-410X(18)30750.
      PubMed     Text format     Abstract available
      
      
      
1002. VERMA S, Sugadev R, Kumar A, Chandna S, et al
      Multi-epitope DnaK peptide vaccine against S.Typhi: An in silico approach.
      Vaccine. 2018 May 31. pii: S0264-410X(18)30773.
      PubMed     Text format     Abstract available
      
      
      
1003. GREGG KA, Harberts E, Gardner FM, Pelletier MR, et al
      A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.
      Vaccine. 2018 May 31. pii: S0264-410X(18)30768.
      PubMed     Text format     Abstract available
      
      
      
1004. GARRETSON TA, Petrie JG, Martin ET, Monto AS, et al
      Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain.
      Vaccine. 2018 May 31. pii: S0264-410X(18)30752.
      PubMed     Text format     Abstract available
      
      
      
1005. GESSNER BD, Jiang Q, Van Werkhoven CH, Sings HL, et al
      A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands.
      Vaccine. 2018 May 31. pii: S0264-410X(18)30763.
      PubMed     Text format     Abstract available
      
      
      
1006. GAO F, Jiang Y, Li G, Zhou Y, et al
      Porcine reproductive and respiratory syndrome virus expressing E2 of classical swine fever virus protects pigs from a lethal challenge of highly-pathogenic PRRSV and CSFV.
      Vaccine. 2018;36:3269-3277.
      PubMed     Text format     Abstract available
      
      
      
1007. ZHANG W, Sun H, Atiquzzaman M, Sou J, et al
      Influenza vaccination for HIV-positive people: Systematic review and network meta-analysis.
      Vaccine. 2018 May 30. pii: S0264-410X(18)30743.
      PubMed     Text format     Abstract available
      
      
      
1008. XIA J, He X, Du LJ, Liu YY, et al
      Preparation and protective efficacy of a chicken embryo kidney cell-attenuation GI-19/QX-like avian infectious bronchitis virus vaccine.
      Vaccine. 2018 May 30. pii: S0264-410X(18)30760.
      PubMed     Text format     Abstract available
      
      
      
1009. FLEMING JA, Baltrons R, Rowley E, Quintanilla I, et al
      Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study.
      Vaccine. 2018 May 30. pii: S0264-410X(18)30762.
      PubMed     Text format     Abstract available
      
      
      
1010. ASTILL J, Alkie T, Yitbarek A, Abdelaziz KTA, et al
      Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
      Vaccine. 2018 May 28. pii: S0264-410X(18)30759.
      PubMed     Text format     Abstract available
      
      
      
1011. LIU X, Yang C, Zhong Q, Song Q, et al
      Improved timely birth dose coverage of hepatitis B vaccine narrows the socio-economic inequality in western China in 2011-2016.
      Vaccine. 2018 May 26. pii: S0264-410X(18)30751.
      PubMed     Text format     Abstract available
      
      
      
1012. LIU H, de Almeida RS, Gil P, Majo N, et al
      Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
      Vaccine. 2018 May 26. pii: S0264-410X(18)30738.
      PubMed     Text format     Abstract available
      
      
      
1013. CHATTOPADHYAY A, Aguilar PV, Bopp NE, Yarovinsky TO, et al
      A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections.
      Vaccine. 2018 May 25. pii: S0264-410X(18)30761.
      PubMed     Text format     Abstract available
      
      
      
1014. ALEXANDER KE, Tong PL, Macartney K, Beresford R, et al
      Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
      Vaccine. 2018 May 25. pii: S0264-410X(18)30744.
      PubMed     Text format     Abstract available
      
      
      
1015. BURGER EA, Campos NG, Sy S, Regan C, et al
      Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country.
      Vaccine. 2018 May 25. pii: S0264-410X(18)30558.
      PubMed     Text format     Abstract available
      
      
      
1016. MARTORELLI L, Garimano N, Fiorentino GA, Vilte DA, et al
      Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
      Vaccine. 2018 May 25. pii: S0264-410X(18)30679.
      PubMed     Text format     Abstract available
      
      
      
1017. HENNINGER ML, Kuntz JL, Firemark AJ, Varga AM, et al
      Feasibility of a pilot intervention to reduce pain and syncope during adolescent vaccination.
      Vaccine. 2018 May 24. pii: S0264-410X(18)30713.
      PubMed     Text format     Abstract available
      
      
      
1018. MARKOWITZ LE, Drolet M, Perez N, Jit M, et al
      Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs.
      Vaccine. 2018 May 22. pii: S0264-410X(18)30117.
      PubMed     Text format     Abstract available
      
      
      
1019. MWANZA-LISULO M, Chomba MS, Chama M, Besa EC, et al
      Retinoic acid elicits a coordinated expression of gut homing markers on T lymphocytes of Zambian men receiving oral Vivotif, but not Rotarix, Dukoral or OPVERO vaccines.
      Vaccine. 2018 May 22. pii: S0264-410X(18)30599.
      PubMed     Text format     Abstract available
      
      
      
1020. KONNO R, Konishi H, Sauvaget C, Ohashi Y, et al
      Effectiveness of HPV vaccination against high grade cervical lesions in Japan.
      Vaccine. 2018 May 21. pii: S0264-410X(18)30668.
      PubMed     Text format     Abstract available
      
      
      
1021. BOYD ED, Phillips JM, Schoenberger YM, Simpson T, et al
      Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers.
      Vaccine. 2018 May 21. pii: S0264-410X(18)30605.
      PubMed     Text format     Abstract available
      
      
      
1022. WANG LJ, Xiao T, Xu C, Li J, et al
      Protective immune response against Toxoplasma gondii elicited by a novel yeast-based vaccine with microneme protein 16.
      Vaccine. 2018 May 21. pii: S0264-410X(18)30715.
      PubMed     Text format     Abstract available
      
      
      
1023. MPABALWANI EM, Simwaka JC, Mwenda JM, Matapo B, et al
      Sustained impact of rotavirus vaccine on rotavirus hospitalisations in Lusaka, Zambia, 2009-2016.
      Vaccine. 2018 May 21. pii: S0264-410X(18)30274.
      PubMed     Text format     Abstract available
      
      
      
1024. LOGAN J, Nederhoff D, Koch B, Griffith B, et al
      'What have you HEARD about the HERD?' Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate?
      Vaccine. 2018 May 19. pii: S0264-410X(18)30657.
      PubMed     Text format     Abstract available
      
      
      
1025. PAGLIUSI S, Dennehy M, Kim H
      Vaccines, inspiring innovation in health.
      Vaccine. 2018 May 19. pii: S0264-410X(18)30655.
      PubMed     Text format     Abstract available
      
      
      
1026. YANG YT, Silverman RD
      Mandatory influenza vaccination and religious accommodation for healthcare workers: Lessons from recent legal challenges.
      Vaccine. 2018 May 19. pii: S0264-410X(18)30714.
      PubMed     Text format    
      
      
      
1027. JACKSON LA, Rupp R, Papadimitriou A, Wallace D, et al
      A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate.
      Vaccine. 2018 May 19. pii: S0264-410X(18)30635.
      PubMed     Text format     Abstract available
      
      
      
1028. DBAIBO G, Tinoco Favila JC, Traskine M, Jastorff A, et al
      Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study.
      Vaccine. 2018 May 18. pii: S0264-410X(18)30666.
      PubMed     Text format     Abstract available
      
      
      
1029. DE MENEZES MARTINS R, Maia MLS, de Lima SMB, de Noronha TG, et al
      Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.
      Vaccine. 2018 May 18. pii: S0264-410X(18)30661.
      PubMed     Text format     Abstract available
      
      
      
1030. CHEN Y, Ma F, Xu Y, Chu X, et al
      Vaccines and the risk of acute disseminated encephalomyelitis.
      Vaccine. 2018 May 18. pii: S0264-410X(18)30703.
      PubMed     Text format     Abstract available
      
      
      
1031. GRIEVES JL, Yin Z, Garcia-Sastre A, Mena I, et al
      A viral-vectored RSV vaccine induces long-lived humoral immunity in cotton rats.
      Vaccine. 2018 May 17. pii: S0264-410X(18)30609.
      PubMed     Text format     Abstract available
      
      
      
1032. FERNANDO GJP, Hickling J, Jayashi Flores CM, Griffin P, et al
      Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch).
      Vaccine. 2018 May 17. pii: S0264-410X(18)30673.
      PubMed     Text format     Abstract available
      
      
      
1033. BOCKSTAL V, Sanders B, Achterberg R, Tiemessen M, et al
      A comparative study between outbred and inbred rat strains for the use in in vivo IPV potency testing.
      Vaccine. 2018;36:2917-2920.
      PubMed     Text format     Abstract available
      
      
      
1034. MARRIE TJ, Tyrrell GJ, Majumdar SR, Eurich DT, et al
      Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.
      Vaccine. 2018;36:2985-2990.
      PubMed     Text format     Abstract available
      
      
      
1035. LUO W, Qu Z, Zhang L, Xie Y, et al
      Recombinant BCG::Rv2645 elicits enhanced protective immunity compared to BCG in vivo with induced ISGylation-related genes and Th1 and Th17 responses.
      Vaccine. 2018;36:2998-3009.
      PubMed     Text format     Abstract available
      
      
      
1036. HOP HT, Arayan LT, Huy TXN, Reyes AWB, et al
      Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
      Vaccine. 2018;36:3027-3033.
      PubMed     Text format     Abstract available
      
      
      
1037. DILLNER J, Nygard M, Munk C, Hortlund M, et al
      Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.
      Vaccine. 2018 May 16. pii: S0264-410X(18)30626.
      PubMed     Text format     Abstract available
      
      
      
1038. SCHNAITH AM, Evans EM, Vogt C, Tinsay AM, et al
      An innovative medical school curriculum to address human papillomavirus vaccine hesitancy.
      Vaccine. 2018 May 16. pii: S0264-410X(18)30621.
      PubMed     Text format     Abstract available
      
      
      
1039. HERBERT JA, Kay EJ, Faustini SE, Richter A, et al
      Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.
      Vaccine. 2018 May 16. pii: S0264-410X(18)30656.
      PubMed     Text format     Abstract available
      
      
      
1040. APAYDIN KZ, Fontenot HB, Shtasel D, Dale SK, et al
      Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center.
      Vaccine. 2018 May 16. pii: S0264-410X(18)30217.
      PubMed     Text format     Abstract available
      
      
      
1041. JONKER EFF, van Ravenhorst MB, Berbers GAM, Visser LG, et al
      Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.
      Vaccine. 2018 May 16. pii: S0264-410X(18)30704.
      PubMed     Text format     Abstract available
      
      
      
1042. BUTTENHEIM AM, Jones M, Mckown C, Salmon D, et al
      Conditional admission, religious exemption type, and nonmedical vaccine exemptions in California before and after a state policy change.
      Vaccine. 2018 May 16. pii: S0264-410X(18)30670.
      PubMed     Text format     Abstract available
      
      
      
1043. CHUAI X, Xie B, Chen H, Tan X, et al
      The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
      Vaccine. 2018 May 16. pii: S0264-410X(18)30681.
      PubMed     Text format     Abstract available
      
      
      
1044. LI T, Wang H, Lu Y, Li Q, et al
      Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China.
      Vaccine. 2018 May 15. pii: S0264-410X(18)30674.
      PubMed     Text format     Abstract available
      
      
      
1045. XU W, Zhang Z, Nfon C, Yang M, et al
      Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
      Vaccine. 2018 May 15. pii: S0264-410X(18)30665.
      PubMed     Text format     Abstract available
      
      
      
1046. CAPEDING MR, Teshome S, Saluja T, Syed KA, et al
      Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.
      Vaccine. 2018 May 15. pii: S0264-410X(18)30658.
      PubMed     Text format     Abstract available
      
      
      
1047. SCHMIDT AL, Zollo F, Scala A, Betsch C, et al
      Polarization of the vaccination debate on Facebook.
      Vaccine. 2018 May 14. pii: S0264-410X(18)30660.
      PubMed     Text format     Abstract available
      
      
      
1048. HIRSH BAR GAI D, Graybill Z, Voevodsky P, Shittu E, et al
      Evaluating scenarios of locations and capacities for vaccine storage in Nigeria.
      Vaccine. 2018 May 14. pii: S0264-410X(18)30579.
      PubMed     Text format     Abstract available
      
      
      
1049. GAO Y, Pei C, Sun X, Zhang C, et al
      Plasmid pcDNA3.1-s11 constructed based on the S11 segment of grass carp reovirus as DNA vaccine provides immune protection.
      Vaccine. 2018 May 12. pii: S0264-410X(18)30663.
      PubMed     Text format     Abstract available
      
      
      
1050. JAIN S, George PJ, Deng W, Koussa J, et al
      The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4(+) T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway.
      Vaccine. 2018 May 12. pii: S0264-410X(18)30636.
      PubMed     Text format     Abstract available
      
      
      
1051. KAHN KE, Santibanez TA, Zhai Y, Bridges CB, et al
      Association between provider recommendation and influenza vaccination status among children.
      Vaccine. 2018 May 12. pii: S0264-410X(18)30584.
      PubMed     Text format     Abstract available
      
      
      
1052. LONGBOTTOM D, Sait M, Livingstone M, Laroucau K, et al
      Genomic evidence that the live Chlamydia abortus vaccine strain 1B is not attenuated and has the potential to cause disease.
      Vaccine. 2018 May 11. pii: S0264-410X(18)30662.
      PubMed     Text format     Abstract available
      
      
      
1053. DESHMUKH U, Oliveira CR, Griggs S, Coleman E, et al
      Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic.
      Vaccine. 2018 May 11. pii: S0264-410X(18)30659.
      PubMed     Text format     Abstract available
      
      
      
1054. LAGOUTTE P, Mignon C, Stadthagen G, Potisopon S, et al
      Simultaneous surface display and cargo loading of encapsulin nanocompartments and their use for rational vaccine design.
      Vaccine. 2018 May 11. pii: S0264-410X(18)30654.
      PubMed     Text format     Abstract available
      
      
      
1055. VAN RIJN PA, Maris-Veldhuis MA, Boonstra J, van Gennip RGP, et al
      Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
      Vaccine. 2018 May 11. pii: S0264-410X(18)30664.
      PubMed     Text format     Abstract available
      
      
      
1056. EDIRISURIYA C, Beard FH, Hendry AJ, Dey A, et al
      Australian rubella serosurvey 2012-2013: On track for elimination?
      Vaccine. 2018;36:2794-2798.
      PubMed     Text format     Abstract available
      
      
      
1057. DAGAN R, Ben-Shimol S, Simell B, Greenberg D, et al
      A toddler PCV booster dose following 3 infancy priming doses increases circulating serotype-specific IGG levels but does not increase protection against carriage.
      Vaccine. 2018;36:2774-2782.
      PubMed     Text format     Abstract available
      
      
      
1058. PRENTICE S, Kamushaaga Z, Nash SB, Elliott AM, et al
      Post-immunization leucocytosis and its implications for the management of febrile infants.
      Vaccine. 2018;36:2870-2875.
      PubMed     Text format     Abstract available
      
      
      
1059. YASUI Y, Mitsui T, Nishimura T, Uchida K, et al
      School-age children and adolescents suspected of having been to be infected with pertussis in Japan.
      Vaccine. 2018;36:2910-2915.
      PubMed     Text format     Abstract available
      
      
      
1060. SIBOMANA H, Rugambwa C, Mwenda JM, Sayinzoga F, et al
      Impact of routine rotavirus vaccination on all-cause and rotavirus hospitalizations during the first four years following vaccine introduction in Rwanda.
      Vaccine. 2018 May 10. pii: S0264-410X(18)30145.
      PubMed     Text format     Abstract available
      
      
      
1061. STANLEY M, Dull P
      HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
      Vaccine. 2018 May 10. pii: S0264-410X(18)30273.
      PubMed     Text format    
      
      
      
1062. WANG R, Liao X, Fan D, Wang L, et al
      Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
      Vaccine. 2018 May 9. pii: S0264-410X(18)30548.
      PubMed     Text format     Abstract available
      
      
      
1063. ROHDE RL, Adjei Boakye E, Christopher KM, Geneus CJ, et al
      Assessing university students' sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior.
      Vaccine. 2018 May 9. pii: S0264-410X(18)30629.
      PubMed     Text format     Abstract available
      
      
      
1064. COLDIRON ME, Guindo O, Makarimi R, Soumana I, et al
      Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial.
      Vaccine. 2018 May 8. pii: S0264-410X(18)30630.
      PubMed     Text format     Abstract available
      
      
      
1065. LANDIS K, Bednarczyk RA, Gaydos LM
      Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen.
      Vaccine. 2018 May 8. pii: S0264-410X(18)30582.
      PubMed     Text format     Abstract available
      
      
      
1066. SAHA A, Hayen A, Ali M, Rosewell A, et al
      Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
      Vaccine. 2018 May 8. pii: S0264-410X(18)30604.
      PubMed     Text format     Abstract available
      
      
      
1067. BUSTOS-ARRIAGA J, Gromowski GD, Tsetsarkin KA, Firestone CY, et al
      Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4Delta30 increases viral susceptibility to type I interferon.
      Vaccine. 2018 May 8. pii: S0264-410X(18)30607.
      PubMed     Text format     Abstract available
      
      
      
1068. MAGWIRA CA, Taylor MB
      Composition of gut microbiota and its influence on the immunogenicity of oral rotavirus vaccines.
      Vaccine. 2018 May 8. pii: S0264-410X(18)30616.
      PubMed     Text format     Abstract available
      
      
      
1069. ENWERONU-LARYEA CC, Armah G, Sagoe KW, Ansong D, et al
      Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children <5years of age, Ghana, 2009-2016.
      Vaccine. 2018 May 8. pii: S0264-410X(18)30245.
      PubMed     Text format     Abstract available
      
      
      
1070. THYSEN SM, Fisker AB
      Selecting the right indicators to ensure optimised implementation of BCG vaccination policy.
      Vaccine. 2018 May 7. pii: S0264-410X(18)30602.
      PubMed     Text format    
      
      
      
1071. HARRISON SM, Wei MY, Lamerato LE, Petrie JG, et al
      Multimorbidity is associated with uptake of influenza vaccination.
      Vaccine. 2018 May 7. pii: S0264-410X(18)30628.
      PubMed     Text format     Abstract available
      
      
      
1072. SHAH PD, Marciniak MW, Golden SD, Trogdon JG, et al
      Pharmacies versus doctors' offices for adolescent vaccination.
      Vaccine. 2018 May 7. pii: S0264-410X(18)30608.
      PubMed     Text format     Abstract available
      
      
      
1073. ARRIOLA CS, Vasconez N, Bresee J, Ropero AM, et al
      "Knowledge, attitudes and practices about influenza vaccination among pregnant women and healthcare providers serving pregnant women in Managua, Nicaragua".
      Vaccine. 2018 May 7. pii: S0264-410X(18)30620.
      PubMed     Text format     Abstract available
      
      
      
1074. SVENSSON T, Kattstrom M, Hammarlund Y, Roth D, et al
      Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.
      Vaccine. 2018 May 7. pii: S0264-410X(18)30619.
      PubMed     Text format     Abstract available
      
      
      
1075. SEO J, Lim J
      Trends in influenza vaccination coverage rates in South Korea from 2005 to 2014: Effect of public health policies on vaccination behavior.
      Vaccine. 2018 May 5. pii: S0264-410X(18)30631.
      PubMed     Text format     Abstract available
      
      
      
1076. JUNG SY, Kang KW, Lee EY, Seo DW, et al
      Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus.
      Vaccine. 2018 May 5. pii: S0264-410X(18)30598.
      PubMed     Text format     Abstract available
      
      
      
1077. YEUNG KHT, Chan KCC, Chan PKS, Lam DSY, et al
      Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data.
      Vaccine. 2018 May 5. pii: S0264-410X(18)30588.
      PubMed     Text format     Abstract available
      
      
      
1078. MISRA N, Wines TF, Knopp CL, Hermann R, et al
      Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.
      Vaccine. 2018 May 5. pii: S0264-410X(18)30564.
      PubMed     Text format     Abstract available
      
      
      
1079. LIM H, In HJ, Lee JA, Sik Yoo J, et al
      The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
      Vaccine. 2018 May 5. pii: S0264-410X(18)30610.
      PubMed     Text format     Abstract available
      
      
      
1080. KOMATSU A, Igimi S, Kawana K
      Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFNgamma-producing cells.
      Vaccine. 2018 May 5. pii: S0264-410X(18)30615.
      PubMed     Text format     Abstract available
      
      
      
1081. MOHAPATRA JK, Das B, Rout M, Sreenivasa BP, et al
      Alternate vaccine strain selection in the wake of emerging foot-and-mouth disease virus serotype A antigenic variants in India.
      Vaccine. 2018 May 4. pii: S0264-410X(18)30614.
      PubMed     Text format     Abstract available
      
      
      
1082. CHEAH BC, Davies J, Singh GR, Wood N, et al
      Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
      Vaccine. 2018 May 4. pii: S0264-410X(18)30122.
      PubMed     Text format     Abstract available
      
      
      
1083. BREDBERG A, Boe OW, Bredberg J, Whist JE, et al
      Detection of hepatitis B surface antigen in blood following vaccination.
      Vaccine. 2018 May 4. pii: S0264-410X(18)30600.
      PubMed     Text format    
      
      
      
1084. GARGANO JW, Zhou F, Stokley S, Markowitz LE, et al
      Human papillomavirus vaccination in commercially-Insured vaccine-eligible males and females, United States, 2007-2014.
      Vaccine. 2018 May 4. pii: S0264-410X(18)30390.
      PubMed     Text format     Abstract available
      
      
      
1085. HANSON CM, Mirza I, Kumapley R, Ogbuanu I, et al
      Enhancing immunization during second year of life by reducing missed opportunities for vaccinations in 46 countries.
      Vaccine. 2018 May 3. pii: S0264-410X(18)30577.
      PubMed     Text format     Abstract available
      
      
      
1086. POULOS C, Curran D, Anastassopoulou A, De Moerlooze L, et al
      Corrigendum to "German travelers' preferences for travel vaccines assessed by a discrete choice experiment" [Vaccine 36 (2018) 969-978].
      Vaccine. 2018 May 3. pii: S0264-410X(18)30549.
      PubMed     Text format    
      
      
      
1087. PARKER KH, Kemp TJ, Pan Y, Yang Z, et al
      Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel(R) sponges.
      Vaccine. 2018;36:2705-2711.
      PubMed     Text format     Abstract available
      
      
      
1088. FENG L, Niu X, Mei W, Li W, et al
      Immunogenicity and protective capacity of EF-Tu and FtsZ of Streptococcus suis serotype 2 against lethal infection.
      Vaccine. 2018;36:2581-2588.
      PubMed     Text format     Abstract available
      
      
      
1089. COUNOUPAS C, Pinto R, Nagalingam G, Britton WJ, et al
      Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis.
      Vaccine. 2018;36:2619-2629.
      PubMed     Text format     Abstract available
      
      
      
1090. OLIVEIRA TL, Schuch RA, Inda GR, Roloff BC, et al
      LemA and Erp Y-like recombinant proteins from Leptospira interrogans protect hamsters from challenge using AddaVax as adjuvant.
      Vaccine. 2018;36:2574-2580.
      PubMed     Text format     Abstract available
      
      
      
1091. GALLARDO C, Sanchez EG, Perez-Nunez D, Nogal M, et al
      African swine fever virus (ASFV) protection mediated by NH/P68 and NH/P68 recombinant live-attenuated viruses.
      Vaccine. 2018;36:2694-2704.
      PubMed     Text format     Abstract available
      
      
      
1092. PHOUMMALAYSITH B, Yamamoto E, Xeuatvongsa A, Louangpradith V, et al
      Factors associated with routine immunization coverage of children under one year old in Lao People's Democratic Republic.
      Vaccine. 2018;36:2666-2672.
      PubMed     Text format     Abstract available
      
      
      
1093. GUALANO MR, Bert F, Voglino G, Buttinelli E, et al
      Attitudes towards compulsory vaccination in Italy: Results from the NAVIDAD multicentre study.
      Vaccine. 2018 May 2. pii: S0264-410X(18)30512.
      PubMed     Text format     Abstract available
      
      
      
1094. LOPEZ AL, Raguindin PF, Esparagoza J, Fox K, et al
      Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country.
      Vaccine. 2018 May 2. pii: S0264-410X(18)30555.
      PubMed     Text format     Abstract available
      
      
      
1095. DEEPE GS JR, Buesing WR, Ostroff GR, Abraham A, et al
      Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.
      Vaccine. 2018 May 2. pii: S0264-410X(18)30544.
      PubMed     Text format     Abstract available
      
      
      
1096. BARTOSZKO JJ, McNamara IF, Aras OAZ, Hylton DA, et al
      Does consecutive influenza vaccination reduce protection against influenza: A systematic review and meta-analysis.
      Vaccine. 2018 May 1. pii: S0264-410X(18)30546.
      PubMed     Text format     Abstract available
      
      
      April 2018
1097. HERBERT GS, Vreeland TJ, Clifton GT, Greene JM, et al
      Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.
      Vaccine. 2018 Apr 30. pii: S0264-410X(18)30585.
      PubMed     Text format     Abstract available
      
      
      
1098. KNUF M, Helm K, Kolhe D, Van Der Wielen M, et al
      Antibody persistence and booster response 68months after vaccination at 2-10years of age with one dose of MenACWY-TT conjugate vaccine.
      Vaccine. 2018 Apr 30. pii: S0264-410X(18)30561.
      PubMed     Text format     Abstract available
      
      
      
1099. DELLEPIANE N, Pagliusi S
      Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processes.
      Vaccine. 2018 Apr 30. pii: S0264-410X(18)30405.
      PubMed     Text format     Abstract available
      
      
      
1100. SHUBITZ LF, Powell DA, Trinh HT, Lewis ML, et al
      Viable spores of Coccidioides posadasii Deltacps1 are required for vaccination and provide long lasting immunity.
      Vaccine. 2018 Apr 30. pii: S0264-410X(18)30507.
      PubMed     Text format     Abstract available
      
      
      
1101. GARLAND SM, Cornall AM, Brotherton JML, Wark JD, et al
      Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
      Vaccine. 2018 Apr 30. pii: S0264-410X(18)30587.
      PubMed     Text format     Abstract available
      
      
      
1102. BOEY L, Bral C, Roelants M, De Schryver A, et al
      Attitudes, believes, determinants and organisational barriers behind the low seasonal influenza vaccination uptake in healthcare workers - A cross-sectional survey.
      Vaccine. 2018 Apr 28. pii: S0264-410X(18)30539.
      PubMed     Text format     Abstract available
      
      
      
1103. VANSKA S, Soderlund-Strand A, Uhnoo I, Lehtinen M, et al
      Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline data.
      Vaccine. 2018 Apr 28. pii: S0264-410X(18)30580.
      PubMed     Text format     Abstract available
      
      
      
1104. TESSIER E, Warburton F, Tsang C, Rafeeq S, et al
      Population-level factors predicting variation in influenza vaccine uptake among adults and young children in England, 2015/16 and 2016/17.
      Vaccine. 2018 Apr 28. pii: S0264-410X(18)30581.
      PubMed     Text format     Abstract available
      
      
      
1105. SKIPETROVA A, Wartel TA, Gailhardou S
      Dengue vaccination during pregnancy - An overview of clinical trials data.
      Vaccine. 2018 Apr 28. pii: S0264-410X(18)30547.
      PubMed     Text format     Abstract available
      
      
      
1106. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
      Hepatitis B vaccination coverage among adults aged >/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
      Vaccine. 2018 Apr 28. pii: S0264-410X(18)30376.
      PubMed     Text format     Abstract available
      
      
      
1107. REGAN AK, Gibbs RA, Effler PV
      An audit of the reliability of influenza vaccination and medical information extracted from eHealth records in general practice.
      Vaccine. 2018 Apr 28. pii: S0264-410X(18)30583.
      PubMed     Text format     Abstract available
      
      
      
1108. SOMES MP, Turner RM, Dwyer LJ, Newall AT, et al
      Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis.
      Vaccine. 2018 Apr 28. pii: S0264-410X(18)30560.
      PubMed     Text format     Abstract available
      
      
      
1109. OLWAGEN CP, Adrian PV, Nunes MC, Madhi SA, et al
      Evaluation of the association of pneumococcal conjugate vaccine immunization and density of nasopharyngeal bacterial colonization using a multiplex quantitative polymerase chain reaction assay.
      Vaccine. 2018 Apr 27. pii: S0264-410X(18)30565.
      PubMed     Text format     Abstract available
      
      
      
1110. VAN DE WITTE S, Nauta J, Montomoli E, Weckx J, et al
      A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
      Vaccine. 2018 Apr 27. pii: S0264-410X(18)30538.
      PubMed     Text format     Abstract available
      
      
      
1111. LEE VY, Booy R, Skinner R, Edwards KM, et al
      The effect of exercise on vaccine-related pain, anxiety and fear during HPV vaccinations in adolescents.
      Vaccine. 2018 Apr 27. pii: S0264-410X(18)30576.
      PubMed     Text format     Abstract available
      
      
      
1112. ZHANG N, Nandakumar KS
      Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases.
      Vaccine. 2018 Apr 26. pii: S0264-410X(18)30559.
      PubMed     Text format     Abstract available
      
      
      
1113. LI R, Xie R, Yang C, Rainey J, et al
      Identifying ways to increase seasonal influenza vaccine uptake among pregnant women in China: A qualitative investigation of pregnant women and their obstetricians.
      Vaccine. 2018 Apr 26. pii: S0264-410X(18)30557.
      PubMed     Text format     Abstract available
      
      
      
1114. REEKIE J, Kaldor JM, Mak DB, Ward J, et al
      Long-term impact of childhood hepatitis B vaccination programs on prevalence among Aboriginal and non-Aboriginal women giving birth in Western Australia.
      Vaccine. 2018 Apr 26. pii: S0264-410X(18)30554.
      PubMed     Text format     Abstract available
      
      
      
1115. HJERTNER B, Bengtsson T, Morein B, Paulie S, et al
      A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine.
      Vaccine. 2018 Apr 26. pii: S0264-410X(18)30551.
      PubMed     Text format     Abstract available
      
      
      
1116. LECOUTURIER V, Berry C, Saulnier A, Naville S, et al
      Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes.
      Vaccine. 2018 Apr 26. pii: S0264-410X(18)30562.
      PubMed     Text format     Abstract available
      
      
      
1117. ZHANG X, Jiang Q, Xu X, Wang Y, et al
      Immune mechanisms induced by an HSV-1 mutant strain: Discrepancy analysis of the immune system gene profile in comparison with a wild-type strain.
      Vaccine. 2018;36:2394-2402.
      PubMed     Text format     Abstract available
      
      
      
1118. MULOIWA R, Wolter N, Mupere E, Tan T, et al
      Pertussis in Africa: Findings and recommendations of the Global Pertussis Initiative (GPI).
      Vaccine. 2018;36:2385-2393.
      PubMed     Text format     Abstract available
      
      
      
1119. YANG H, Yang H, Li Z, Liu L, et al
      Japanese encephalitis virus/yellow fever virus chimera is safe and confers full protection against yellow fever virus in intracerebrally challenged mice.
      Vaccine. 2018;36:2450-2455.
      PubMed     Text format     Abstract available
      
      
      
1120. OHLROGGE AW, Suggs LS
      Flu vaccination communication in Europe: What does the government communicate and how?
      Vaccine. 2018 Apr 24. pii: S0264-410X(18)30525.
      PubMed     Text format     Abstract available
      
      
      
1121. MOK CC, Ho LY, To CH
      Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus.
      Vaccine. 2018 Apr 23. pii: S0264-410X(18)30553.
      PubMed     Text format     Abstract available
      
      
      
1122. THAKUR A, Ingvarsson PT, Schmidt ST, Rose F, et al
      Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
      Vaccine. 2018 Apr 23. pii: S0264-410X(18)30552.
      PubMed     Text format     Abstract available
      
      
      
1123. KUCK LR, Byrne-Nash R, Gillis J, Bueter K, et al
      VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
      Vaccine. 2018 Apr 23. pii: S0264-410X(18)30545.
      PubMed     Text format     Abstract available
      
      
      
1124. WU Y, Marsh JA, McBryde ES, Snelling TL, et al
      The influence of incomplete case ascertainment on measures of vaccine efficacy.
      Vaccine. 2018 Apr 23. pii: S0264-410X(18)30541.
      PubMed     Text format     Abstract available
      
      
      
1125. RAFFERTY E, Hetherington E, Tough S, Aujla S, et al
      The impact of time since vaccination and study design on validity in parental recall of childhood vaccination status in the All Our Families cohort.
      Vaccine. 2018 Apr 23. pii: S0264-410X(18)30540.
      PubMed     Text format     Abstract available
      
      
      
1126. WALZ PH, Riddell KP, Newcomer BW, Neill JD, et al
      Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.
      Vaccine. 2018 Apr 23. pii: S0264-410X(18)30473.
      PubMed     Text format     Abstract available
      
      
      
1127. HANIFI SMA, Ravn H, Aaby P, Bhuiya A, et al
      Where girls are less likely to be fully vaccinated than boys: Evidence from a rural area in Bangladesh.
      Vaccine. 2018 Apr 23. pii: S0264-410X(18)30556.
      PubMed     Text format     Abstract available
      
      
      
1128. DALE LP, White L, Mitchell M, Faulkner G, et al
      Smartphone app uses loyalty point incentives and push notifications to encourage influenza vaccine uptake.
      Vaccine. 2018 Apr 23. pii: S0264-410X(18)30487.
      PubMed     Text format     Abstract available
      
      
      
1129. BETSCH C, Bodeker B, Schmid P, Wichmann O, et al
      How baby's first shot determines the development of maternal attitudes towards vaccination.
      Vaccine. 2018 Apr 21. pii: S0264-410X(18)30492.
      PubMed     Text format     Abstract available
      
      
      
1130. VERHEES RAF, Dondorp W, Thijs C, Dinant GJ, et al
      Influenza vaccination in the elderly: Is a trial on mortality ethically acceptable?
      Vaccine. 2018 Apr 21. pii: S0264-410X(18)30510.
      PubMed     Text format     Abstract available
      
      
      
1131. METHNER U
      Immunisation of chickens with live Salmonella vaccines - Role of booster vaccination.
      Vaccine. 2018 Apr 21. pii: S0264-410X(18)30524.
      PubMed     Text format     Abstract available
      
      
      
1132. GOMEZ L, Alvarez F, Betancur D, Onate A, et al
      Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
      Vaccine. 2018 Apr 20. pii: S0264-410X(18)30483.
      PubMed     Text format     Abstract available
      
      
      
1133. SUZUKI M, Katsurada N, Le MN, Kaneko N, et al
      Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged >/=65years in Japan.
      Vaccine. 2018 Apr 20. pii: S0264-410X(18)30520.
      PubMed     Text format     Abstract available
      
      
      
1134. TOGASHI T, Mitsuya N, Sumino S, Takanami Y, et al
      Safety, tolerability and immunogenicity of intramuscular administration of PRP-CRM197 Hib vaccine to healthy Japanese children: An open-label trial.
      Vaccine. 2018 Apr 20. pii: S0264-410X(18)30523.
      PubMed     Text format     Abstract available
      
      
      
1135. 
      Response to three Letters to the Editor regarding: Donahue JG, et al. "Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12". Vaccine 35 (2017) 5314-5322.
      Vaccine. 2018;36:2231-2232.
      PubMed     Text format    
      
      
      
1136. AN SJ, Scaria PV, Chen B, Barnafo E, et al
      Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.
      Vaccine. 2018 Apr 19. pii: S0264-410X(18)30518.
      PubMed     Text format     Abstract available
      
      
      
1137. TANG X, Liu F, Sheng X, Xing J, et al
      Recombinant NADP-dependent isocitrate dehydrogenase of Edwardsiella tarda induces both Th1 and Th2 type immune responses and evokes protective efficacy against edwardsiellosis.
      Vaccine. 2018;36:2337-2345.
      PubMed     Text format     Abstract available
      
      
      
1138. SARKAR I, Garg R, van Drunen Littel-van den Hurk S
      The respiratory syncytial virus fusion protein formulated with a polymer-based adjuvant induces multiple signaling pathways in macrophages.
      Vaccine. 2018;36:2326-2336.
      PubMed     Text format     Abstract available
      
      
      
1139. WEN Y, Palladino G, Xie Y, Ferrari A, et al
      Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
      Vaccine. 2018 Apr 18. pii: S0264-410X(18)30490.
      PubMed     Text format     Abstract available
      
      
      
1140. VINCENT LR, Jerse AE
      Biological feasibility and importance of a gonorrhea vaccine for global public health.
      Vaccine. 2018 Apr 18. pii: S0264-410X(18)30278.
      PubMed     Text format     Abstract available
      
      
      
1141. JACA A, Mathebula L, Iweze A, Pienaar E, et al
      A systematic review of strategies for reducing missed opportunities for vaccination.
      Vaccine. 2018 Apr 18. pii: S0264-410X(18)30511.
      PubMed     Text format     Abstract available
      
      
      
1142. HOSCHLER K, Southern J, Thompson C, Warburton F, et al
      Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3B adjuvanted pandemic A/H1N1pdm09).
      Vaccine. 2018 Apr 18. pii: S0264-410X(18)30486.
      PubMed     Text format     Abstract available
      
      
      
1143. SZILAGYI PG, Schaffer S, Rand CM, Goldstein NPN, et al
      Impact of elementary school-located influenza vaccinations: A stepped wedge trial across a community.
      Vaccine. 2018 Apr 17. pii: S0264-410X(18)30403.
      PubMed     Text format     Abstract available
      
      
      
1144. GARNER-SPITZER E, Seidl-Friedrich C, Zwazl I, Hofer M, et al
      Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias.
      Vaccine. 2018 Apr 16. pii: S0264-410X(18)30454.
      PubMed     Text format     Abstract available
      
      
      
1145. LINK-GELLES R, Hofmeister MG, Nelson NP
      Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40years of age: A systematic review of published studies and recommendations for vaccine use.
      Vaccine. 2018 Apr 16. pii: S0264-410X(18)30484.
      PubMed     Text format     Abstract available
      
      
      
1146. SHIBATA N, Kimura S, Hoshino T, Takeuchi M, et al
      Effectiveness of influenza vaccination for children in Japan: Four-year observational study using a large-scale claims database.
      Vaccine. 2018 Apr 13. pii: S0264-410X(18)30460.
      PubMed     Text format     Abstract available
      
      
      
1147. BISSET KA, Paterson P
      Strategies for increasing uptake of vaccination in pregnancy in high-income countries: A systematic review.
      Vaccine. 2018 Apr 13. pii: S0264-410X(18)30482.
      PubMed     Text format     Abstract available
      
      
      
1148. SCHWAMBORN K
      Back to the future - Is the drug repositioning concept applicable to vaccines?
      Vaccine. 2018 Apr 13. pii: S0264-410X(18)30489.
      PubMed     Text format    
      
      
      
1149. WORLD HEALTH ORGANIZATION
      Typhoid vaccines: WHO position paper, March 2018 - Recommendations.
      Vaccine. 2018 Apr 13. pii: S0264-410X(18)30491.
      PubMed     Text format     Abstract available
      
      
      
1150. FONSECA JA, McCaffery JN, Caceres J, Kashentseva E, et al
      Inclusion of the murine IgGkappa signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.
      Vaccine. 2018 Apr 12. pii: S0264-410X(18)30474.
      PubMed     Text format     Abstract available
      
      
      
1151. SEGURA-CERDA CA, Aceves-Sanchez MJ, Marquina-Castillo B, Mata-Espinoza D, et al
      Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence.
      Vaccine. 2018;36:2069-2078.
      PubMed     Text format     Abstract available
      
      
      
1152. VAEZIRAD MM, Koene MG, Wagenaar JA, van Putten JPM, et al
      Chicken immune response following in ovo delivery of bacterial flagellin.
      Vaccine. 2018;36:2139-2146.
      PubMed     Text format     Abstract available
      
      
      
1153. PALOMARES LA, Mukhopadhyay TK, Genzel Y, Lua LHL, et al
      Vaccine Technology VI: Innovative and integrated approaches in vaccine development.
      Vaccine. 2018 Apr 11. pii: S0264-410X(18)30455.
      PubMed     Text format    
      
      
      
1154. METCALFE HJ, Biffar L, Steinbach S, Guzman E, et al
      Ag85A-specific CD4(+) T cell lines derived after boosting BCG-vaccinated cattle with Ad5-85A possess both mycobacterial growth inhibition and anti-inflammatory properties.
      Vaccine. 2018 Apr 11. pii: S0264-410X(18)30437.
      PubMed     Text format     Abstract available
      
      
      
1155. JANI B, Hokororo A, Mchomvu J, Cortese MM, et al
      Detection of rotavirus before and after monovalent rotavirus vaccine introduction and vaccine effectiveness among children in mainland Tanzania.
      Vaccine. 2018 Apr 11. pii: S0264-410X(18)30144.
      PubMed     Text format     Abstract available
      
      
      
1156. MACDONALD SE, Dover DC, Hill MD, Kirton A, et al
      Is varicella vaccination associated with pediatric arterial ischemic stroke? A population-based cohort study.
      Vaccine. 2018 Apr 11. pii: S0264-410X(18)30481.
      PubMed     Text format     Abstract available
      
      
      
1157. STANFIELD BA, Rider PJF, Caskey J, Del Piero F, et al
      Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses.
      Vaccine. 2018 Apr 11. pii: S0264-410X(18)30444.
      PubMed     Text format     Abstract available
      
      
      
1158. LYAMUYA F, Michael F, Jani B, Fungo Y, et al
      Trends in diarrhea hospitalizations among infants at three hospitals in Tanzania before and after rotavirus vaccine introduction.
      Vaccine. 2018 Apr 11. pii: S0264-410X(17)31615.
      PubMed     Text format     Abstract available
      
      
      
1159. HANEY DJ, Lock MD, Gurwith M, Simon JK, et al
      Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
      Vaccine. 2018 Apr 11. pii: S0264-410X(18)30480.
      PubMed     Text format     Abstract available
      
      
      
1160. HUIJBERS EJM, van Beijnum JR, Le CT, Langman S, et al
      An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature.
      Vaccine. 2018 Apr 11. pii: S0264-410X(18)30433.
      PubMed     Text format     Abstract available
      
      
      
1161. MA R, Lu L, Zhou T, Pan J, et al
      Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016.
      Vaccine. 2018 Apr 10. pii: S0264-410X(18)30443.
      PubMed     Text format     Abstract available
      
      
      
1162. ROBERTS JR, Morella K, Dawley EH, Madden CA, et al
      Direct-to-adolescent text messaging for vaccine reminders: What will parents permit?
      Vaccine. 2018 Apr 10. pii: S0264-410X(18)30466.
      PubMed     Text format     Abstract available
      
      
      
1163. LOPES PD, Okino CH, Fernando FS, Pavani C, et al
      Inactivated infectious bronchitis virus vaccine encapsulated in chitosan nanoparticles induces mucosal immune responses and effective protection against challenge.
      Vaccine. 2018 Apr 10. pii: S0264-410X(18)30434.
      PubMed     Text format     Abstract available
      
      
      
1164. HOFFMANN A, Dumke C, Hanschmann KO, Wicker S, et al
      Local thermal reaction after influenza vaccination: Quantification by infrared imaging and biometric considerations.
      Vaccine. 2018 Apr 10. pii: S0264-410X(18)30467.
      PubMed     Text format     Abstract available
      
      
      
1165. LARSON WILLIAMS A, McCloskey L, Mwale M, Mwananyanda L, et al
      "When you are injected, the baby is protected:" Assessing the acceptability of a maternal Tdap vaccine based on mothers' knowledge, attitudes, and beliefs of pertussis and vaccinations in Lusaka, Zambia.
      Vaccine. 2018 Apr 10. pii: S0264-410X(18)30459.
      PubMed     Text format     Abstract available
      
      
      
1166. LEWIS RM, Markowitz LE
      Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007-2016.
      Vaccine. 2018 Apr 9. pii: S0264-410X(18)30461.
      PubMed     Text format     Abstract available
      
      
      
1167. BRANDILEONE MC, Almeida SCG, Minamisava R, Andrade AL, et al
      Distribution of invasive Streptococcus pneumoniae serotypes before and 5years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
      Vaccine. 2018 Apr 9. pii: S0264-410X(18)30479.
      PubMed     Text format     Abstract available
      
      
      
1168. IBARZ-PAVON AB, French N
      No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi.
      Vaccine. 2018 Apr 7. pii: S0264-410X(18)30478.
      PubMed     Text format     Abstract available
      
      
      
1169. MATSUYAMA T, Sano N, Takano T, Sakai T, et al
      Antibody profiling using a recombinant protein-based multiplex ELISA array accelerates recombinant vaccine development: Case study on red sea bream iridovirus as a reverse vaccinology model.
      Vaccine. 2018 Apr 6. pii: S0264-410X(18)30415.
      PubMed     Text format     Abstract available
      
      
      
1170. DING X, Li H, Li Y, Huang D, et al
      Two B-cell epitope vaccines based on uPA effectively inhibit fertility in male mice.
      Vaccine. 2018 Apr 6. pii: S0264-410X(18)30440.
      PubMed     Text format     Abstract available
      
      
      
1171. REHER D, Fuhrmann V, Kluge S, Nierhaus A, et al
      A rare case of septic shock due to Neisseria meningitidis serogroup B infection despite prior vaccination in a young adult with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
      Vaccine. 2018 Apr 6. pii: S0264-410X(18)30465.
      PubMed     Text format     Abstract available
      
      
      
1172. HYER R, McGuire DK, Xing B, Jackson S, et al
      Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults.
      Vaccine. 2018 Apr 5. pii: S0264-410X(18)30436.
      PubMed     Text format     Abstract available
      
      
      
1173. LAPUENTE D, Ruzsics Z, Thirion C, Tenbusch M, et al
      Evaluation of adenovirus 19a as a novel vector for mucosal vaccination against influenza A viruses.
      Vaccine. 2018 Apr 5. pii: S0264-410X(18)30262.
      PubMed     Text format     Abstract available
      
      
      
1174. MUKARATIRWA A, Berejena C, Nziramasanga P, Ticklay I, et al
      Distribution of rotavirus genotypes associated with acute diarrhoea in Zimbabwean children less than five years old before and after rotavirus vaccine introduction.
      Vaccine. 2018 Apr 5. pii: S0264-410X(18)30438.
      PubMed     Text format     Abstract available
      
      
      
1175. ISABEL S, Higgins RR, Peci A, Isabel MR, et al
      Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program.
      Vaccine. 2018;36:2033-2040.
      PubMed     Text format     Abstract available
      
      
      
1176. HUSSAIN I, Mach O, Hamid NA, Bhatti ZS, et al
      Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017.
      Vaccine. 2018;36:1921-1924.
      PubMed     Text format     Abstract available
      
      
      
1177. TAVOSCHI L, Severi E, Carrillo Santisteve P, Lopalco P, et al
      Hepatitis A in the EU/EEA: The case for scaling up prevention.
      Vaccine. 2018 Apr 5. pii: S0264-410X(18)30299.
      PubMed     Text format    
      
      
      
1178. MAERTENS K, Braeckman T, Blaizot S, Theeten H, et al
      Coverage of recommended vaccines during pregnancy in Flanders, Belgium. Fairly good but can we do better?
      Vaccine. 2018 Apr 4. pii: S0264-410X(18)30378.
      PubMed     Text format     Abstract available
      
      
      
1179. KORNIDES ML, Fontenot HB, McRee AL, Panozzo CA, et al
      Associations between parents' satisfaction with provider communication and HPV vaccination behaviors.
      Vaccine. 2018 Apr 4. pii: S0264-410X(18)30416.
      PubMed     Text format     Abstract available
      
      
      
1180. ZHAO M, Vandersluis M, Stout J, Haupts U, et al
      Affinity chromatography for vaccines manufacturing: Finally ready for prime time?
      Vaccine. 2018 Apr 4. pii: S0264-410X(18)30289.
      PubMed     Text format     Abstract available
      
      
      
1181. DABAGHIAN M, Latifi AM, Tebianian M, NajmiNejad H, et al
      Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
      Vaccine. 2018 Apr 4. pii: S0264-410X(18)30259.
      PubMed     Text format     Abstract available
      
      
      
1182. GIDDING HF, McCallum L, Fathima P, Moore HC, et al
      Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.
      Vaccine. 2018 Apr 4. pii: S0264-410X(18)30414.
      PubMed     Text format     Abstract available
      
      
      
1183. SUTTON P, Boag JM
      Status of vaccine research and development for Helicobacter pylori.
      Vaccine. 2018 Apr 4. pii: S0264-410X(18)30017.
      PubMed     Text format     Abstract available
      
      
      
1184. LACOMBE-DUNCAN A, Newman PA, Baiden P
      Human papillomavirus vaccine acceptability and decision-making among adolescent boys and parents: A meta-ethnography of qualitative studies.
      Vaccine. 2018 Apr 3. pii: S0264-410X(18)30276.
      PubMed     Text format     Abstract available
      
      
      
1185. SPICKNALL IH, Looker KJ, Gottlieb SL, Chesson HW, et al
      Review of mathematical models of HSV-2 vaccination: Implications for vaccine development.
      Vaccine. 2018 Apr 3. pii: S0264-410X(18)30254.
      PubMed     Text format     Abstract available
      
      
      
1186. CONLIN AMS, Bukowinski AT, Levine JA, Khodr ZG, et al
      A follow-up comparative safety analysis of pandemic H1N1 vaccination during pregnancy and risk of infant birth defects among U.S. military mothers.
      Vaccine. 2018 Apr 3. pii: S0264-410X(18)30417.
      PubMed     Text format     Abstract available
      
      
      
1187. NG SS, Hutubessy R, Chaiyakunapruk N
      Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination.
      Vaccine. 2018 Apr 3. pii: S0264-410X(18)30369.
      PubMed     Text format     Abstract available
      
      
      
1188. PLOTKIN SA, Boppana SB
      Vaccination against the human cytomegalovirus.
      Vaccine. 2018 Apr 2. pii: S0264-410X(18)30288.
      PubMed     Text format     Abstract available
      
      
      
1189. NISHIKAWA AM, Sartori AMC, Mainardi GM, Freitas AC, et al
      Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60years of age or older.
      Vaccine. 2018 Apr 2. pii: S0264-410X(18)30439.
      PubMed     Text format     Abstract available
      
      
      March 2018
1190. ESPOSITO S, Franco E, Gavazzi G, de Miguel AG, et al
      The public health value of vaccination for seniors in Europe.
      Vaccine. 2018 Mar 31. pii: S0264-410X(18)30409.
      PubMed     Text format     Abstract available
      
      
      
1191. GARCIA D, Porras A, Rico Mendoza A, Alvis N, et al
      Hepatitis B infection control in Colombian Amazon after 15years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
      Vaccine. 2018 Mar 30. pii: S0264-410X(17)31546.
      PubMed     Text format     Abstract available
      
      
      
1192. WORLD HEALTH ORGANIZATION
      BCG vaccine: WHO position paper, February 2018 - Recommendations.
      Vaccine. 2018 Mar 30. pii: S0264-410X(18)30345.
      PubMed     Text format     Abstract available
      
      
      
1193. WANG Z, Wang J, Fang Y, Gross DL, et al
      Parental acceptability of HPV vaccination for boys and girls aged 9-13years in China - A population-based study.
      Vaccine. 2018 Mar 29. pii: S0264-410X(18)30413.
      PubMed     Text format     Abstract available
      
      
      
1194. HARRER T, Dinges W, Roman F
      Long-term follow-up of HIV-1-infected adults who received the F4/AS01B HIV-1 vaccine candidate in two randomised controlled trials.
      Vaccine. 2018 Mar 29. pii: S0264-410X(18)30388.
      PubMed     Text format     Abstract available
      
      
      
1195. WENDLANDT R, Cowling BJ, Chen Y, Havers F, et al
      Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China.
      Vaccine. 2018 Mar 29. pii: S0264-410X(18)30408.
      PubMed     Text format     Abstract available
      
      
      
1196. LANE S, MacDonald NE, Marti M, Dumolard L, et al
      Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017.
      Vaccine. 2018 Mar 28. pii: S0264-410X(18)30419.
      PubMed     Text format     Abstract available
      
      
      
1197. KASSIANOS G, Kuchar E, Nitsch-Osuch A, Kyncl J, et al
      Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries.
      Vaccine. 2018 Mar 28. pii: S0264-410X(18)30205.
      PubMed     Text format     Abstract available
      
      
      
1198. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
      Hepatitis B vaccination coverage among adults aged>/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
      Vaccine. 2018 Mar 28. pii: S0264-410X(18)30375.
      PubMed     Text format     Abstract available
      
      
      
1199. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
      Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
      Vaccine. 2018 Mar 27. pii: S0264-410X(18)30382.
      PubMed     Text format     Abstract available
      
      
      
1200. LATSUZBAIA A, Arbyn M, Weyers S, Mossong J, et al
      Human papillomavirus vaccination coverage in Luxembourg - Implications of lowering and restricting target age groups.
      Vaccine. 2018 Mar 27. pii: S0264-410X(18)30410.
      PubMed     Text format     Abstract available
      
      
      
1201. GROMOWSKI GD, Henein S, Kannadka CB, Barvir DA, et al
      Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine.
      Vaccine. 2018 Mar 27. pii: S0264-410X(18)30411.
      PubMed     Text format     Abstract available
      
      
      
1202. AKMATOV MK, Rubsamen N, Deyneko IV, Karch A, et al
      Poor knowledge of vaccination recommendations and negative attitudes towards vaccinations are independently associated with poor vaccination uptake among adults - Findings of a population-based panel study in Lower Saxony, Germany.
      Vaccine. 2018 Mar 27. pii: S0264-410X(18)30406.
      PubMed     Text format     Abstract available
      
      
      
1203. CHEMINAY C, Korner J, Bernig C, Bruckel M, et al
      A single vaccination with non-replicating MVA at birth induces both immediate and long-term protective immune responses.
      Vaccine. 2018 Mar 27. pii: S0264-410X(18)30404.
      PubMed     Text format     Abstract available
      
      
      
1204. GYE HJ, Oh MJ, Nishizawa T
      Lack of nervous necrosis virus (NNV) neutralizing antibodies in convalescent sevenband grouper Hyporthodus septemfasciatus after NNV infection.
      Vaccine. 2018;36:1863-1870.
      PubMed     Text format     Abstract available
      
      
      
1205. PEREIRA SILVA BEZERRA I, Amaral Abib M, Rossi-Bergmann B
      Intranasal but not subcutaneous vaccination with LaAg allows rapid expansion of protective immunity against cutaneous leishmaniasis.
      Vaccine. 2018 Mar 26. pii: S0264-410X(18)30356.
      PubMed     Text format     Abstract available
      
      
      
1206. PORTER RM, Amin AB, Bednarczyk RA, Omer SB, et al
      Cancer-salient messaging for Human Papillomavirus vaccine uptake: A randomized controlled trial.
      Vaccine. 2018 Mar 26. pii: S0264-410X(18)30076.
      PubMed     Text format     Abstract available
      
      
      
1207. CITRON MP, Patel M, Purcell M, Lin SA, et al
      A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates.
      Vaccine. 2018 Mar 26. pii: S0264-410X(18)30320.
      PubMed     Text format     Abstract available
      
      
      
1208. KANCI A, Wijesurendra DS, Wawegama NK, Underwood GJ, et al
      Evaluation of Mycoplasma gallisepticum (MG) ts-304 vaccine as a live attenuated vaccine in turkeys.
      Vaccine. 2018 Mar 26. pii: S0264-410X(18)30329.
      PubMed     Text format     Abstract available
      
      
      
1209. LI X, Xu Y, Dong Y, Yang X, et al
      Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
      Vaccine. 2018 Mar 24. pii: S0264-410X(18)30389.
      PubMed     Text format     Abstract available
      
      
      
1210. CLEATON JM, Wallace RM, Crowdis K, Gibson A, et al
      Impact of community-delivered SMS alerts on dog-owner participation during a mass rabies vaccination campaign, Haiti 2017.
      Vaccine. 2018 Mar 23. pii: S0264-410X(18)30353.
      PubMed     Text format     Abstract available
      
      
      
1211. GALLAGHER KE, LaMontagne DS, Watson-Jones D
      Status of HPV vaccine introduction and barriers to country uptake.
      Vaccine. 2018 Mar 23. pii: S0264-410X(18)30167.
      PubMed     Text format     Abstract available
      
      
      
1212. MOHANTY L, Sharma S, Behera B, Panwar S, et al
      A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix) to licensed combination vaccines in healthy infants.
      Vaccine. 2018 Mar 23. pii: S0264-410X(17)31250.
      PubMed     Text format     Abstract available
      
      
      
1213. KRETZSCHMAR E, Muckenfuss H, Pfleiderer M
      Official batch control of influenza vaccines: Is it still useful?
      Vaccine. 2018 Mar 23. pii: S0264-410X(18)30275.
      PubMed     Text format     Abstract available
      
      
      
1214. WANG Y, Chen L, Yu J, Pang Y, et al
      The effectiveness of influenza vaccination among nursery school children in China during the 2016/17 influenza season.
      Vaccine. 2018 Mar 23. pii: S0264-410X(18)30384.
      PubMed     Text format     Abstract available
      
      
      
1215. POELAERT D, Pereira P, Gardner R, Standaert B, et al
      A review of recommendations for rotavirus vaccination in Europe: Arguments for change.
      Vaccine. 2018 Mar 22. pii: S0264-410X(18)30277.
      PubMed     Text format     Abstract available
      
      
      
1216. KLEIN NP, Habanec T, Kosina P, Shah NR, et al
      Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
      Vaccine. 2018 Mar 22. pii: S0264-410X(18)30284.
      PubMed     Text format     Abstract available
      
      
      
1217. PARK JE, Shin HJ
      Porcine epidemic diarrhea vaccine efficacy evaluation by vaccination timing and frequencies.
      Vaccine. 2018 Mar 22. pii: S0264-410X(18)30386.
      PubMed     Text format     Abstract available
      
      
      
1218. FERNANDES S, Jit M, Bozzani F, Griffiths UK, et al
      A bibliometric analysis of systematic reviews on vaccines and immunisation.
      Vaccine. 2018 Mar 22. pii: S0264-410X(18)30236.
      PubMed     Text format     Abstract available
      
      
      
1219. MARLOW R, Kuriyakose S, Mesaros N, Han HH, et al
      A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella v
      Vaccine. 2018 Mar 22. pii: S0264-410X(18)30366.
      PubMed     Text format     Abstract available
      
      
      
1220. WEI S, Lei Y, Yang J, Wang X, et al
      Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
      Vaccine. 2018 Mar 22. pii: S0264-410X(18)30381.
      PubMed     Text format     Abstract available
      
      
      
1221. KLINGER G, Chodick G, Levy I
      Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
      Vaccine. 2018 Mar 21. pii: S0264-410X(18)30373.
      PubMed     Text format     Abstract available
      
      
      
1222. NLINWE ON, Kusi KA, Adu B, Sedegah M, et al
      T-cell responses against Malaria: Effect of parasite antigen diversity and relevance for vaccine development.
      Vaccine. 2018 Mar 21. pii: S0264-410X(18)30368.
      PubMed     Text format     Abstract available
      
      
      
1223. POOL V, Tomovici A, Johnson DR, Greenberg DP, et al
      Humoral immunity 10years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.
      Vaccine. 2018 Mar 21. pii: S0264-410X(18)30374.
      PubMed     Text format     Abstract available
      
      
      
1224. LEE JS, Lourenco J, Gupta S, Farlow A, et al
      A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia.
      Vaccine. 2018 Mar 21. pii: S0264-410X(18)30328.
      PubMed     Text format     Abstract available
      
      
      
1225. FRANCESCHI S, Clifford GM, Baussano I
      Options for design of real-world impact studies of single-dose vaccine schedules.
      Vaccine. 2018 Mar 20. pii: S0264-410X(18)30166.
      PubMed     Text format     Abstract available
      
      
      
1226. PANDEY RK, Ojha R, Aathmanathan VS, Krishnan M, et al
      Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection.
      Vaccine. 2018 Mar 20. pii: S0264-410X(18)30387.
      PubMed     Text format     Abstract available
      
      
      
1227. LIU Y, Ma C, Jia H, Xu E, et al
      Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.
      Vaccine. 2018 Mar 19. pii: S0264-410X(18)30354.
      PubMed     Text format     Abstract available
      
      
      
1228. STELZNER JJ, Behrens M, Behrens SE, Mader K, et al
      Squalene containing solid lipid nanoparticles, a promising adjuvant system for yeast vaccines.
      Vaccine. 2018 Mar 19. pii: S0264-410X(18)30355.
      PubMed     Text format     Abstract available
      
      
      
1229. GLASS RI, Jiang B, Parashar U
      The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem?
      Vaccine. 2018 Mar 19. pii: S0264-410X(18)30344.
      PubMed     Text format     Abstract available
      
      
      
1230. ERMLICH SJ, Andrews CP, Folkerth S, Rupp R, et al
      Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults >/=50 years of age.
      Vaccine. 2018 Mar 17. pii: S0264-410X(18)30348.
      PubMed     Text format     Abstract available
      
      
      
1231. WORLD HEALTH ORGANIZATION
      Cholera vaccine: WHO position paper, August 2017 - Recommendations.
      Vaccine. 2018 Mar 17. pii: S0264-410X(17)31263.
      PubMed     Text format     Abstract available
      
      
      
1232. ALFELALI M, Barasheed O, Badahdah AM, Bokhary H, et al
      Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriers.
      Vaccine. 2018 Mar 16. pii: S0264-410X(18)30343.
      PubMed     Text format     Abstract available
      
      
      
1233. LI Y, Xue M, Yu L, Luo G, et al
      Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
      Vaccine. 2018 Mar 16. pii: S0264-410X(18)30347.
      PubMed     Text format     Abstract available
      
      
      
1234. HOEKSEMA F, Karpilow J, Luitjens A, Lagerwerf F, et al
      Enhancing viral vaccine production using engineered knockout vero cell lines - A second look.
      Vaccine. 2018 Mar 16. pii: S0264-410X(18)30346.
      PubMed     Text format     Abstract available
      
      
      
1235. WALKER JL, Andrews NJ, Amirthalingam G, Forbes H, et al
      Effectiveness of herpes zoster vaccination in an older United Kingdom population.
      Vaccine. 2018 Mar 16. pii: S0264-410X(18)30195.
      PubMed     Text format     Abstract available
      
      
      
1236. MEUNIER M, Guyard-Nicodeme M, Vigouroux E, Poezevara T, et al
      A DNA prime/protein boost vaccine protocol developed against Campylobacter jejuni for poultry.
      Vaccine. 2018 Mar 16. pii: S0264-410X(18)30331.
      PubMed     Text format     Abstract available
      
      
      
1237. SANKARANARAYANAN R, Joshi S, Muwonge R, Esmy PO, et al
      Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an indian study.
      Vaccine. 2018 Mar 15. pii: S0264-410X(18)30286.
      PubMed     Text format     Abstract available
      
      
      
1238. SOEDJATMIKO S, Medise BE, Gunardi H, Sekartini R, et al
      Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children.
      Vaccine. 2018 Mar 15. pii: S0264-410X(18)30324.
      PubMed     Text format     Abstract available
      
      
      
1239. GALDO NOVO S, Malirat V, Maradei ED, Pedemonte AR, et al
      Efficacy of a high quality O1/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs.
      Vaccine. 2018;36:1570-1576.
      PubMed     Text format     Abstract available
      
      
      
1240. ZHU C, Lin H, Tang L, Chen J, et al
      Oral Chlamydia vaccination induces transmucosal protection in the airway.
      Vaccine. 2018 Mar 14. pii: S0264-410X(18)30351.
      PubMed     Text format     Abstract available
      
      
      
1241. HANSEN J, Zhang L, Eaton A, Baxter R, et al
      Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children.
      Vaccine. 2018 Mar 14. pii: S0264-410X(18)30317.
      PubMed     Text format     Abstract available
      
      
      
1242. LINDSAY BJ, Bonar MM, Costas-Cancelas IN, Hunt K, et al
      Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.
      Vaccine. 2018 Mar 14. pii: S0264-410X(18)30316.
      PubMed     Text format     Abstract available
      
      
      
1243. SU Q, Ma C, Wen N, Fan C, et al
      Epidemiological profile and progress toward rubella elimination in China. 10 years after nationwide introduction of rubella vaccine.
      Vaccine. 2018 Mar 14. pii: S0264-410X(18)30349.
      PubMed     Text format     Abstract available
      
      
      
1244. ZHANG L, Yan B, Lv J, Liu J, et al
      Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in China.
      Vaccine. 2018 Mar 13. pii: S0264-410X(18)30213.
      PubMed     Text format     Abstract available
      
      
      
1245. NICHOLS MK, Andrew MK, Hatchette TF, Ambrose A, et al
      Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious
      Vaccine. 2018 Mar 13. pii: S0264-410X(18)30292.
      PubMed     Text format     Abstract available
      
      
      
1246. TETE SM, Jul-Larsen A, Rostami S, Lunde THF, et al
      Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
      Vaccine. 2018 Mar 13. pii: S0264-410X(18)30196.
      PubMed     Text format     Abstract available
      
      
      
1247. CHEN C, Beutels P, Newall AT
      Evolution over time in the cost-effectiveness of pneumococcal conjugate vaccine (PCV13) in older Australians due to herd protection from infant vaccination.
      Vaccine. 2018 Mar 13. pii: S0264-410X(18)30342.
      PubMed     Text format     Abstract available
      
      
      
1248. LIU T, Zhou Z, Tian X, Liu W, et al
      A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
      Vaccine. 2018 Mar 13. pii: S0264-410X(18)30237.
      PubMed     Text format     Abstract available
      
      
      
1249. KESHTKAR-JAHROMI M, Ouyang M, Keshtkarjahromi M, Almed S, et al
      Effect of influenza vaccine on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in older adults.
      Vaccine. 2018 Mar 13. pii: S0264-410X(17)31609.
      PubMed     Text format     Abstract available
      
      
      
1250. DE VLEESCHAUWER AR, Zhou X, Lefebvre DJ, Garnier A, et al
      A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
      Vaccine. 2018 Mar 12. pii: S0264-410X(18)30261.
      PubMed     Text format     Abstract available
      
      
      
1251. ATHERTON MJ, Stephenson KB, Nikota JK, Hu QN, et al
      Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer.
      Vaccine. 2018 Mar 12. pii: S0264-410X(18)30257.
      PubMed     Text format     Abstract available
      
      
      
1252. SANNEH B, Papa Sey A, Shah M, Tate J, et al
      Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia.
      Vaccine. 2018 Mar 12. pii: S0264-410X(18)30290.
      PubMed     Text format     Abstract available
      
      
      
1253. KOLE S, Kumari R, Anand D, Kumar S, et al
      Nanoconjugation of bicistronic DNA vaccine against Edwardsiella tarda using chitosan nanoparticles: Evaluation of its protective efficacy and immune modulatory effects in Labeo rohita vaccinated by different delivery routes.
      Vaccine. 2018 Mar 12. pii: S0264-410X(18)30298.
      PubMed     Text format     Abstract available
      
      
      
1254. ZHENG M, Jiang J, Zhang X, Wang N, et al
      Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
      Vaccine. 2018 Mar 12. pii: S0264-410X(18)30341.
      PubMed     Text format     Abstract available
      
      
      
1255. SALAMA II, Sami SM, Said ZN, Salama SI, et al
      Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
      Vaccine. 2018 Mar 9. pii: S0264-410X(18)30313.
      PubMed     Text format     Abstract available
      
      
      
1256. CASHMAN P, Moberley S, Durrheim D
      MMRV vaccine safety.
      Vaccine. 2018 Mar 8. pii: S0264-410X(18)30318.
      PubMed     Text format    
      
      
      
1257. RINTA-KOKKO H, Palmu AA, Auranen K, Nuorti JP, et al
      Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.
      Vaccine. 2018 Mar 8. pii: S0264-410X(18)30327.
      PubMed     Text format     Abstract available
      
      
      
1258. ORBEGOZO-MEDINA RA, Martinez-Sernandez V, Gonzalez-Warleta M, Castro-Hermida JA, et al
      Vaccination of sheep with Quil-A(R) adjuvant expands the antibody repertoire to the Fasciola MF6p/FhHDM-1 antigen and administered together impair the growth and antigen release of flukes.
      Vaccine. 2018 Mar 8. pii: S0264-410X(18)30325.
      PubMed     Text format     Abstract available
      
      
      
1259. ROWE SL, Tay EL, Franklin LJ, Stephens N, et al
      Effectiveness of parental cocooning as a vaccination strategy to prevent pertussis infection in infants: A case-control study.
      Vaccine. 2018 Mar 7. pii: S0264-410X(18)30293.
      PubMed     Text format     Abstract available
      
      
      
1260. VANNICE KS, Wilder-Smith A, Barrett ADT, Carrijo K, et al
      Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines.
      Vaccine. 2018 Mar 7. pii: S0264-410X(18)30249.
      PubMed     Text format     Abstract available
      
      
      
1261. RAMIREZ M, Santos S, Martinez O, Rodriguez R, et al
      Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA.
      Vaccine. 2018 Mar 7. pii: S0264-410X(18)30207.
      PubMed     Text format     Abstract available
      
      
      
1262. FERNANDEZ COTRINA J, Iniesta V, Monroy I, Baz V, et al
      A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend(R) against canine leishmaniosis.
      Vaccine. 2018 Mar 7. pii: S0264-410X(18)30321.
      PubMed     Text format     Abstract available
      
      
      
1263. RIKIN S, Jia H, Vargas CY, Castellanos de Belliard Y, et al
      Assessment of temporally-related acute respiratory illness following influenza vaccination.
      Vaccine. 2018 Mar 7. pii: S0264-410X(18)30315.
      PubMed     Text format     Abstract available
      
      
      
1264. VAN RIJN PA, Maris-Veldhuis MA, Potgieter CA, van Gennip RGP, et al
      African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
      Vaccine. 2018 Mar 7. pii: S0264-410X(18)30330.
      PubMed     Text format     Abstract available
      
      
      
1265. PERRETT S, Lesellier S, Rogers F, Williams GA, et al
      Assessment of the safety of Bacillus Calmette-Guerin vaccine administered orally to badgers (Meles meles).
      Vaccine. 2018 Mar 7. pii: S0264-410X(18)30311.
      PubMed     Text format     Abstract available
      
      
      
1266. ZHU B, Shi F, Zhang A, Sun X, et al
      Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China.
      Vaccine. 2018 Mar 7. pii: S0264-410X(18)30322.
      PubMed     Text format     Abstract available
      
      
      
1267. SCHOEPS A, Nebie E, Fisker AB, Sie A, et al
      No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial.
      Vaccine. 2018 Mar 6. pii: S0264-410X(18)30314.
      PubMed     Text format     Abstract available
      
      
      
1268. HERWEIJER E, Ploner A, Sparen P
      Substantially reduced incidence of genital warts in women and men six years after HPV vaccine availability in Sweden.
      Vaccine. 2018 Mar 6. pii: S0264-410X(18)30296.
      PubMed     Text format     Abstract available
      
      
      
1269. LI S, Wen G, Cao X, Guo D, et al
      Molecular characteristics of Streptococcus agalactiae in a mother-baby prospective cohort study: Implication for vaccine development and insights into vertical transmission.
      Vaccine. 2018 Mar 5. pii: S0264-410X(18)30319.
      PubMed     Text format     Abstract available
      
      
      
1270. SUNDARAM N, Duckett K, Yung CF, Thoon KC, et al
      "I wouldn't really believe statistics" - Challenges with influenza vaccine acceptance among healthcare workers in Singapore.
      Vaccine. 2018 Mar 5. pii: S0264-410X(18)30312.
      PubMed     Text format     Abstract available
      
      
      
1271. MOUTON L, Dekker A, Bleijenberg M, Blanchet M, et al
      A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
      Vaccine. 2018 Mar 3. pii: S0264-410X(18)30295.
      PubMed     Text format     Abstract available
      
      
      
1272. MEYNET E, Laurin D, Lenormand JL, Camara B, et al
      Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
      Vaccine. 2018 Mar 2. pii: S0264-410X(18)30214.
      PubMed     Text format     Abstract available
      
      
      
1273. WARD JK, Colgrove J, Verger P
      Why France is making eight new vaccines mandatory.
      Vaccine. 2018 Mar 2. pii: S0264-410X(18)30294.
      PubMed     Text format     Abstract available
      
      
      
1274. WATERS R, Ludi AB, Fowler VL, Wilsden G, et al
      Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage.
      Vaccine. 2018 Mar 2. pii: S0264-410X(18)30190.
      PubMed     Text format     Abstract available
      
      
      
1275. SURTEES TC, Teh BW, Slavin MA, Worth LJ, et al
      Factors contributing to declination of annual influenza vaccination by healthcare workers caring for cancer patients: An Australian experience.
      Vaccine. 2018 Mar 1. pii: S0264-410X(18)30297.
      PubMed     Text format     Abstract available
      
      
      
1276. CZAKO R, Vogel L, Sutton T, Matsuoka Y, et al
      H5N2 vaccine viruses on Russian and US live attenuated influenza virus backbones demonstrate similar infectivity, immunogenicity and protection in ferrets.
      Vaccine. 2018 Mar 1. pii: S0264-410X(18)30248.
      PubMed     Text format     Abstract available
      
      
      
1277. CUTLAND CL, Nolan T, Halperin SA, Kurugol Z, et al
      Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study.
      Vaccine. 2018 Mar 1. pii: S0264-410X(18)30187.
      PubMed     Text format     Abstract available
      
      
      
1278. PALMU AA, Jokinen J, Nieminen H, Rinta-Kokko H, et al
      Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial.
      Vaccine. 2018 Mar 1. pii: S0264-410X(18)30287.
      PubMed     Text format     Abstract available
      
      
      February 2018
1279. SAUL N, Wang K, Bag S, Baldwin H, et al
      Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study.
      Vaccine. 2018 Feb 28. pii: S0264-410X(18)30234.
      PubMed     Text format     Abstract available
      
      
      
1280. GUERRA FM, Crowcroft NS, Friedman L, Deeks SL, et al
      Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.
      Vaccine. 2018;36:1248-1255.
      PubMed     Text format     Abstract available
      
      
      
1281. NORHEIM G, Mueller JE, Njanpop-Lafourcade BM, Delrieu I, et al
      Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.
      Vaccine. 2018;36:1297-1303.
      PubMed     Text format     Abstract available
      
      
      
1282. OSOWICKI J, Vekemans J, Kaslow DC, Friede MH, et al
      WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12-13 December 2016.
      Vaccine. 2018 Feb 26. pii: S0264-410X(18)30255.
      PubMed     Text format     Abstract available
      
      
      
1283. NYON MP, Du L, Tseng CK, Seid CA, et al
      Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.
      Vaccine. 2018 Feb 26. pii: S0264-410X(18)30252.
      PubMed     Text format     Abstract available
      
      
      
1284. YAN S, Zhao J, Xie D, Huang X, et al
      Attenuation, safety, and efficacy of a QX-like infectious bronchitis virus serotype vaccine.
      Vaccine. 2018 Feb 26. pii: S0264-410X(18)30240.
      PubMed     Text format     Abstract available
      
      
      
1285. LAI H, Paul AM, Sun H, He J, et al
      A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
      Vaccine. 2018 Feb 26. pii: S0264-410X(18)30260.
      PubMed     Text format     Abstract available
      
      
      
1286. LALSIAMTHARA J, Senevirathne A, So MY, Lee JH, et al
      Safety implication of Salmonella based Brucella vaccine candidate in mice and in vitro human cell culture.
      Vaccine. 2018 Feb 24. pii: S0264-410X(18)30256.
      PubMed     Text format     Abstract available
      
      
      
1287. HEALY J, Rodriguez-Lainz A, Elam-Evans LD, Hill HA, et al
      Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps - National Immunization Survey-Teen, 2012-2014.
      Vaccine. 2018 Feb 23. pii: S0264-410X(18)30239.
      PubMed     Text format     Abstract available
      
      
      
1288. ARMITAGE EP, Camara J, Bah S, Forster AS, et al
      Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia.
      Vaccine. 2018 Feb 23. pii: S0264-410X(18)30211.
      PubMed     Text format     Abstract available
      
      
      
1289. ATTWELL K, Wiley KE, Waddington C, Leask J, et al
      Midwives' attitudes, beliefs and concerns about childhood vaccination: A review of the global literature.
      Vaccine. 2018 Feb 23. pii: S0264-410X(18)30202.
      PubMed     Text format     Abstract available
      
      
      
1290. SHAGHAGHI M, Soleyman-Jahi S, Abolhassani H, Yazdani R, et al
      New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.
      Vaccine. 2018 Feb 22. pii: S0264-410X(18)30246.
      PubMed     Text format     Abstract available
      
      
      
1291. HARE KM, Smith-Vaughan HC, Leach AJ, Pizzutto SJ, et al
      Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine.
      Vaccine. 2018 Feb 22. pii: S0264-410X(18)30241.
      PubMed     Text format     Abstract available
      
      
      
1292. DORJI K, Phuntsho S, Pempa, Kumluang S, et al
      Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option.
      Vaccine. 2018 Feb 22. pii: S0264-410X(18)30235.
      PubMed     Text format     Abstract available
      
      
      
1293. CHIA MY, Chung WY, Wang CH, Chang WH, et al
      Development of a high-growth enterovirus 71 vaccine candidate inducing cross-reactive neutralizing antibody responses.
      Vaccine. 2018;36:1167-1173.
      PubMed     Text format     Abstract available
      
      
      
1294. BRYDEN GM, Browne M, Rockloff M, Unsworth C, et al
      Anti-vaccination and pro-CAM attitudes both reflect magical beliefs about health.
      Vaccine. 2018;36:1227-1234.
      PubMed     Text format     Abstract available
      
      
      
1295. BAVDEKAR A, Oswal J, Ramanan PV, Aundhkar C, et al
      Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial.
      Vaccine. 2018;36:1220-1226.
      PubMed     Text format     Abstract available
      
      
      
1296. KING JP, McLean HQ, Meece JK, Levine MZ, et al
      Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
      Vaccine. 2018;36:1214-1219.
      PubMed     Text format     Abstract available
      
      
      
1297. WU W, Wang H, Li K, Pekka Nuorti J, et al
      Recipient vaccine-associated paralytic poliomyelitis in China, 2010-2015.
      Vaccine. 2018;36:1209-1213.
      PubMed     Text format     Abstract available
      
      
      
1298. YUE X, Black CL, O'Halloran A, Lu PJ, et al
      Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.
      Vaccine. 2018;36:1183-1189.
      PubMed     Text format     Abstract available
      
      
      
1299. PINHEIRO AF, Roloff BC, da Silveira Moreira A, Berne MEA, et al
      Identification of suitable adjuvant for vaccine formulation with the Neospora caninum antigen NcSRS2.
      Vaccine. 2018;36:1154-1159.
      PubMed     Text format     Abstract available
      
      
      
1300. WHITE KM, Ayllon J, Mena I, Potenski A, et al
      Influenza B virus reverse genetic backbones with improved growth properties in the EB66(R) cell line as basis for vaccine seed virus generation.
      Vaccine. 2018;36:1146-1153.
      PubMed     Text format     Abstract available
      
      
      
1301. MEDAGLINI D, De Azero MR, Leroy O, Bietrix F, et al
      Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow.
      Vaccine. 2018;36:1136-1145.
      PubMed     Text format     Abstract available
      
      
      
1302. ARANA JE, Harrington T, Cano M, Lewis P, et al
      Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
      Vaccine. 2018 Feb 21. pii: S0264-410X(18)30208.
      PubMed     Text format     Abstract available
      
      
      
1303. SALEEM AF, Yousafzai MT, Mach O, Khan A, et al
      Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan.
      Vaccine. 2018 Feb 21. pii: S0264-410X(18)30238.
      PubMed     Text format     Abstract available
      
      
      
1304. KHOURI JM, Motter RN, Arnon SS
      Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.
      Vaccine. 2018 Feb 20. pii: S0264-410X(18)30216.
      PubMed     Text format     Abstract available
      
      
      
1305. NAVIN MC, Kozak AT, Clark EC
      The evolution of immunization waiver education in Michigan: A qualitative study of vaccine educators.
      Vaccine. 2018 Feb 20. pii: S0264-410X(18)30233.
      PubMed     Text format     Abstract available
      
      
      
1306. BERNAU M, Liesner BG, Schwanitz S, Kraus AS, et al
      Vaccine safety testing using magnetic resonance imaging in suckling pigs.
      Vaccine. 2018 Feb 19. pii: S0264-410X(18)30199.
      PubMed     Text format     Abstract available
      
      
      
1307. KOVAC M, Lal H, Cunningham AL, Levin MJ, et al
      Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.
      Vaccine. 2018 Feb 17. pii: S0264-410X(18)30203.
      PubMed     Text format     Abstract available
      
      
      
1308. AKEDA Y, Koizumi Y, Takanami Y, Sumino S, et al
      Comparison of serum bactericidal and antibody titers induced by two Haemophilus influenzae type b conjugate vaccines: A phase III randomized double-blind study.
      Vaccine. 2018 Feb 16. pii: S0264-410X(18)30185.
      PubMed     Text format     Abstract available
      
      
      
1309. SHOUKAT A, Van Exan R, Moghadas SM
      Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype 'a'.
      Vaccine. 2018 Feb 16. pii: S0264-410X(18)30096.
      PubMed     Text format     Abstract available
      
      
      
1310. KUNTZ J, Crane B, Weinmann S, Naleway AL, et al
      Myocarditis and pericarditis are rare following live viral vaccinations in adults.
      Vaccine. 2018 Feb 15. pii: S0264-410X(18)30204.
      PubMed     Text format     Abstract available
      
      
      
1311. DJAGBARE MD, Yu L, Parupudi A, Sun J, et al
      Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
      Vaccine. 2018 Feb 15. pii: S0264-410X(18)30115.
      PubMed     Text format     Abstract available
      
      
      
1312. IBANEZ LI, Caldevilla CA, Paredes Rojas Y, Mattion N, et al
      Genetic and subunit vaccines based on the stem domain of the equine influenza hemagglutinin provide homosubtypic protection against heterologous strains.
      Vaccine. 2018 Feb 15. pii: S0264-410X(18)30193.
      PubMed     Text format     Abstract available
      
      
      
1313. SYCHEVA AL, Pogorelyy MV, Komech EA, Minervina AA, et al
      Quantitative profiling reveals minor changes of T cell receptor repertoire in response to subunit inactivated influenza vaccine.
      Vaccine. 2018 Feb 15. pii: S0264-410X(18)30201.
      PubMed     Text format     Abstract available
      
      
      
1314. JOHN S, Yuzhakov O, Woods A, Deterling J, et al
      Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.
      Vaccine. 2018 Feb 14. pii: S0264-410X(18)30063.
      PubMed     Text format     Abstract available
      
      
      
1315. MOUCHET J, Salvo F, Raschi E, Poluzzi E, et al
      Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.
      Vaccine. 2018 Feb 14. pii: S0264-410X(18)30210.
      PubMed     Text format     Abstract available
      
      
      
1316. AMERATUNGA R, Gillis D, Langguth D, Hawkes D, et al
      Ad hominem attacks on vaccine safety researchers.
      Vaccine. 2018 Feb 14. pii: S0264-410X(18)30102.
      PubMed     Text format    
      
      
      
1317. UTAZI CE, Thorley J, Alegana VA, Ferrari MJ, et al
      High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries.
      Vaccine. 2018 Feb 14. pii: S0264-410X(18)30194.
      PubMed     Text format     Abstract available
      
      
      
1318. LEI J, Balakrishnan MR, Gidudu JF, Zuber PLF, et al
      Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015.
      Vaccine. 2018 Feb 14. pii: S0264-410X(18)30186.
      PubMed     Text format     Abstract available
      
      
      
1319. KOURKOUNTI S, Retsas T, Paparizos V, Tsimpidakis A, et al
      Evaluation of a convenient vaccination schedule against hepatitis B in HIV-patients with undetectable HIV viral load.
      Vaccine. 2018 Feb 12. pii: S0264-410X(18)30192.
      PubMed     Text format     Abstract available
      
      
      
1320. NELSON NP, Yankey D, Singleton JA, Elam-Evans LD, et al
      Hepatitis A vaccination coverage among adolescents (13-17years) in the United States, 2008-2016.
      Vaccine. 2018 Feb 12. pii: S0264-410X(18)30163.
      PubMed     Text format     Abstract available
      
      
      
1321. SEDITA J, Perrella S, Morio M, Berbari M, et al
      Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats.
      Vaccine. 2018 Feb 12. pii: S0264-410X(18)30035.
      PubMed     Text format     Abstract available
      
      
      
1322. ATTWELL K, Smith DT, Ward PR
      'The Unhealthy Other': How vaccine rejecting parents construct the vaccinating mainstream.
      Vaccine. 2018 Feb 12. pii: S0264-410X(18)30149.
      PubMed     Text format     Abstract available
      
      
      
1323. LATASA P, Garcia-Comas L, Gil de Miguel A, Barranco MD, et al
      Effectiveness of acellular pertussis vaccine and evolution of pertussis incidence in the community of Madrid from 1998 to 2015.
      Vaccine. 2018 Feb 10. pii: S0264-410X(18)30143.
      PubMed     Text format     Abstract available
      
      
      
1324. NIELSEN CM, Vekemans J, Lievens M, Kester KE, et al
      RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype.
      Vaccine. 2018 Feb 10. pii: S0264-410X(18)30142.
      PubMed     Text format     Abstract available
      
      
      
1325. BAYER L, Fertey J, Ulbert S, Grunwald T, et al
      Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice.
      Vaccine. 2018 Feb 10. pii: S0264-410X(18)30188.
      PubMed     Text format     Abstract available
      
      
      
1326. PFAFF F, Muller T, Freuling CM, Fehlner-Gardiner C, et al
      In-depth genome analyses of viruses from vaccine-derived rabies cases and corresponding live-attenuated oral rabies vaccines.
      Vaccine. 2018 Feb 10. pii: S0264-410X(18)30156.
      PubMed     Text format     Abstract available
      
      
      
1327. ANIL K, Desai S, Bhamare C, Dharmadhikari A, et al
      Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adults.
      Vaccine. 2018 Feb 10. pii: S0264-410X(18)30198.
      PubMed     Text format     Abstract available
      
      
      
1328. SAGY I, Novack V, Gdalevich M, Greenberg D, et al
      Mass media effect on vaccines uptake during silent polio outbreak.
      Vaccine. 2018 Feb 10. pii: S0264-410X(18)30209.
      PubMed     Text format     Abstract available
      
      
      
1329. DANIEL P, Rodrigo C, Bewick T, Sheppard C, et al
      13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups.
      Vaccine. 2018 Feb 10. pii: S0264-410X(18)30169.
      PubMed     Text format     Abstract available
      
      
      
1330. DAWSON R, Lemmon K, Trivedi NJ, Hansen S, et al
      Improving human papilloma virus vaccination rates throughout military treatment facilities.
      Vaccine. 2018 Feb 9. pii: S0264-410X(18)30171.
      PubMed     Text format     Abstract available
      
      
      
1331. DEBRIE AS, Coutte L, Raze D, Mooi F, et al
      Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
      Vaccine. 2018 Feb 9. pii: S0264-410X(18)30191.
      PubMed     Text format     Abstract available
      
      
      
1332. NICKEL AJ, Puumala SE, Kharbanda AB
      Vaccine-preventable, hospitalizations among American Indian/Alaska Native children using the 2012 Kid's Inpatient Database.
      Vaccine. 2018;36:945-948.
      PubMed     Text format     Abstract available
      
      
      
1333. SCHAUT RG, Brewer MT, Mendoza K, Jackman J, et al
      A polyanhydride-based implantable single dose vaccine platform for long-term immunity.
      Vaccine. 2018;36:1024-1025.
      PubMed     Text format    
      
      
      
1334. SCHAUT RG, Brewer MT, Hostetter JM, Mendoza K, et al
      A single dose polyanhydride-based vaccine platform promotes and maintains anti-GnRH antibody titers.
      Vaccine. 2018;36:1016-1023.
      PubMed     Text format     Abstract available
      
      
      
1335. YUN KW, Lee HJ, Park JY, Cho HK, et al
      Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivat
      Vaccine. 2018 Feb 8. pii: S0264-410X(18)30148.
      PubMed     Text format     Abstract available
      
      
      
1336. MASTERS NB, Wagner AL, Carlson BF, Boulton ML, et al
      Vaccination timeliness and co-administration among Kenyan children.
      Vaccine. 2018 Feb 8. pii: S0264-410X(18)30165.
      PubMed     Text format     Abstract available
      
      
      
1337. PANDO R, Sharabi S, Mandelboim M
      Exceptional influenza morbidity in summer season of 2017 in Israel may predict the vaccine efficiency in the coming winter.
      Vaccine. 2018 Feb 8. pii: S0264-410X(18)30158.
      PubMed     Text format     Abstract available
      
      
      
1338. WILSON E, Zhu C, Galea S, Marko A, et al
      Turning up the heat: Effect of new vaccine for children's (VFC) program recommendations for use of temperature monitors upon incorrect product storage adverse event reporting.
      Vaccine. 2018 Feb 8. pii: S0264-410X(17)31467.
      PubMed     Text format     Abstract available
      
      
      
1339. SUAYA JA, Jiang Q, Scott DA, Gruber WC, et al
      Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults.
      Vaccine. 2018 Feb 8. pii: S0264-410X(18)30098.
      PubMed     Text format     Abstract available
      
      
      
1340. LIU X, Jiao C, Ma Y, Wang Q, et al
      A live attenuated Vibrio anguillarum vaccine induces efficient immunoprotection in Tiger puffer (Takifugu rubripes).
      Vaccine. 2018 Feb 8. pii: S0264-410X(18)30128.
      PubMed     Text format     Abstract available
      
      
      
1341. HUANG T, Liu Y, Li Y, Liao Y, et al
      Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5years of follow-up.
      Vaccine. 2018 Feb 7. pii: S0264-410X(18)30170.
      PubMed     Text format     Abstract available
      
      
      
1342. WIDDICE LE, Hoagland R, Callahan ST, Kahn JA, et al
      Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.
      Vaccine. 2018 Feb 7. pii: S0264-410X(17)31821.
      PubMed     Text format     Abstract available
      
      
      
1343. PEZZOTTI P, Bellino S, Prestinaci F, Iacchini S, et al
      The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015.
      Vaccine. 2018 Feb 7. pii: S0264-410X(18)30126.
      PubMed     Text format     Abstract available
      
      
      
1344. WANLAPAKORN N, Maertens K, Chaithongwongwatthana S, Srimuan D, et al
      Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women.
      Vaccine. 2018 Feb 6. pii: S0264-410X(18)30119.
      PubMed     Text format     Abstract available
      
      
      
1345. DE BEKKER-GROB EW, Veldwijk J, Jonker M, Donkers B, et al
      The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people: A discrete choice experiment.
      Vaccine. 2018 Feb 6. pii: S0264-410X(18)30103.
      PubMed     Text format     Abstract available
      
      
      
1346. LI Q, Peng O, Wu T, Xu Z, et al
      PED subunit vaccine based on COE domain replacement of flagellin domain D3 improved specific humoral and mucosal immunity in mice.
      Vaccine. 2018 Feb 6. pii: S0264-410X(18)30159.
      PubMed     Text format     Abstract available
      
      
      
1347. AJIBOLA O, Omoleke SA, Omisakin OA
      Current status of cerebrospinal meningitis and impact of the 2015 meningococcal C vaccination in Kebbi, Northwest Nigeria.
      Vaccine. 2018 Feb 6. pii: S0264-410X(18)30157.
      PubMed     Text format     Abstract available
      
      
      
1348. MARTIRE B, Azzari C, Badolato R, Canessa C, et al
      Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET).
      Vaccine. 2018 Feb 6. pii: S0264-410X(18)30121.
      PubMed     Text format     Abstract available
      
      
      
1349. KOECK JL, Auguste J, Floret D
      MesVaccins.net: A global, multi-functional and integrated platform for information and communication on vaccination.
      Vaccine. 2018 Feb 6. pii: S0264-410X(18)30147.
      PubMed     Text format    
      
      
      
1350. YANG YT, Reiss DR
      French mandatory vaccine policy.
      Vaccine. 2018 Feb 6. pii: S0264-410X(18)30146.
      PubMed     Text format    
      
      
      
1351. XIE Y, Wu J, Xu A, Ahmeqd S, et al
      Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice.
      Vaccine. 2018 Feb 5. pii: S0264-410X(18)30151.
      PubMed     Text format     Abstract available
      
      
      
1352. THOMPSON KM, Gellin BG, Hinman AR, Orenstein WA, et al
      The National Vaccine Advisory Committee at 30: Impact and opportunity.
      Vaccine. 2018 Feb 5. pii: S0264-410X(18)30129.
      PubMed     Text format     Abstract available
      
      
      
1353. VAN AALST S, Jansen MAA, Ludwig IS, van der Zee R, et al
      Routing dependent immune responses after experimental R848-adjuvated vaccination.
      Vaccine. 2018 Feb 3. pii: S0264-410X(18)30150.
      PubMed     Text format     Abstract available
      
      
      
1354. RUSSELL K, Chung JR, Monto AS, Martin ET, et al
      Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
      Vaccine. 2018 Feb 2. pii: S0264-410X(18)30094.
      PubMed     Text format     Abstract available
      
      
      
1355. SUN X, Wang F, Zheng H, Miao N, et al
      The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
      Vaccine. 2018 Feb 1. pii: S0264-410X(18)30092.
      PubMed     Text format     Abstract available
      
      
      
1356. ROBINSON C, Frykberg L, Flock M, Guss B, et al
      Strangvac: A recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi.
      Vaccine. 2018 Feb 1. pii: S0264-410X(18)30064.
      PubMed     Text format     Abstract available
      
      
      
1357. BERAN J, Lattanzi M, Xie F, Moraschini L, et al
      Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10years antibody persistence.
      Vaccine. 2018 Feb 1. pii: S0264-410X(18)30022.
      PubMed     Text format     Abstract available
      
      
      January 2018
1358. N'DIAYE DS, Launay O, Picone O, Tsatsaris V, et al
      Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.
      Vaccine. 2018 Jan 31. pii: S0264-410X(18)30091.
      PubMed     Text format     Abstract available
      
      
      
1359. TSOLENYANU E, Djadou KE, Fiawoo M, Akolly DAE, et al
      Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.
      Vaccine. 2018 Jan 31. pii: S0264-410X(18)30118.
      PubMed     Text format     Abstract available
      
      
      
1360. XING J, Zhou X, Tang X, Sheng X, et al
      FlaC supplemented with VAA, OmpK or OmpR as bivalent subunit vaccine candidates induce immune responses against Vibrio anguillarum in flounder (Paralichthys olivaceus).
      Vaccine. 2018 Jan 31. pii: S0264-410X(17)31717.
      PubMed     Text format     Abstract available
      
      
      
1361. CHEN C, Wood JG, Beutels P, Menzies R, et al
      The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia.
      Vaccine. 2018 Jan 30. pii: S0264-410X(18)30101.
      PubMed     Text format     Abstract available
      
      
      
1362. KRISHNASWAMY S, Wallace EM, Buttery J, Giles ML, et al
      Strategies to implement maternal vaccination: A comparison between standing orders for midwife delivery, a hospital based maternal immunisation service and primary care.
      Vaccine. 2018 Jan 30. pii: S0264-410X(18)30021.
      PubMed     Text format     Abstract available
      
      
      
1363. TROGDON JG, Shafer P, Lindsay B, Coyne-Beasley T, et al
      Impact of introduction of the 9-valent human papillomavirus vaccine on vaccination coverage of youth in North Carolina.
      Vaccine. 2018 Jan 29. pii: S0264-410X(18)30037.
      PubMed     Text format     Abstract available
      
      
      
1364. PEZZI C, McCulloch A, Joo H, Cochran J, et al
      Vaccine delivery to newly arrived refugees and estimated costs in selected U.S. clinics, 2015.
      Vaccine. 2018 Jan 26. pii: S0264-410X(17)31776.
      PubMed     Text format     Abstract available
      
      
      
1365. QAZI U, Malik S, Raza UA, Saad M, et al
      Compliance to timely vaccination in an Expanded Program on Immunization center of Pakistan.
      Vaccine. 2018 Jan 26. pii: S0264-410X(18)30093.
      PubMed     Text format     Abstract available
      
      
      
1366. VEKEMANS J, Moorthy V, Giersing B, Friede M, et al
      Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.
      Vaccine. 2018 Jan 25. pii: S0264-410X(17)31364.
      PubMed     Text format     Abstract available
      
      
      
1367. COOPER LV, Stuart JM, Okot C, Asiedu-Bekoe F, et al
      Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana.
      Vaccine. 2018 Jan 20. pii: S0264-410X(17)31832.
      PubMed     Text format     Abstract available
      
      
      
1368. LARTEY BL, Damanka S, Dennis FE, Enweronu-Laryea CC, et al
      Rotavirus strain distribution in Ghana pre- and post- rotavirus vaccine introduction.
      Vaccine. 2018 Jan 20. pii: S0264-410X(18)30034.
      PubMed     Text format     Abstract available
      
      
      
1369. VAN BEURDEN SJ, Berends AJ, Kramer-Kuhl A, Spekreijse D, et al
      Recombinant live attenuated avian coronavirus vaccines with deletions in the accessory genes 3ab and/or 5ab protect against infectious bronchitis in chickens.
      Vaccine. 2018 Jan 20. pii: S0264-410X(18)30051.
      PubMed     Text format     Abstract available
      
      
      
1370. HIRTH JM, Batuuka DN, Gross TT, Cofie L, et al
      Human papillomavirus vaccine motivators and barriers among community college students: Considerations for development of a successful vaccination program.
      Vaccine. 2018 Jan 20. pii: S0264-410X(18)30072.
      PubMed     Text format     Abstract available
      
      
      
1371. KAPLAN BS, Souza CK, Gauger PC, Stauft CB, et al
      Vaccination of pigs with a codon-pair bias de-optimized live attenuated influenza vaccine protects from homologous challenge.
      Vaccine. 2018 Jan 20. pii: S0264-410X(18)30061.
      PubMed     Text format     Abstract available
      
      
      
1372. LINDLEY MC, Hurley LP, Beaty BL, Allison MA, et al
      Vaccine financing and billing in practices serving adult patients: A follow-up survey.
      Vaccine. 2018 Jan 20. pii: S0264-410X(18)30039.
      PubMed     Text format     Abstract available
      
      
      
1373. TROGDON JG, Shafer P, Lindsay B, Coyne-Beasley T, et al
      Determinants of the receipt of the 9-valent human papillomavirus vaccine in the first year after introduction in North Carolina.
      Vaccine. 2018 Jan 20. pii: S0264-410X(18)30038.
      PubMed     Text format     Abstract available
      
      
      
1374. MARCHETTI S, Guzzetta G, Flem E, Mirinaviciute G, et al
      Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
      Vaccine. 2018 Jan 20. pii: S0264-410X(18)30073.
      PubMed     Text format     Abstract available
      
      
      
1375. KREIMER AR, Herrero R, Sampson JN, Porras C, et al
      Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.
      Vaccine. 2018 Jan 20. pii: S0264-410X(18)30018.
      PubMed     Text format     Abstract available
      
      
      
1376. HAN Y, Liu Q, Willias S, Liang K, et al
      A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
      Vaccine. 2018 Jan 18. pii: S0264-410X(18)30071.
      PubMed     Text format     Abstract available
      
      
      
1377. BARRERA J, Schutta C, Pisano M, Grubman MJ, et al
      Use of ENABL(R) adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
      Vaccine. 2018 Jan 18. pii: S0264-410X(18)30060.
      PubMed     Text format     Abstract available
      
      
      
1378. TAFURI S, Fortunato F, Gallone MS, Stefanizzi P, et al
      Systematic causality assessment of adverse events following HPV vaccines: Analysis of current data from Apulia region (Italy).
      Vaccine. 2018 Jan 18. pii: S0264-410X(18)30052.
      PubMed     Text format     Abstract available
      
      
      
1379. GARZA-CUARTERO L, Geurden T, Mahan SM, Hardham JM, et al
      Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
      Vaccine. 2018 Jan 17. pii: S0264-410X(18)30054.
      PubMed     Text format     Abstract available
      
      
      
1380. DE BOER PT, Kelso JK, Halder N, Nguyen TP, et al
      The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.
      Vaccine. 2018 Jan 17. pii: S0264-410X(17)31836.
      PubMed     Text format     Abstract available
      
      
      
1381. MORIMOTO N, Takeishi K
      Change in the efficacy of influenza vaccination after repeated inoculation under antigenic mismatch: A systematic review and meta-analysis.
      Vaccine. 2018 Jan 17. pii: S0264-410X(18)30057.
      PubMed     Text format     Abstract available
      
      
      
1382. PINTO LA, Dillner J, Beddows S, Unger ER, et al
      Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development.
      Vaccine. 2018 Jan 17. pii: S0264-410X(18)30020.
      PubMed     Text format     Abstract available
      
      
      
1383. SUGAYA N, Shinjoh M, Nakata Y, Tsunematsu K, et al
      Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016.
      Vaccine. 2018 Jan 17. pii: S0264-410X(18)30058.
      PubMed     Text format     Abstract available
      
      
      
1384. KOSTER S, Klevorn T, Papavinasasundaram K, Sassetti CM, et al
      Consequence of enhanced LC3-trafficking for a live, attenuated M. tuberculosis vaccine.
      Vaccine. 2018 Jan 15. pii: S0264-410X(18)30036.
      PubMed     Text format     Abstract available
      
      
      
1385. POULOS C, Curran D, Anastassopoulou A, De Moerlooze L, et al
      German travelers' preferences for travel vaccines assessed by a discrete choice experiment.
      Vaccine. 2018 Jan 12. pii: S0264-410X(18)30028.
      PubMed     Text format     Abstract available
      
      
      
1386. FORD AQ, Touchette N, Fenton Hall B, Hwang A, et al
      Meeting report: Global vaccine and immunization research forum.
      Vaccine. 2018 Jan 12. pii: S0264-410X(17)31753.
      PubMed     Text format     Abstract available
      
      
      
1387. ROERINK F, Morgan CL, Knetter SM, Passat MH, et al
      A novel inactivated vaccine against Lawsonia intracellularis induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function.
      Vaccine. 2018 Jan 11. pii: S0264-410X(17)31810.
      PubMed     Text format     Abstract available
      
      
      
1388. OMENACA F, Vazquez L, Garcia-Corbeira P, Mesaros N, et al
      Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.
      Vaccine. 2018 Jan 11. pii: S0264-410X(18)30029.
      PubMed     Text format     Abstract available
      
      
      
1389. ORELLANO P, Vezzani D, Quaranta N, Reynoso J, et al
      Estimation of expected dengue seroprevalence from passive epidemiological surveillance systems in selected areas of Argentina: A proxy to evaluate the applicability of dengue vaccination.
      Vaccine. 2018 Jan 11. pii: S0264-410X(18)30031.
      PubMed     Text format     Abstract available
      
      
      
1390. ORENSTEIN WA, Cairns L, Hinman A, Nkowane B, et al
      Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
      Vaccine. 2018;36 Suppl 1:A35-A42.
      PubMed     Text format     Abstract available
      
      
      
1391. ORENSTEIN WA, Hinman A, Nkowane B, Olive JM, et al
      Measles and Rubella Global Strategic Plan 2012-2020 midterm review.
      Vaccine. 2018;36 Suppl 1:A1-A34.
      PubMed     Text format     Abstract available
      
      
      
1392. MCREE AL, Shoben A, Bauermeister JA, Katz ML, et al
      Outsmart HPV: Acceptability and short-term effects of a web-based HPV vaccination intervention for young adult gay and bisexual men.
      Vaccine. 2018 Jan 10. pii: S0264-410X(18)30033.
      PubMed     Text format     Abstract available
      
      
      
1393. LU PJ, Srivastav A, Amaya A, Dever JA, et al
      Association of provider recommendation and offer and influenza vaccination among adults aged >/=18years - United States.
      Vaccine. 2018 Jan 9. pii: S0264-410X(17)31759.
      PubMed     Text format     Abstract available
      
      
      
1394. SHIM E, Smith KJ, Nowalk MP, Raviotta JM, et al
      Impact of seasonal influenza vaccination in the presence of vaccine interference.
      Vaccine. 2018 Jan 9. pii: S0264-410X(17)31830.
      PubMed     Text format     Abstract available
      
      
      
1395. GIAMBI C, Fabiani M, D'Ancona F, Ferrara L, et al
      Parental vaccine hesitancy in Italy - Results from a national survey.
      Vaccine. 2018 Jan 8. pii: S0264-410X(17)31837.
      PubMed     Text format     Abstract available
      
      
      
1396. JUNG MH, Nikapitiya C, Jung SJ
      DNA vaccine encoding myristoylated membrane protein (MMP) of rock bream iridovirus (RBIV) induces protective immunity in rock bream (Oplegnathus fasciatus).
      Vaccine. 2018 Jan 8. pii: S0264-410X(17)31840.
      PubMed     Text format     Abstract available
      
      
      
1397. VOS A, Freuling C, Ortmann S, Kretzschmar A, et al
      An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species.
      Vaccine. 2018 Jan 8. pii: S0264-410X(17)31839.
      PubMed     Text format     Abstract available
      
      
      
1398. SCHILLER J, Lowy D
      Explanations for the high potency of HPV prophylactic vaccines.
      Vaccine. 2018 Jan 8. pii: S0264-410X(18)30019.
      PubMed     Text format     Abstract available
      
      
      
1399. TAHA-ABDELAZIZ K, Hodgins DC, Alkie TN, Quinteiro-Filho W, et al
      Oral administration of PLGA-encapsulated CpG ODN and Campylobacter jejuni lysate reduces cecal colonization by Campylobacter jejuni in chickens.
      Vaccine. 2018;36:388-394.
      PubMed     Text format     Abstract available
      
      
      
1400. MCCARTY JM, Lock MD, Hunt KM, Simon JK, et al
      Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45.
      Vaccine. 2018 Jan 6. pii: S0264-410X(17)31823.
      PubMed     Text format     Abstract available
      
      
      
1401. SEAGLE EE, Bednarczyk RA, Hill T, Fiebelkorn AP, et al
      Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
      Vaccine. 2018 Jan 6. pii: S0264-410X(17)31838.
      PubMed     Text format     Abstract available
      
      
      
1402. BIEZEN R, Grando D, Mazza D, Brijnath B, et al
      Why do we not want to recommend influenza vaccination to young children? A qualitative study of Australian parents and primary care providers.
      Vaccine. 2018 Jan 5. pii: S0264-410X(17)31828.
      PubMed     Text format     Abstract available
      
      
      
1403. YANG F, Zhu Z, Cao W, Liu H, et al
      Immunogenicity and protective efficacy of an inactivated cell culture-derived Seneca Valley virus vaccine in pigs.
      Vaccine. 2018 Jan 5. pii: S0264-410X(17)31816.
      PubMed     Text format     Abstract available
      
      
      
1404. CISZEWSKI A
      Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases.
      Vaccine. 2018;36:202-206.
      PubMed     Text format     Abstract available
      
      
      
1405. PRZEDPELSKI A, Tepp WH, Zuverink M, Johnson EA, et al
      Enhancing toxin-based vaccines against botulism.
      Vaccine. 2018 Jan 4. pii: S0264-410X(17)31826.
      PubMed     Text format     Abstract available
      
      
      
1406. ADRIANI R, Mousavi Gargari SL, Nazarian S, Sarvary S, et al
      Immunogenicity of Vibrio cholerae outer membrane vesicles secreted at various environmental conditions.
      Vaccine. 2018;36:322-330.
      PubMed     Text format     Abstract available
      
      
      
1407. FRAWLEY JE, Foley H, McIntyre E
      The associations between medical, allied and complementary medicine practitioner visits and childhood vaccine uptake.
      Vaccine. 2018 Jan 3. pii: S0264-410X(17)31789.
      PubMed     Text format     Abstract available
      
      
      
1408. RAMIREZ A, Morris S, Maucourant S, D'Ascanio I, et al
      A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
      Vaccine. 2018 Jan 3. pii: S0264-410X(17)31814.
      PubMed     Text format     Abstract available
      
      
      
1409. HE Q, Gao H, Gao M, Qi S, et al
      Immunogenicity and safety of a novel tetanus toxoid-conjugated anti-gastrin vaccine in BALB/c mice.
      Vaccine. 2018 Jan 3. pii: S0264-410X(17)31815.
      PubMed     Text format     Abstract available
      
      
      
1410. WIDDICE LE, Unger ER, Panicker G, Hoagland R, et al
      Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.
      Vaccine. 2018 Jan 3. pii: S0264-410X(17)31795.
      PubMed     Text format     Abstract available
      
      
      
1411. BRYAN MA, Gunningham H, Moreno MA
      Content and accuracy of vaccine information on pediatrician blogs.
      Vaccine. 2018 Jan 2. pii: S0264-410X(17)31829.
      PubMed     Text format     Abstract available
      
      
      
1412. BREAKWELL L, Whaley M, Khan UI, Bandy U, et al
      Meningococcal carriage among a university student population - United States, 2015.
      Vaccine. 2018;36:29-35.
      PubMed     Text format     Abstract available
      
      
      
1413. PORTNOY A, Jit M, Helleringer S, Verguet S, et al
      Impact of measles supplementary immunization activities on reaching children missed by routine programs.
      Vaccine. 2018;36:170-178.
      PubMed     Text format     Abstract available
      
      
      
1414. SILVA MTO, Bezerra FSB, de Pinho RB, Begnini KR, et al
      Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
      Vaccine. 2018;36:74-83.
      PubMed     Text format     Abstract available
      
      
      December 2017
1415. DAI W, Zhang C, Zhang X, Xiong P, et al
      A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice.
      Vaccine. 2017 Dec 30. pii: S0264-410X(17)31818.
      PubMed     Text format     Abstract available
      
      
      
1416. TSUZUKI S, Schwehm M, Eichner M
      Simulation studies to assess the long-term effects of Japan's change from trivalent to quadrivalent influenza vaccination.
      Vaccine. 2017 Dec 29. pii: S0264-410X(17)31819.
      PubMed     Text format     Abstract available
      
      
      
1417. GUPTA A, Popowich S, Ojkic D, Kurukulasuriya S, et al
      Inactivated and live bivalent fowl adenovirus (FAdV8b+FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH).
      Vaccine. 2017 Dec 29. pii: S0264-410X(17)31808.
      PubMed     Text format     Abstract available
      
      
      
1418. BONKOUNGOU IJO, Aliabadi N, Leshem E, Kam M, et al
      Impact and effectiveness of pentavalent rotavirus vaccine in children <5years of age in Burkina Faso.
      Vaccine. 2017 Dec 28. pii: S0264-410X(17)31817.
      PubMed     Text format     Abstract available
      
      
      
1419. INGRAO F, Rauw F, Steensels M, van den Berg T, et al
      Early immune responses and profiling of cell-mediated immunity-associated gene expression in response to rHVT-IBD vaccination.
      Vaccine. 2017 Dec 28. pii: S0264-410X(17)31820.
      PubMed     Text format     Abstract available
      
      
      
1420. LI L, Fu J, Li S, Guo D, et al
      Phenotypic and molecular characterization of Streptococcus pneumoniae in pre-conjugate vaccine era: A Chinese hospital-based retrospective study.
      Vaccine. 2017 Dec 27. pii: S0264-410X(17)31824.
      PubMed     Text format     Abstract available
      
      
      
1421. SHAPIRO GK, Tatar O, Dube E, Amsel R, et al
      The vaccine hesitancy scale: Psychometric properties and validation.
      Vaccine. 2017 Dec 27. pii: S0264-410X(17)31796.
      PubMed     Text format     Abstract available
      
      
      
1422. JACKSON S, Lentino J, Kopp J, Murray L, et al
      Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
      Vaccine. 2017 Dec 27. pii: S0264-410X(17)31791.
      PubMed     Text format     Abstract available
      
      
      
1423. IZADI S, Zahraei SM, Salehi M, Mohammadi M, et al
      Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.
      Vaccine. 2017 Dec 27. pii: S0264-410X(17)31809.
      PubMed     Text format     Abstract available
      
      
      
1424. YANG YT, Shaw J
      Sudden infant death syndrome, attention-deficit/hyperactivity disorder and vaccines: Longitudinal population analyses.
      Vaccine. 2017 Dec 27. pii: S0264-410X(17)31827.
      PubMed     Text format     Abstract available
      
      
      
1425. JORGENSEN P, Mereckiene J, Cotter S, Johansen K, et al
      How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
      Vaccine. 2017 Dec 26. pii: S0264-410X(17)31762.
      PubMed     Text format     Abstract available
      
      
      
1426. DAVIDSON I, Natour-Altory A, Raibstein I, Kin E, et al
      Monitoring the uptake of live avian vaccines by their detection in feathers.
      Vaccine. 2017 Dec 26. pii: S0264-410X(17)31813.
      PubMed     Text format     Abstract available
      
      
      
1427. ZHANG H, Xu Y, Zhang Z, You J, et al
      Protective immunity of a Multivalent Vaccine Candidate against piglet diarrhea caused by enterotoxigenic Escherichia coli (ETEC) in a pig model.
      Vaccine. 2017 Dec 26. pii: S0264-410X(17)31779.
      PubMed     Text format     Abstract available
      
      
      
1428. GOUNDER PP, Bruden D, Rudolph K, Zulz T, et al
      Re-emergence of pneumococcal colonization by vaccine serotype 19F in persons aged >/=5 years after 13-valent pneumococcal conjugate vaccine introduction-Alaska, 2008-2013.
      Vaccine. 2017 Dec 23. pii: S0264-410X(17)31788.
      PubMed     Text format     Abstract available
      
      
      
1429. BASINSKI AJ, Varrelman TJ, Smithson MW, May RH, et al
      Evaluating the promise of recombinant transmissible vaccines.
      Vaccine. 2017 Dec 23. pii: S0264-410X(17)31790.
      PubMed     Text format     Abstract available
      
      
      
1430. LAZALDE GE, Gilkey MB, Kornides ML, McRee AL, et al
      Parent perceptions of dentists' role in HPV vaccination.
      Vaccine. 2017 Dec 23. pii: S0264-410X(17)31763.
      PubMed     Text format     Abstract available
      
      
      
1431. JACKSON LA, El Sahly HM, George S, Winokur P, et al
      Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
      Vaccine. 2017 Dec 23. pii: S0264-410X(17)31822.
      PubMed     Text format     Abstract available
      
      
      
1432. ZAMAN K, Zaman SF, Zaman F, Aziz A, et al
      Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase
      Vaccine. 2017 Dec 22. pii: S0264-410X(17)31787.
      PubMed     Text format     Abstract available
      
      
      
1433. ROECA C, Polotsky AJ
      Influenza vaccination in early pregnancy.
      Vaccine. 2017 Dec 21. pii: S0264-410X(17)31785.
      PubMed     Text format    
      
      
      
1434. GALLAGHER N, Jessop L, Sartaj M, Johnston J, et al
      Impact of live attenuated influenza vaccination programme for healthy children in Northern Ireland: A comparison of seven influenza seasons, 2010/11-2016/17.
      Vaccine. 2017 Dec 21. pii: S0264-410X(17)31730.
      PubMed     Text format     Abstract available
      
      
      
1435. REGAN AK, Moore HC, Sullivan SG
      Does influenza vaccination during early pregnancy really increase the risk of miscarriage?
      Vaccine. 2017 Dec 20. pii: S0264-410X(17)31786.
      PubMed     Text format    
      
      
      
1436. MELIDOU A, Broberg E
      Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition cons
      Vaccine. 2017 Dec 20. pii: S0264-410X(17)31792.
      PubMed     Text format    
      
      
      
1437. FEIRING B, Laake I, Trogstad L
      No conflicting results in the article "HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway".
      Vaccine. 2017;35:7082-7083.
      PubMed     Text format    
      
      
      
1438. ANDERSSON L
      Conflicting results in article describing "HPV-vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis".
      Vaccine. 2017;35:7081.
      PubMed     Text format    
      
      
      
1439. HOSHI SL, Kondo M, Okubo I
      Response to Curran and Mrkvan, Letter to the Editor: Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
      Vaccine. 2017;35:7080.
      PubMed     Text format    
      
      
      
1440. CURRAN D, Mrkvan T
      Response to publication by Hoshi SL et al.: Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
      Vaccine. 2017;35:7079.
      PubMed     Text format    
      
      
      
1441. VAN RENTERGHEM DM
      CAPiTA: The urine antigen detection (SSUAD) was not validated for PCV13 vaccinated patients.
      Vaccine. 2017;35:7077.
      PubMed     Text format    
      
      
      
1442. VISSER O, Hulscher MEJL, Antonise-Kamp L, Akkermans R, et al
      Assessing determinants of the intention to accept a pertussis cocooning vaccination: A survey among healthcare workers in maternity and paediatric care.
      Vaccine. 2017 Dec 18. pii: S0264-410X(17)31774.
      PubMed     Text format     Abstract available
      
      
      
1443. KABA SA, Karch CP, Seth L, Ferlez KMB, et al
      Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine.
      Vaccine. 2017 Dec 18. pii: S0264-410X(17)31728.
      PubMed     Text format     Abstract available
      
      
      
1444. TANG N, Zhang Y, Pedrera M, Chang P, et al
      A simple and rapid approach to develop recombinant avian herpesvirus vectored vaccines using CRISPR/Cas9 system.
      Vaccine. 2017 Dec 18. pii: S0264-410X(17)31778.
      PubMed     Text format     Abstract available
      
      
      
1445. SHIVE CL, Judge CJ, Clagett B, Kalayjian RC, et al
      Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.
      Vaccine. 2017 Dec 15. pii: S0264-410X(17)31761.
      PubMed     Text format     Abstract available
      
      
      
1446. CERNUSCHI T, Malvolti S, Nickels E, Friede M, et al
      Bacillus Calmette-Guerin (BCG) vaccine: A global assessment of demand and supply balance.
      Vaccine. 2017 Dec 15. pii: S0264-410X(17)31748.
      PubMed     Text format     Abstract available
      
      
      
1447. JACKSON ML, Phillips CH, Benoit J, Kiniry E, et al
      The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
      Vaccine. 2017 Dec 15. pii: S0264-410X(17)31775.
      PubMed     Text format     Abstract available
      
      
      
1448. JACKSON ML, Phillips CH, Benoit J, Jackson LA, et al
      Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.
      Vaccine. 2017 Dec 14. pii: S0264-410X(17)31755.
      PubMed     Text format     Abstract available
      
      
      
1449. ANDRADE AL, da Silva Vieira MA, Minamisava R, Toscano CM, et al
      Single-dose varicella vaccine effectiveness in Brazil: A case-control study.
      Vaccine. 2017 Dec 14. pii: S0264-410X(17)31751.
      PubMed     Text format     Abstract available
      
      
      
1450. FLOREK NW, Campos LM, Braun KM, McLean HQ, et al
      An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.
      Vaccine. 2017 Dec 14. pii: S0264-410X(17)31777.
      PubMed     Text format     Abstract available
      
      
      
1451. ROWELL J, Lo CY, Price GE, Misplon JA, et al
      Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.
      Vaccine. 2017 Dec 14. pii: S0264-410X(17)31676.
      PubMed     Text format     Abstract available
      
      
      
1452. LIPSITCH M, Li LM, Patterson S, Trammel J, et al
      Serotype-specific immune responses to pneumococcal conjugate vaccine among children are significantly correlated by individual: Analysis of randomized controlled trial data.
      Vaccine. 2017 Dec 13. pii: S0264-410X(17)31758.
      PubMed     Text format     Abstract available
      
      
      
1453. ASHBAUGH HR, Hoff NA, Doshi RH, Alfonso VH, et al
      Predictors of measles vaccination coverage among children 6-59months of age in the Democratic Republic of the Congo.
      Vaccine. 2017 Dec 13. pii: S0264-410X(17)31613.
      PubMed     Text format     Abstract available
      
      
      
1454. HIBBS BF, Miller E, Shi J, Smith K, et al
      Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012.
      Vaccine. 2017 Dec 13. pii: S0264-410X(17)31726.
      PubMed     Text format &